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1 Summary
The large isoforms of the Rab3 interacting molecule (RIM) family, RIM1α/β and RIM2α/β
are integral components of the cytomatrix of the presynaptic active zone. Through multiple
interactions with other active zone proteins they are involved in regulating several steps of
presynaptic neurotransmitter release. The RIM protein family contains two additional isoforms,
RIM3γ and RIM4γ, whose functions remain to be elucidated.
In this study we could show that RIM3γ and RIM4γ are key regulators in neuronal growth
involved in the establishment of axons and dendrites, formation of synapses and dendritic spines.
Furthermore, the loss of RIM3γ leads to a dispersion of the Golgi apparatus whereas the loss
of RIM4γ induces the condensation of the Golgi in the cell’s soma. These findings provide
first hints that the small γ-Rims are involved in neuronal growth by regulating processes of
vesicular traffic. Live cell imaging of Rab-protein marked vesicles in RIM3γ and RIM4γ knock-
down neurons revealed changes in the velocity and the path length of Rab11 and Rab8 vesicles,
confirming that the loss RIM3γ and RIM4γ has an effect on intracellular transport routes.
In an affinity purification mass spectrometry based search for novel γ-RIM interaction partners
we identified a large set of proteins that have been associated with neuronal growth through the
remodeling of the cytoskeleton or vesicular traffic and in addition a smaller group of synaptic
proteins. A comparison of the individual affinity purification mass spectrometry approaches
performed in different tissue fractions revealed that a cluster of new γ-RIM interaction partners
was repeatedly detected. This cluster contained proteins involved in the remodeling of the
cytoskeleton, site directed transport of vesicles and proteins that belong to signaling cascades
important for axonal and dendritic growth. We performed first validation experiments using in
vitro binding assays to decipherer the direct interactions of this complex. These experiments
confirmed in vitro an interaction between γ-RIMs and the cytoskeleton regulator IQGAP3, the
adhesion molecule plakophilin4 and Syd-1 an important initiator of synapse assembly.
To get further insights in the cellular functions of RIM3γ and RIM4γ we generated constitutive
knock-out mouse lines for both proteins. RIM3γ and RIM4γ knock-out mice are viable and
not distinguishable from wild type litters until 20 days after birth. Around an age of three
weeks RIM4γ knock-out mice develop a strong episodic motor phenotype, most prominent in
the hind limbs, whereas RIM3γ knock-out mice show no obvious phenotype. Behavioral tests
of motor coordination revealed that RIM4γ knock-out mice suffer also during phenotypic in-
conspicuous periods from milder coordinative disturbances suggesting impairments in cerebellar
functions. Interestingly, after the induction of neuronal activity in an animal model of epilepsy
RIM4γ transcripts were strongly upregulated in the hippocampus 12 hours after status epilepti-
cus whereas RIM3γ transcripts were downregulated in the hippocampal subregion dentate gyrus
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after 36 hours. These findings suggest that the γ-RIMs might be either involved in patholog-
ical changes occurring during epileptogenesis or in neuroprotective mechanisms in response to
increased network activity.
Taken together, the results of this study provide new insights into the function of RIM3γ and
RIM4γ in the development and the function of a healthy brain and form the basis for future
studies on the precise understanding of the role of RIM3γ and RIM4γ during the pathogenesis
of neurological disorders.
2 Introduction
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Introduction
Already in 1865 the German Neuroanatomist Otto Deiters described the three structurally
distinct compartments of a nerve cell: the cell body, which is continuous and has a variable
number of processes that frequently branch, ultimately get thinner and disappear. Besides
these numerous processes the neuron exhibits one major process which when it leaves the cell
body appears as a rigid hyaline mass. Today we refer to these processes as dendrites and axon.
The unique molecular composition and the morphological polarization of these structures gives
a neuron the ability to receive information by its dendrites, compute it, and deliver information
via its axon to other neurons or muscle cells. Since the times of Otto Deiters a lot of progress has
been made in the characterization of the physiological properties of axons and dendrites as well
as the general cellular mechanisms, which enable the neuron to form these highly specialized
compartments. Neuronal growth involves remodeling of the cytoskeleton, as well as synthesis,
transport, and integration of membrane, lipids and proteins in a highly organized manner. Every
compartment has its unique composition which allows the neuron to process information in a
fast and precise manner. However, as much as we understood of the great picture of these
mechanisms as little we understand of the precise molecular pathways and especially how they
converge together.
2.1 Neuronal growth: establishment of axons and dendrites
2.1.1 Remodeling of the cytoskeleton during neuronal growth
The cytoskeleton provides structure and stability to the cell, but it is in no way just a rigid
and stable scaffold. At least in parts the cytoskeleton is constantly destroyed, renewed, or
newly constructed, making it a highly dynamic structure. These dynamic properties enable
the cytoskeleton to participate in and to regulate multiple cellular processes [Gardner et al.,
2013, Edwards et al., 2014]. The expansion of the cytoskeleton determines the cells size and
shape. Remodeling of the cytoskeleton regulates formation and structural organization of cel-
lular organelles [de Forges et al., 2012, Pollard & Cooper, 2009]. Furthermore, the cytoskeleton
serves as a scaffold along which proteins and cellular organelles are transported throughout the
cell [Schliwa, 2006]. The filamentous structure of the cytoskeleton is build up by intermediate fil-
aments, microtubules and actin filaments. Structural variability and dynamics of these filaments
is provided by hundreds of accessory proteins, which converge extrinsic and intrinsic signals on
the cytoskeleton and regulate assembly and location of the different filamentous components
[Wickstead & Gull, 2011].
10
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2.1.1.1 Regulation of the actin cytoskeleton during neuronal growth
Forward movement and extension of neuronal branches take place at the growing tip of a neurite
the so-called growth cone. The growth cone forms a hand like structure, in which actin is
localized at the outline of the finger like fine tips followed by microtubules reaching from the
cells soma into the center of growth cone. Remodeling of F-actin leads to local instability of the
actin network and allows microtubules and other protein to enter the growth cone, leading to
an extension of the neuronal branch [Witte & Bradke, 2008].
Important regulators of the actin cytoskeleton during neuronal growth are the three members of
the Rho family of small GTPases, RhoA, CDC42 and Rac1. Rac1 and CDC42 have been shown
to be mainly growth promoting, whereas RhoA has rather growth inhibitory effects [Luo, 2000].
Rac1 regulates actin dynamics through two major downstream effectors, the WAVE complex
and p21-activated kinase (PAK) [Miki et al., 1998, Burridge & Wennerberg, 2004]. Rac1 activa-
tion of the WAVE complex leads to actin polymerization through the Arp2/3 complex [Govek
et al., 2005], whereas the activation of PAK leads to the phosphorylation of Cofillin, an actin
depolymerization factor, shown to be involved in neurite formation [Arber et al., 1998, Edwards
et al., 1999, Meberg & Bamburg, 2000]. This shows, that both actin polymerization and de-
polymerization are important for neuronal growth. The balance of actin polymerization and
depolymerization allows the neuron to remodel and also elongate the cytoskeleton simultane-
ously in an appropriate fashion. This also explains why actin polymerization or depolymerization
can on the one hand be growth promotive and on the other hand growth inhibitory.
CDC42, like Rac1, regulates actin dynamics through the Arp2/3 complex and phosphorylation
of cofilin. CDC42 deficient neurons exhibit defects in axon formation and reduced neurite length
[Garvalov et al., 2007, Rohatgi et al., 1999, Rohatgi et al., 2000].
RhoA is mainly suggested to be growth inhibitory but contradicting findings on RhoA’s function
during neuronal growth have been reported. Two major downstream effectors of RhoA involved
in neuronal growth are ROCK, a member of the Rho Kinase family, and a formin related
protein, mammalian diaphanous (mDia) [Leung et al., 1996, Watanabe et al., 1997, Amano
et al., 1996]. ROCK regulates actin bundling and accumulation of actin filaments and has
been shown to mediate RhoA signaling during dendrite retraction and the inhibition of axon
initiation [Nakayama et al., 2000, Bito et al., 2000, Amano et al., 1996]. mDia was suggested to
initiate actin nucleation by binding to free actin monomers [Li & Higgs, 2003, Higashida et al.,
2004]. However, in contrast to ROCK mDia was suggested to promote axongenesis, which could
explain how RhoA is growth inhibitory or supportive [Arakawa et al., 2003]. Taken together,
tight temporal and spatial control of actin dynamics is an important mechanism for a neuron
to specifically regulate the different steps of dendritic and axonal growth.
2.1.1.2 Microtubule remodeling during neuronal development
Microtubules are the second group of cytoskeletal filaments playing an important role in the reg-
ulation of neuronal growth. Microtubules grow as hollow tubes and rapidly switch from growth
to shrinkage (catastrophes) and shrinkage to growth (rescue). Thus microtubules never attain a
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steady state length but exist either in a growing (polymerization) phase or a shrinking phase (de-
polymerization) [Burbank & Mitchison, 2006]. This dynamic instability allows microtubules to
rapidly reorganize and differentiate spatially and temporarily in accordance to the cells context
[Kirschner & Mitchison, 1986]. Ultrastructural analysis showed that microtubules form parallel
bundles in axons and dendrites, which extend during neuronal growth [Yamada et al., 1971].
Additionally, pharmacological studies revealed that microtubule depolymerizing drugs inhibit
growth and lead to neurite retraction [Daniels, 1973]. However, microtubule organization differs
between axons and dendrites. Axonal microtubules show a uniform orientation and are comple-
mented by the microtubule associated protein (MAP) tau whereas dendritic microtubules show
a mixed orientation and are complemented by the microtubule associated protein MAP2 [Fer-
reira et al., 1989]. Tau has been shown to be required for axon formation and growth [Dawson
et al., 2001, DiTella et al., 1996, Takei et al., 2000]. Besides stabilizing microtubules itself, tau
also protects microtubules from depolymerization and interacts with components of the actin
cytoskeleton during stimulated neurite outgrowth [Yu & Rasenick, 2006, Sharma et al., 2007].
In dendrites MAP2 binds along the side of microtubules and contributes to their stabilization
by crosslinking adjacent microtubules. Overexpression of MAP2 in non-neuronal cells leads to
the growth of dendritic like processes, whereas depletion of MAP2 in primary neuronal cultures
inhibits neurite formation [LeClerc et al., 1993, Caceres et al., 1992]. Aditionally, MAP2 was
also suggested to link the rough endoplasmic reticulum to microtubules of dendrites and thereby
to contribute to the differential expression of organelles in axons and dendrites [Farah et al.,
2005].
One specialized class of microtubule associated proteins are the microtubule plus end tracking
proteins (+TIPs). +TIPs show a high affinity to the plus end of polymerizing microtubules and
are involved in the control of microtubule dynamics, growth directionality, interactions with
other cytoskeletal components and correct positioning of organelles, receptors, and channels.
Therefore +TIPs are important regulators of neuronal growth during development and of neu-
ronal communication in mature neurons [Jaworski et al., 2008, Temburni et al., 2004, Williams
et al., 2004, Gu et al., 2006]. The first identified microtubule plus end tracking protein is the
cytoplasmic linker protein 170 (CLIP170). Interactions between CLIP170 and the IQ-motif
GTPase-activating protein 1 (IQGAP1), an actin binding protein, provide a possible link be-
tween microtubules and the actin cytoskeleton [Fukata et al., 2002, Watanabe et al., 2004].
IQGAP1 interacts additionally with the microtubule plus end tracking protein CLASP2 pro-
viding a further link between microtubules and the actin cytoskeleton [Watanabe et al., 2009].
Neurons deficient for CLASP2 show impairments in axon elongation and reductions in dendritic
branch length. The overexpression of CLASP2 on the other hand leads to formation of multiple
axons and enhanced dendritogenesis [Beffert et al., 2012]. These findings shows that the correct
interplay between microtubules and actin and the concomitant distribution of organelles and
proteins are important for neuronal growth, polarization and function.
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2.1.2 Membrane transport processes during neuronal growth
The elongation of axons and dendrites requires, besides structural changes associated with the
cytoskeleton, the addition of an enormous amount of new plasma membrane in order to carry
out the vast increase in the neuronal surface area. The plasma membrane of a mature neuron
can reach a surface area of about 250,000μm2 and is thereby the neuron’s biggest organ. Its
correct polarized composition of lipids and proteins is fundamental for the neuron’s function of
receiving and propagating electrical signals. During neuronal growth new membrane is synthe-
sized, equipped with differential sets of proteins and lipids, transported by site specific carriers
and finally targeted to the place of destination, where fusion with the plasma membrane occurs
[Horton et al., 2003, Pfenninger, 2009].
2.1.2.1 Controlled transport of membrane: RAB proteins
Members of the Rab protein family of small GTPases are hypothesized to act as intracellular
’cargo address labels’ of vesicular membrane transport in neuronal and non-neuronal cells. With
over 60 family members in mammals, Rab proteins constitute the largest family of small GTPases
[Klöpper et al., 2012, Zerial & McBride, 2001]. Rab proteins function as molecular switches,
by cycling between a GTP bound active form and a GDP bound inactive form. The activity
status of Rab proteins, is regulated by guanine exchange factors (GEFs) and GTPase activating
proteins (GAPs). GEFs are activators of Rab proteins; by binding to the GTPase they reduce
its affinity for GDP and promote the exchange from GDP to GTP. GTPase activating proteins
on the other hand serve as negative regulators; they increase the intrinsic GTPase activity of the
Rab protein and accelerate the conversion of the GTP bound active to the GDP bound inactive
form [Barr & Lambright, 2010]. The spatial and temporal distribution of GEFs and GAPs and
numerous additional Rab effector proteins including motor proteins and tethering complexes,
allows Rab GTPases to govern various steps in membrane trafficking, including vesicle budding,
vesicle movement, site specific vesicle docking and vesicle fusion [Jordens et al., 2005, Grosshans
et al., 2006].
In neurons, proteins and lipids are synthesized by the endoplasmic reticulum and subsequently
transported to the Golgi apparatus, from where they are distributed either directly to the
plasma membrane or further to the different compartments of the endsosome. The endosome
is composed of three different kinds of vesicular compartments, the early, the late, and the
recycling endosome [Bard & Malhotra, 2006, De Matteis & Luini, 2008, Horton & Ehlers, 2003].
Vesicles endocytosed by the plasma membrane are first transported to the early endosome, from
where proteins targeted to degradation move to the late endosome and further to the lysosome,
whereas other proteins are transported to the recycling endosome for eventual reinsertion into
the plasma membrane. Additionally, all three endosomal compartments receive vesicles from and
send vesicles back to the trans-Golgi network [Maxfield & McGraw, 2004] (Fig 2.1). Several Rab
proteins have been implicated in regulating the various vesicular transport routes between the
different secretory compartments have been shown to be crucial for neuronal growth [Villarroel-
Campos et al., 2014].
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Figure 2.1: Vesicular transport throughout the neuron is regulated by Rab proteins. Schematic rep-
resentation of the various transport routes and associated Rab proteins. In the soma of the cell the endoplasmic
reticulum (ER) sends proteins to the Golgi apparatus from there cargo vesicles are distributed to the endosomal
compartments the early endosome (EE), the late endosome (LE) and the recycling endosome (RE) or directly
to the plasma membrane. At the plasma membrane proteins can be endocytosed and transported to the early
endosome from where they are sorted either to the late endosome for degradation or to the recycling endosome
for eventual reinsertion.
Among the Rab GTPases present at the trans-Golgi network, Rab6 might play a role in neu-
rite outgrowth by regulating intra-Golgi traffic and trafficking from the Golgi to the plasma
membrane [Martinez et al., 1994, Grigoriev et al., 2007]. Both, knock-down of Rab6 in hip-
pocampal cultures and overexpression of the Rab6 negative regulator Bicaudal-D related protein
1 (BICDR-1) reduces total neurite length. BICDR-1 inhibits the trafficking of Rab6 positive
vesicles to the cell periphery, supporting the idea that Rab6 mediated exocytic traffic towards
the plasma membrane is involved in the membrane addition during neuronal growth [Schlager
et al., 2010].
Rab8 another important regulator of the trans-Golgi network is recruited to exocytic vesicles by
Rab6 [Grigoriev et al., 2011]. Additionally, Rab8 localizes to the recycling endosome, suggesting
that Rab8 might be involved in several aspects of membrane trafficking important for neurite
formation. Indeed, antisense suppression of Rab8 in neuronal cultures prevented initial neurite
outgrowth and concentrated vesicles of the trans-Golgi-network, originally destined to the axon
in the cell body. These data suggest, that Rab8 might function in neurite outgrowth by support-
ing exocytic traffic from the trans-Golgi network. Overexpression of Rab8 in fibroblasts, leads
to the formation of neurite like protrusions and relocalization of actin filaments towards these
protrusions. This effect is probably dependent on the recycling activity of Rab8 as it involves
the movement of vesicular structures from the plasma membrane to the cell center and back to
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the leading edge [Huber et al., 1995, Hattula et al., 2006].
Besides the Golgi apparatus, the endosome acts as an important regulatory unit of membrane
traffic. In contrast to the Golgi, which sends out newly synthesized proteins to the plasma
membrane, the endosome receives vesicles form the cell surface membrane and recycles them
or routes them to degradation. This enables the endosome to control the density of receptors
and other signaling molecules at the plasma membrane during establishment of the different
functional compartments of a neuron but also in response to growth promoting signals or changes
due to neuronal activity. Rab5 is a key regulator of the early endocytic pathway; it controls
vesicle transport from the plasma membrane to the early endosomes as well as vesicle fusion
within the early endosome [Zerial & McBride, 2001]. Studies of Rab5-GFP localization and
movement in Drosophila melanogaster dendritic arborization (da) neurons showed, that Rab5
positive endocytic vesicles are transported out into dendrites. Further inhibition of Rab5 positive
vesicle transport out into dendrites in dynein mutant Drosophila da-neurons leads to drastically
reduced dendritic arbor complexity. In addition the knock-down of Rab5 simplified dendritic
branching. Indicating, that Rab5 controlled endocytic traffic in dendrites might be important to
induce dendritic branching [Satoh et al., 2008]. In hippocampal neurons knock-down of Rab5 or
its upstream regulator Rabex-5 impairs not only dendritic but also axonal growth [Mori et al.,
2013].
The recycling endosome serves as an important source of membrane during neurite extension.
Additionally it regulates the availability and surface distribution of endocytosed plasma mem-
brane receptors and thereby also the associated signaling pathways. This makes the recycling
endosome to an ideal regulator of locally induced neurite branching and elongation [Platta &
Stenmark, 2011, Yap & Winckler, 2012]. Rab11 is a well-known regulator of the recycling en-
dosome, suggested to control the traffic of endocytic vesicles from the plasma membrane to the
recycling endosome and from the recycling compartment back to the plasma membrane [Ullrich
et al., 1996, Sönnichsen et al., 2000, Takahashi et al., 2012]. During neuronal growth Rab11
seems to be involved in axon and dendrite elongation and dendritic branching [Brown et al.,
2007, Park et al., 2004, Kawauchi et al., 2010]. Overexpression of Rab11 in cortical neuronal
cultures promotes axon growth and increases axon length. Consistently, knock-down of Rab11
or expression of a dominant negative version lead to the opposing effect and decrease the axonal
length [Takano et al., 2012]. Further blocking the transport of Rab11 positive vesicles out into
dendrites impairs dendritic elongation and branching [Takano et al., 2014a].
In summary, transport of newly synthesized membrane and its correct delivery to sites of neu-
ronal outgrowth is primarily essential for the vast increase in neuronal surface area during neu-
ronal growth. Control of the protein and lipid composition of the newly inserted membrane parts
allows the neuron to create specialized neuronal subcompartments with divergent biochemical
composition and function.
2.1.2.2 Site specific fusion: The Exocyst complex
In addition to mechanisms, which control the traffic of vesicles between the different organelles of
membranous transport and the composition of cargo vesicles, it is important that the transported
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vesicles are targeted to sites where new membrane and proteins are needed. The tethering of
transport vesicles to their desired destination is mediated in many cases by the Exocyst complex.
The Exocyst complex is an octameric protein complex of Rab effectors thought to mediate the
initial interaction between transport vesicles and the acceptor membrane and therefore tether
vesicles to their correct fusion sites. The Exocyst complex is highly conserved from yeast to
mammals and made up of the eight tightly associated proteins Sec3, Sec5, Sec6, Sec8, Sec10,
Sec15, Exo70, and Exo84 [Hsu et al., 1996, Hsu et al., 1999, TerBush et al., 1996]. In budding
yeast all Exocyst components localize to the growing end of a daughter cell, but their targeting
to the desired site of membrane insertion differs. Sec3 localization to the bud tip is independent
from actin cables, along which vesicles are transported. Similarly Exo70 seems to only partially
depend on actin cables. In contrast all other Exocyst components are associated with exocytic
vesicles and their delivery to the site of membrane insertion is dependent on actin cables. This
indicates, that Sec3 and Exo70 are associated with the plasma membrane and interact with the
other Exocyst component on the arriving vesicles (Fig 2.2). Thus the assembly of the Exocyst
complex could tether arriving transport vesicles to correct fusion sites at the plasma membrane
[Boyd et al., 2004, Zhang et al., 2005].
Figure 2.2: Exocyst complex assembly at the plasma membrane. Exo70 and Sec3 are directly associated with
the plasma membrane whereas the other exocyst subunits are localized on arriving secretory vesicles. Exo70 and
Sec3 interact with the other exocyst subunits and target thereby the secretory vesicles to the correct fusion site
(modified from He et al., 2007).
Data from primary hippocampal neurons suggest, that the localization of the Exocyst complex
to sites of membrane extension also holds true for neurons [Hazuka et al., 1999]. Furthermore the
expression of dominant negative Sec8 or Sec10 impairs neurite outgrowth in PC12 cells and Sec5
Drosophila mutants show impairments in neurite extension [Vega & Hsu, 2001, Murthy et al.,
2003]. These studies gave first evidence that Exocyst components are involved in directing
membrane addition during neuronal growth. Exo70 was shown to be involved in the regulation
of neuronal growth during neurite outgrowth in PC12 cells and axonal growth and polarization
of hippocampal cultures in cooperation with the small GTPase TC10 [Pommereit & Wouters,
2007, Dupraz et al., 2009]. TC10 localizes to transport vesicles positive for Rab11, which plays a
central role in regulating recycling pathways at the sites of neuronal growth. Therefore TC10’s
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interaction with Exo70 and Rab11 can connect specialized transport routes to site specific vesicle
tethering. This emphasizes the importance of both protein families the Rabs as transport cargo
labels to direct vesicles to correct pathways and areas where their cargo might be needed and
the Exocyst family as recruiters at the sites where fusion should take place [Fujita et al., 2013].
2.1.3 Synaptic proteins in neuronal growth and development
Synapses are highly specialized subcompartments of axons and dendrites. They are intercellular
junctions constituting the main site of communication between neurons and their target cells,
where information is send from the presynaptic neuron to the postsynaptic cell. Synaptogenesis
like neurite outgrowth relies on cytoskeletal remodeling as well as on the transport and site
specific delivery of its protein and membrane complement. Cell adhesion molecules at both sites
of the synapse link the two cells to each other and initiate the first contact. Later, specific pre-
and postsynaptic proteins regulate the establishment of specialized protein networks at both
sides of the newly forming synapse. Before a new synapse can be formed, neurons need to
grow out axons and dendrites to reach their future synaptic partner cell. Interestingly, several
proteins playing an important role in synapse formation have been shown to be also involved in
general axonal or dendritic growth early in neuronal development.
One important presynaptic cell adhesion molecule, with a suggested dual role in dendritic devel-
opment, is neurexin. Together with its postsynaptic interaction partner neuroligin, neurexin is
involved in mediating the initial contact between the pre- and the postsynaptic cell and also the
subsequent formation of pre- and postsynaptic compartments [Scheiffele et al., 2000, Graf et al.,
2006]. In primary cultures of dissociated neurons, neurexin and neuroligin are expressed already
before synapse formation, indicating that they might be involved in neuronal development. Fur-
ther overexpression experiments of neuroligin in primary hippocampal neurons showed, that
neuroligin can induce neurite outgrowth and elongation through its interaction with neurexin
[?].
Another Synaptic protein with a suggested role in neuronal development is Liprin-α. Liprin-α
is a key regulator in the assembly of the pre- and postsynaptic protein network. It’s presynap-
tic function was suggested by the observation that mutants in the C.elegans Liprin-α homolog
SYD-2 show an abnormal diffuse distribution of presynaptic markers, widening of presynaptic
neurotransmitter release sites and impaired synaptic transmission [Zhen & Jin, 1999]. A function
for liprin-α in dendritic growth and development was suggested by several studies. In cooper-
ation with the leukocyte common antigen-related (LAR) family of receptor protein tyrosine
phosphatases (LAR-RPTPs) Liprin-α targets the cell adhesion molecule β-catenin to dendrites
promoting dendritic spine development and maintenance [Dunah et al., 2005]. Furthermore, it
was shown that knock-down of LAR and disruption of the LAR-Liprin-α interaction leads to a
strong simplification of the dendritic arbor in cultured hippocampal neurons [Hoogenraad et al.,
2007]. The Liprin-α interaction partner GRIP1 has been proposed to regulate the targeting of
newly synthesized synaptic proteins, like AMPA receptors and the EphB2 receptors from the
Golgi apparatus to developing dendrites and thereby support dendritic growth. Concomitantly,
knock-down of GRIP1 in hippocampal cultures leads to a reduction in the length of primary
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dendrites. This indicates, that GRIP1 and Liprin-α could be involved in the regulation of den-
dritic growth by targeting proteins which locally induce dendrite formation and growth to the
correct transport complexes [Wyszynski et al., 2002, Hoogenraad et al., 2005].
In summary synaptic proteins are not only important for synaptic signaling, but might also
be involved in the regulation of neuronal growth by preassembling cargo complexes of synaptic
proteins in the cell body and directing them to the correct transport routes. Additionally,
synaptic proteins might be important to locally induce and promote growth and regulate thereby
the fine-tuning of neuronal networks.
2.1.4 Transcriptional regulation of neuronal growth
Cellular processes like growth and development depend on the regulated expression of specific
subsets of proteins, which initiate growth promoting signaling cascades and cellular processes
necessary for neuronal growth. Protein expression patterns are mainly governed by the tran-
scriptional regulation of gene expression making transcriptional programs a driving force of
neuronal growth. Transcription factors can govern entire cell intrinsic developmental programs,
direct distinct stages of neuronal development and alter the neurons ability to respond to ex-
trinsic growth promoting signals. Already the expression of one set of transcription factors can
determine the specific morphology and projection patterns of a single neuron [Arlotta et al.,
2005, Molyneaux et al., 2007, Polleux et al., 2007]. Accordingly, the FOXO transcription factors
have been discovered to regulate polarization during the early steps of neuronal development.
FOXO transcription factors regulate the expression of a whole set of polarity associated genes
involved in cytoskeleton remodeling and protein transport. Knock-down of FOXO by RNA
interference in granule cell cultures leads to non-polarized neurons, unable to establish the mor-
phological distinct axonal and dendritic branches [de la Torre-Ubieta et al., 2010].
Transcriptional factors regulating axonal growth of granule cell neurons are the transcription
factors SnoN and Id2. Both transcription factors are targets of the CdH1-APC E3 ubiquitin
ligase, which targets them to degradation and thereby restricts axonal growth [Stegmüller et al.,
2006, Lasorella et al., 2006]. SnoN drives axon growth by triggering the expression of regulators
of the actin cytoskeleton [Ikeuchi et al., 2009]. Id2 on the other hand is thought to promote
axon growth by antagonizing the function of transcription factors, which are involved in axon
repulsion [Lasorella et al., 2006].
Several transcription factors have been implicated in dendritic growth [de la Torre-Ubieta &
Bonni, 2011]. For example the transcription factor NeuroD was shown to stimulate dendritic
growth and arborization. Knock-down of NeuroD in granule cell cultures reduced dendritic
length, but had no effect on axonal growth [Gaudilliere et al., 2004]. Furthermore, NeuroD defi-
cient mice exhibit granule cells with shorter dendrites and impaired cerebellar and hippocampal
brain development [Miyata et al., 1999]. One important feature of the transcriptional regulation
of dendritic growth is its modulation by Ca2+-signaling and consequently by neuronal activity.
NeuroD has been shown to be phosphorylated by the activity-regulated kinase CamKII. Strik-
ingly, phosphorylation of NeuroD triggers NeuroD dependent transcription and dendritic growth
[Gaudilliere et al., 2004].
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Taken together, different transcriptional programs regulate dendritic and axonal growth in their
distinct developmental stages of initial branch initiation, branch elongation and pruning and
pre- and postsynaptic development. Additionally, specific sets of transcriptional factors seem to
be responsible for the establishment of the great variety of different neuronal populations in the
brain. But to date the full set of downstream effectors, which mediate the differential growth
promoting mechanisms have remained elusive.
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2.2 The Synapse a highly specialized neuronal subcompartment
Neurons in the brain communicate with each other at synapses, intercellular contacts which are
able to convey information with high spatial precision and speed from one cell to the other.
Synapses are formed when axons reach their target cells and form stable contacts with them.
The axon terminal, the so-called presynapse can send information to the opposing postsynaptic
cell by releasing neurotransmitters into the synaptic cleft between both synaptic partners. The
released neurotransmitter docks to receptors of the postsynapse and conveys thereby the signal
send from the presynapse to the postsynapse. Fundamental for a functional synapse is therefore
the close apposition of highly specialized plasma membrane regions of the two participating cells.
In the presynaptic terminal the release of neurotransmitters takes place at a highly specialized
section of the of the plasma membrane the so called active zone. The active zone lies at the
at the presynaptic plasma membrane facing the synaptic cleft and is composed of an electron
dense protein network of scaffolding proteins, fusion proteins, ion channels, and cell adhesion
molecules (Fig 2.3).
Figure 2.3: Electron micrograph and schematic representation of the synapse. The electron micrograph
shows a hippocampal synapse. In the presynaptic terminal synaptic vesicles cluster at the active zone opposed
to the postsynaptic density of the postsynaptic partner neuron. The postsynaptic density is characterized by the
concentration of darker appearing electron dense material. In between the two synaptic partners cells lies the
synaptic cleft.
This orchestra of proteins mediates the release of synaptic vesicles and their concomitant re-
cycling in the molecular defined steps of the synaptic vesicle cycle. First synaptic vesicles are
filled up with neurotransmitters in the center of the presynaptic terminal. From there they
are transported to the active zone, the neurotransmitter release site at the presynaptic plasma
membrane. After docking to the active zone synaptic vesicles are prepared for synaptic vesicle
release in a multi-step maturation process called priming. When an action potential arrives at
the presynaptic terminal calcium enters the presynapse through voltage gated Ca2+-channels
and induces the exocytosis of primed synaptic vesicles. After fusion with the plasma membrane
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synaptic vesicles are rapidly reuptaken and recycled. The reuptaken empty vesicles are either
immediately refilled to directly reinitiate the synaptic vesicle cycle or transported to the endo-
somal compartment for further sorting before they reenter the synaptic vesicle cycle [Sudhof,
2004] (Fig 2.4). A synaptic vesicle needs approximately only 60 seconds to go through the whole
synaptic vesicle cycle. Fusion of the synaptic vesicle and the presynaptic plasma membrane
takes even less than one millisecond, making the release of neurotransmitter to one of the fastest
and spatially and temporarily, best controlled processes of membrane fusion [Betz & Bewick,
1992, Sabatini & Regehr, 1999].
Figure 2.4: The synaptic vesicle cycle. Synaptic vesicles are filled with neurotransmitter, targeted to the active
zone (Docking) where they are brought in a fusion competent state (Priming). Upon arrival of an action potential
Ca2+ enters the cell through voltage gated Ca2+-channels triggering the fusion of readily releasable vesicles with
the presynaptic plasma membrane. The released neurotransmitters diffuses through the synaptic cleft and binds
to receptors of the postsynaptic density. After fusion synaptic vesicles are either directly refilled or recycled via
the early endosome.
2.3 RIM protein family
Rab3-interacting molecules (RIM proteins) are core members of the active zone protein network.
RIM1α the first discovered member of the RIM protein family was identified as a putative effector
of the synaptic vesicle protein Rab3 [Wang et al., 1997]. Later genetic analyses revealed that
the RIM protein family consists of seven members (RIM1α, 1β, 2α, 2β, 2γ, 3γ, 4γ), which are
encoded by the four different genes, RIM1-4 [Wang et al., 2000, Wang & Südhof, 2003, Kaeser
et al., 2008]. The RIM1 gene encompasses two internal promoters, which lead to the expression
of the two RIM1 isoforms RIM1α and RIM1β. Similarly, in the RIM2 gene three internal
promoters are regulating the expression of RIM2α, RIM2β and RIM2γ. Both RIM1 and RIM2
genes are extensively alternatively spliced resulting in over 200 different variants. In strong
contrast the RIM3 and RIM4 genes are not spliced and encode for only one single RIM isoform,
CHAPTER 2. INTRODUCTION 22
namely RIM3γ or RIM4γ [Wang & Südhof, 2003]. The different RIM isoforms differ in size
and composition of protein domains. α-RIMs, the largest RIM isoform, are composed of the
full set of RIM domains, an N-terminal zinc-finger domain, a central PDZ domain, and tow
C-terminal C2-domains (C2A and C2B), which are separated by an SH3-domain binding motif.
β-RIMs are identical to α-RIMs except for their N-terminal sequence, in which RIM1β lacks the
Rab3-binding sequence and RIM2β lacks both the Rab-3 and the Munc-13-binding sequence.
γ-RIMs are much smaller and consist of only the C-terminal C2B domain and an isoform specific
N-terminal sequence (Fig 2.5).
Figure 2.5: Protein domain composition of the RIM family. RIM1α and RIM2α compromise the full set of
RIM protein domains: An N-terminal Zn2+-finger domain a PDZ domain, the C2A-domain a proline rich sequence
and the C2B domain. RIM1β lacks only all small N-terminal part whereas in RIM2β also the Zn2+-finger domain
is absent. In strong contrast to theses large RIM proteins the γ-RIMs are composed of only the C2B domain and
a isoform N-terminal sequence.
2.3.1 Synaptic functions of RIM1 and RIM2
The large members of the RIM protein family (Rim1α, 1β, 2α, 2β) are central organizers of the
protein network at the active zone, the presynaptic neurotransmitter release site. At the active
zone the large RIM proteins form a scaffold by interacting directly or indirectly with all other
known active zone proteins. These multiple interactions enable RIM proteins to participate in
several aspects of the presynaptic neurotransmitter release [Mittelstaedt et al., 2010]. Briefly,
RIM proteins have been suggested to play a role in docking and priming of synaptic vesicles
and in the recruitment of Ca2+-channels to the active zone [Schoch et al., 2002, Deng et al.,
2011, Han et al., 2011, Kaeser, 2011] (Fig 2.6).
A function in the docking of synaptic vesicles was suggested by the finding that synapses of
RIM1/2 double knock-out mice display a reduction in the fraction of docked vesicles. Docked
vesicles are synaptic vesicle that are attached to the active zone and thereby brought in close
proximity to voltage-gated Ca2+-channels and the presynaptic release machinery. In electron
micrographs of synaptic contacts docked vesicles can be visualized as fraction of vesicles, which
are attached to the electron dense meshwork of the active zone but not yet fused with the
presynaptic plasma membrane. Further it was shown that RIMs interact with both Rab3, a
protein present on synaptic vesicles and Ca2+-channels of the active zone. This suggests, that
the tripartite interaction between RIM proteins, Rab3 and Ca2+-channels might bring synaptic
vesicles in close proximity of voltage-gated Ca2+-channels and thereby dock synaptic vesicles
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to the active zone [Gracheva et al., 2008, Han et al., 2011]. After docking to the plasma
membrane synaptic vesicles are brought into a fusion competent state by assembling the vesicle
fusion machinery and its regulatory proteins to them. Primed synaptic vesicles compromise the
readily releasable pool and determine therefore the release probability of a synapse. Cultured
neurons of RIM1/2 double knock-out mice show a reduction in the synaptic release probability
suggesting, that RIM proteins also function in priming of synaptic vesicles. It was proposed that
this function is mediated by interaction of RIM proteins with the active zone protein Munc13.
Munc13 itself brings synaptic vesicles in a fusion competent state by changing the conformation
of syntaxin, a member of the vesicle fusion machinery, to allow for the assembly of the fusion
machinery. Munc 13’s function is inhibited, when unbound Munc13 self assembles to Munc13
homodimers. Binding of RIM1 to Munc13 disrupts these homodimers, leading to the activation
of Munc13 [Richmond et al., 2001, Gerber et al., 2008, Ma et al., 2011, Deng et al., 2011].
A further important mechanism in the regulation of fast synchronous neurotransmitters release
is the recruitment of voltage-gated Ca2+-channels to the active zone and the alignment of Ca2+-
channels with the synaptic vesicle release machinery [Llinás et al., 1992, Meinrenken et al.,
2002]. Presynaptic release relies predominately on N- and P/Q-type Ca2+-channels, which are
enriched at the active zone [Takahashi & Momiyama, 1993, Regehr & Mintz, 1994, Castillo et al.,
1994, Qian & Noebels, 2001]. RIM proteins bind via their PDZ domain directly to N- and P/Q-
type Ca2+-channels and with their proline rich sequence between the two C2 domains to RIM-
binding proteins. They in turn bind to L-, N- and P/Q-type Ca2+-channels. Synapses of RIM1/2
double knock-out mice show reduced levels of P/Q-type Ca2+-channels and a desynchronization
of neurotransmitter release in addition to the reduction in release probability described above.
Both, the reduction in Ca2+-channel levels and the desynchronization of neurotransmitter release
at RIM1/2 deficient synapses can be restored by expressing only the two RIM domains that
are responsible for the direct and indirect interaction between RIM proteins and Ca2+-channels
[Kaeser et al., 2011]. Thus, RIM proteins might tether Ca2+-channels to the active zone through
two parallel mechanisms: a direct interaction with N- and P/Q-type Ca2+-channels and an
indirect interaction with L-, N- and P/Q-type Ca2+-channels via RIM-binding proteins and
thereby modulate efficiency speed and synchrony of neurotransmitter release.
RIM proteins were also shown to modulate Ca2+-channel openings times in vitro. However, if
this mechanism plays a role in their function during neurotransmitter release is still a matter
of debate. Several lines of evidence show that RIM proteins bind via their C2B domain, which
is shared among all RIM isforms to the β4-subunit of voltage-gated Ca2+-channels and are able
to shift their inactivation curve to higher voltages [Uriu et al., 2010, Kaeser et al., 2012]. But
it could not be shown that the loss of this activity contributes to the impairment in Ca2+influx
and neurotransmitter release caused by the double knock-out of RIM1 and RIM2 in vivo [Uriu
et al., 2010, Kiyonaka et al., 2007, Kaeser et al., 2012].
Accordingly to this multiple functions in the regulation of neurotransmitter release, RIM1α was
shown to be a key player of presynaptic short- and longterm plasticity [Südhof, 2012]. Analysis
of RIM1a knock-out mice revealed an impairment in presynaptic short term plasticity at exci-
tatory Schaffer collateral synapses in the hippocampus and at cortico-LA (lateral nucleus of the
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amygdala) synapses in the amygdala [Schoch et al., 2002, Fourcaudot & Gambino, 2008]. Fur-
thermore RIM proteins have been shown to be involved in PKA dependent long-term presynaptic
plasticity in the hippocampus at mossy fibers and Schaffer collateral synapses, in the cerebellum
at parallel fibers to Purkinje cell synapses and in the amygdala at cortico-LA synapses [Castillo
et al., 2002, Huang & Zakharenko, 2005, Lonart et al., 2003, Fourcaudot & Gambino, 2008].
However the detailed molecular mechanism how RIM proteins are involved in the different forms
of presynaptic short- and long-term plasticity have remained elusive so far.
In summary, the multiple interactions of the large RIM proteins within the active zone protein
network make them to powerful regulators of presynaptic neurotransmitter release. RIM proteins
regulate the number of attached vesicles to the active zone and also in their ability to fuse with
the presynaptic plasma membrane through different mechanisms. However, which molecular
mechanism are rate limiting and how these molecular processes influence each other remains to
be resolved.
Figure 2.6: RIM1 at the presynaptic active zone. RIM1 is a central component of the protein network at
the active zone involved in multiple steps of neurotransmitter release. Via its interaction with Rab3, RIM1 brings
synaptic vesicles in close proximity of voltage-gated Ca2+-channels. Through its interaction with Munc13 RIM1
participates in the priming of synaptic vesicles. The direct interaction with voltage-gated Ca2+-channels and via
the interaction with RIM-binding proteins (RIM-BP), allows RIM1 to tether Ca2+-channel to the active zone and
to regulate thereby the efficiency speed and synchrony of neurotransmitter release.
2.3.2 Function of the small RIM proteins: RIM3γ and RIM4γ
In contrast to the large members of the RIM protein family much less is known about the
functional role of RIM3γ and RIM4γ. γ-RIMs are much smaller than the large α- and β-RIM
proteins, as they miss most of the protein interaction domains present in the large RIM proteins
and consist of only the RIM specific C2B domain and an isoform specific N-terminal sequence.
First experiments on the expression pattern of RIM3γ and RIM4γ revealed, that they are brain
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specific proteins, expressed with overlapping patterns throughout the rodent brain. From birth
on the expression levels of RIM3γ and RIM4γ increase during development and reach a plateau
around postnatal day 20, similar to the large RIM proteins [Kaeser et al., 2008]. In Contrast to
the specific synaptic localization of α- and β-RIMs, RIM3γ and RIM4γ show a broader subcellular
localization. RIM3γ seems to be expressed in dendrites and axons, where it colocalizes with pre-
and postsynaptic markers. In the neuronal cell body RIM3γ shows a strong enrichment to the
nucleus. RIM4γ is absent from the nucleus and shows a diffuse distribution along axons and
dendrites.
In search of a potential presynaptic function RIM3γ and RIM4γ were suggested to modulate
presynaptic Ca2+ influx through direct binding to voltage-gated Ca2+-channel and either modu-
lating Ca2+-channel opening times or recruit Ca2+-channels to the active zone or to interfere with
the anchoring of synaptic vesicles to voltage gated Ca2+-channels mediated by α-RIMs. How-
ever γ-RIMs seem to be much less effective in binding to voltage-gated Ca2+-channels and also
in modulating neurotransmitter release than the large RIM proteins [Uriu et al., 2010, Kaeser
et al., 2012]. Surprisingly shRNA mediated knock-down of RIM3γ and RIM4γ in vitro and
in vivo resulted in neuronal growth defects and lead to a drastically simplified dendritic tree
[Alvaréz-Baron, 2010]. This suggests that apart from a possible synaptic role RIM3γ and RIM4γ
might mediate important functions during neuronal growth and development.
2.3.3 RIMs in neuronal pathologies
Neuronal networks in the brain are cascades of synaptic connections which process sensory
inputs and transform them into appropriate motor outputs. This makes synapses to fundamental
regulators of correct brain function. The dysregulation of neuronal networks due to inappropriate
changes in synaptic function might therefore play an important role in the pathogenesis of
neurological disorders like schizophrenia, autism spectrum disorders, Parkinson’s disease, and
epilepsy [Stephan et al., 2009, Pardo & Eberhart, 2007, Scharfman, 2008, Chandrasekaran &
Bonchev, 2013]. RIM proteins and their regulatory effect on synaptic neurotransmitter release
have been associated with several neurological disorders.
The changes of synaptic function in RIM1 knock-out mice lead to strong impairments in learning
and memory and additionally to behaviors, which have been linked to schizophrenia [Powell
et al., 2004, Lipska & Weinberger, 2000, Blundell et al., 2010b]. Two other members of the
RIM family, RIM2, and RIM3γ were found to be upregulated in the amygdala of schizophrenia
patients. The amygdala is a subcortical region that shows structural changes and reduced
emotion evoked responses during schizophrenia and is therefore suggested to take part in the
dysfunction of emotional processing in schizophrenia [Weidenhofer et al., 2006, Weidenhofer
et al., 2009, Aleman & Kahn, 2005]. Further genomic expression profiles revealed, that the
RIM3γ gene expression was additionally upregulated in other brain regions like the entorhinal
cortex and the prefrontal cortex of schizophrenic patients [Hemby et al., 2002, Hakak et al.,
2001]. Thus several members of the RIM family might be involved in the pathological changes
occurring during schizophrenia.
A point mutation in the RIM1 gene has been identified in patients of autosomal dominant
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cone rod dystrophy. The patients first experience reduced color vision and visual acuity, later
patients have problems in seeing bright light. Interestingly, affected individuals show an increase
in cognitive abilities [Michaelides et al., 2005, Sisodiya et al., 2007]. This increase in cognitive
abilities is associated with a enhanced synaptic function mediated by the mutated version of
RIM1. Thus the change in synaptic function might have differential effects depending on which
neuronal network is affected [Miki et al., 2007].
Physiological processes like learning and memory, but also pathophysiological processes like
epiletopgenesis are accompanied by an increased network activity. In response to an increase
in network activity neurons can change their molecular composition and structure in order to
adjust their synaptic strength [Milner et al., 1998, Scharfman, 2008]. This synaptic adaptation
has been shown to be dependent on changes in gene expression, leading to the synthesis of
proteins, which can modulate the composition and function of the synaptic protein network
[Goelet et al., 1986, Flavell & Greenberg, 2008]. Recently, the gene expression of RIM4γ has
been shown to be upregulated in the hippocampus of mice after the induction of epileptic
seizures, which goes along with strong synchronous neuronal activity [Hermey et al., 2013].
Additionally, RIM1 knock-out mice have been shown to be more sensitive to strong synchronous
neuronal activity, as they show an increase in spontaneous seizures after induced epileptogenesis
[Pitsch et al., 2012].
Taken together all members of the RIM family could be associated to physiological and patho-
logical changes in brain function but seem to contribute to different symptoms. Their divergent
contributions could be explained on the one hand by varying expression patterns in the different
brain region or in the different subcellular compartments of neurons on the other hand also by
isoform specific functions.
3 Aims of the study
The RIM protein family compromises large multidomain proteins (RIM1α/β, RIM2 α/β) besides
three small γ-RIMs (RIM2γ, RIM3γ, RIM4γ) that are composed of only one single RIM specific
domain and a short isoform specific N-terminus. In the recent years, RIM1 and RIM2 have
emerged as important regulators of synaptic transmission and plasticity. At the presynaptic
active zone the large RIM proteins are integrated in a network of protein interactions allowing
them to participate in the docking and priming of synaptic vesicles and the recruitment of
Ca2+ channels. The small members of the RIM protein family, RIM3γ and RIM4γ have been
suggested as important regulators of neuronal outgrowth in first shRNA mediated knock-down
experiments. However, the precise function of RIM3γ and RIM4γ is still not defined, therefore
we set out to address the following goals in this study.
The first aim is to characterize the full consequences of the loss of RIM3γ and RIM4γ on the
development of axons and dendrites and the formation of their synaptic specializations. This will
also involve analysis of vesicular transport in RIM3γ and RIM4γ knock-down neurons, to unravel
if γ–RIMs promote neuronal growth trough an involvement in vesicular trafficking routes.
Secondly, we want to identify novel γ–RIM interaction partners, especially interactions that are
involved in their growth promoting function, in order to elucidate the molecular mechanism
underlying the role of RIM3γ and RIM4γ in the elongation of axons and dendrites. In addition
to growth promoting proteins we aim to find potential synaptic γ-RIM interaction partners to
gain insight into a potential synaptic function of RIM3γ and RIM4γ in accordance to the role
of RIM1 and RIM2 in presynaptic vesicle exocytosis.
The third goal is to analyze which functional domains of γ-RIMs are involved in their subcellular
localization. Strikingly RIM3γ shows a strong nuclear enrichment in addition to its pre- and
postsynaptic localization, suggesting a function of RIM3γ in synapse to nucleus signaling.
The fourth goal is to generate constitutive RIM3γ and RIM4γ knock-out mice allowing to analyze
the consequence of the ablation of the both proteins from development on and perform a first
characterization of the resulting phenotypes.
Taken together this study will provide novel insights into the functional role of RIM3γ and
RIM4γ in the development and function of neuronal structures in the brain.
27
4 Material & Methods
28
CHAPTER 4. MATERIAL & METHODS 29
4.1 Material
4.1.1 Equipment
Equipment Model Company
Acrylamid electrophoresis
system
Mini-PROTEAN 3
Electrophoresis System
BioRad
Agarose electrophoresis
system
SUB-CELL GT BioRad
Analytical balance BP210S Sartorius
Autoclave HSP Laboklav Steril Technik AG
Balance SBC53 SCALTEC
Cat walk Cat walk XT system Noldus
Capillary Sequencer 3130/xl/ Genetic Analyzer Applied Biosystems
Cell culture hood MSC-Advantage Thermo Scientific
Centrifuge Function line Heraeus
Centrifuge 5415C Eppendorf
Centrifuge Mikro 22R Hettich
Centrifuge Mikro 200R Hettich
Centrifuge Rotina 220R Hettich
Cryostat HM 560 MICROM
Confocal laser scanning
microscope
Eclipse Ti Nikon
Controller Micro4 Controller,
4-Channel
World Precision
Instruments
CO2-controller (life cell
imaging)
CO2-controller Pecon
Cryostat HM 560 MICROM
Gel documentation system AlphaImager Alpha Innotech
Incubator (cells/cell
culture)
HERAcell 150 / 150i Thermo Scientific
Incubator (media/cell
culture)
Modell 100 Memmert
Incubator small Inkubator 1000, Unimay
1010
Heidolph
Incubator small Incubating Mini shaker VWR
Infrared imaging system Odyssey Li-cor
Inverse microscope Axio Observer 1A Zeiss
Inverse microscope Axiovert 40 CF Zeiss
Microtome Microm HM 335 E Microm
PCR-Cycler UNOII Biometra
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PCR-Cycler T3 Biometra
PCR-Cycler T3000 Biometra
pH-meter pHMeter 766 Calimatic Knick
Photometer BIO eppendorf
Power Supplies Agarose PHERO-stab.500 BIOTEC-FISCHER
Power Supplies Agarose Power Pack 25 Biometra
Precision Syringe Nanofil Hamilton 10μl World Precision
Instruments
Real time PCR (Taqman) 9700HT ABI Prism
Rotating rod Rota-Rod ENV-575MA Med Associates Inc.
Rotor Type 70 Ti Beckman Coulter
Shaker plate Polymax 1040 Heidolph
Spectrophotometer ND-1000 NanoDrop
Temperature controller (life
cell imaging)
Tempcontrol 37-2 Pecon
Thermo shaker MKR13 HLC
Thermo shaker Thermomixer compact Eppendorf
Ultrasonicator Processor UP50H Hielscher
Ultrasonicator Labosonic 2000 B.Braun
Ultracentrifuge Optima L-70K Beckman Coulter
Vibratome Microm HM 650V Thermo Scientific
Vortex Vortex-Genie 2 Scientific Industries
Vortex Reax control Heidolph
Table 4.1: Equipment used for this study
4.1.2 Chemicals
Chemical Company
4’,6-diamidino-2-phenylindolindole,
dihydrocholoride (DAPI)
Life technologies
1,4-Dithiothreitol Roche
6 x loading buffer Fermentas
Acetic acid Roth
Acrylamide Roth
Agarose peqLab
Ammoniumpersulfate (APS) Roth
Ampicillin Roth
Aqua ad injectabilia Delta Select
Bovine serum albumin (BSA) Sigma-Aldrich
Bromphenolblue Roth
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Calcium chloride Sigma-Aldrich
Chloroform Roth
Complete Mini Protease Inhibitor Roche
Cryo-preserving medium (Tissue-Tek) Dako
Dimethylsulfoxide (DMSO) Roth
Ethylenediaminetetraacetic acid (EDTA) Calbiochem
Ethanol Fluka
Ethidiumbromide Merck
Fetal calf serum (FCS) Life technologies
Gelatin from cold water fish skin Sigma-Aldrich
Formamide Roth
Glucose solution 5 % Fresenius
Glycerol Sigma-Aldrich
HEPES Sigma-Aldrich
HCl 2N Merck
Iodoacetamide Sigma-Aldrich
Isofluorane Sigma-Aldrich
Isopropanol Fluka
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Roth
Kanamycin Sigma-Aldrich
Luria Broth-Agar LabM/idg
Luria Broth-Medium LabM/idg
Lipofectamine 2000 Invitrogen
Leptomycin B Sigma-Aldrich
Magnesium chloride Merck
Methanol Merck
Milk powder Roth
Mowiol 4-88 Roth
Paraformaldehyd Roth
PBS Biochrom AG
Penicilin Sigma-Aldrich
Polyethylenimine Polyscience
RNAse away Molecular BioProducts
Saccharose Sigma
Sodium acetic Merck
Sodiumchloride Roth
Sodiumdodecylsulfate (SDS) Roth
Sodiumhydrogenphosphate Merck
ß-Marcaptoethanol Roth
TEMED Roth
CHAPTER 4. MATERIAL & METHODS 32
Tris-Base Sigma
Tris-HCl Roth
Triton-X-100 Roche
Trypan-Blue Invitrogen
Xylol Merck
Table 4.2: Chemicals used for this study
4.1.3 Cell culture media and reagents
Cell culture medium Company
B27 Gibco
Basal Medium Eagle (BME) Life technologies
Dulbecco’s Modified Eagle’s Medium (DMEM) Gibco
Fetal calf serum (FCS) Life technologies
Glucose Sigma-Aldrich
Hank’s Buffered Salt Solution (HBSS) Gibco
Iscove’s Modified Dulbecco’s Medium (IMDM) Gibco
L-Glutamine Gibco
Minimum essential medium (MEM) Sigma-Aldrich
Opti-MEM Gibco
Papain Sigma-Aldrich
Penicillin-Streptomycin Gibco
Phospate saline buffer (PBS) Gibco
Poly-D-Lysin Sigma-Aldrich
Sodium bicarbonate Life technologies
Sodium hypoxanthine, aminopterin, thymidine
(HAT)
Life technologies
Trypsin-EDTA Gibco
Table 4.3: Culture media used for this study
4.1.4 Antibodies
4.1.4.1 Primary Antibodies
Antibody Dilutions Company
β-actin mouse monoclonal (ab6276) 1:500 Abcam
β-Tubulin mouse 1:10000 BD Pharminogen
FLAG M2 mouse monoclonal 1:1000-1:5000 Sigma-Aldrich
GFP rabbit polyclonal (ab290) 1:1000 Abcam
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GFP mouse monoclonal 1:1000 Santa Cruz Biotechnology
GM130 mouse 1:500 BD Transduction
Laboratories
HA mouse monoclonal 1:1000 Convance
RIM3γ polyclonal 1:100 Pineda AK Service
RIM4γ polyclonal 1:100 Pineda AK Service
Synapsin 1.2 guinea pig polyclonal 1:500 Synaptic Systems
PSD-95 MAGUK scaffold protein mouse
monoclonal
1:100 Neuromab
Table 4.4: List of primary antibodies
4.1.4.2 Secondary Antibodies
Antibody Dilutions Company
Cy3-anti mouse IgG 1:200 Jackson immuno reseearch
Cy3-anti rabbit IgG 1:200 Jackson immuno reseearch
Cy5-anti mouse IgG 1:200 Jackson immuno reseearch
Cy5-anti rabbit IgG 1:200 Jackson immuno reseearch
Cy5-guinea pig rabbit IgG 1:200 Jackson immuno reseearch
Fitc-anti mouse IgG 1:200 Jackson immuno reseearch
Fitc-anti rabbit IgG 1:200 Jackson immuno reseearch
IRDye 680-anti mouse IgG 1:20000 LI-COR Odyssey
IRDye 680-anti rabbit IgG 1:20000 LI-COR Odyssey
IRDye 800-anti mouse IgG 1:20000 LI-COR Odyssey
IRDye 800-anti rabbit IgG 1:20000 LI-COR Odyssey
Table 4.5: List of secondary antibodies
4.1.5 Kits
Kit Company
BigDye® Terminator v3.1 Cycle Sequencing Kit Applied Biosystems
Cell viability imaging kit Roche
DNA Clean and Concentration kit Zymo Research
DyeEx 2.0 (Purification of Sequencing) Qiagen
Dynabeads® mRNA DIRECT™ Micro Kit Life technologies
EndoFree Plasmid Maxi Kit Quiagen
GeneJET™ Plasmid Miniprep Kit Thermo Scientific
High Capacity cDNA Reverse Transcription Kit Applied Biosystems
PureLink™ HiPure Plasmid Filter Maxiprep Kit Life technologies
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PureLink™ HiPure Plasmid Filter Midiprep Kit Life technologies
RevertAid First Strand cDNA Synthesis Kit Thermo Scientific
Trypsin profile IGD Kit Sigma-Aldrich
Zymoclean DNA Clean&Concentrator kit Zymo Research
Zymoclean Gel DNA recovery kit Zymo Research
Table 4.6: Kits used in this study
4.1.6 Other material
Product Company
Nitrocellulose membrane (Protran® 0,45 μm
pore size)
Watman, GE Healthcare
Tissue tek Sakura Finetek
Anti-FLAG M2 Magnetic Beads Sigma-Aldrich
Glutathione−Agarose Sigma-Aldrich
Table 4.7: List of diverse material
4.1.7 Oligo nucleotides
4.1.7.1 Cloning Primers
Template Direction Primer 5’-sequence-3’ Enzyme Vector
SF-TAP fw GCGGAATTCACCATGGATTATAA
AGATGATGATGA
EcoRI pAAV-CMV
SF-TAP rev GCGTCTAGATGGTCCTGGTTTCT
CGAACTGCGGGTG
XbaI pAAV-CMV
RIM3γ fw GCGTCTAGAATGTTTAACGGGG
AGCCTG
XbaI pAAV-CMV
RIM4γ rev GCGGTCGACTTAGGAGCACGAG
GGGCT
SaII pAAV-CMV
RIM4γ fw GCGTCTAGAATGGAGCGCTCGC
AGAG
XbaI pAAV-CMV
RIM4γ rev GCGGTCGACTTAAGATCGCTCG
CCACA
SaII pAAV-CMV
RIM4γ fw GAATTCACCTAATGGAGCGCTC
GCAGAG
EcoRI pgex
RIM4γ rev GTCCGACTTAAGATCGCTCGCC
ACAG
SaII pgex
Table 4.8: Primers used for cloning.(fw: forward; rev:reverse)
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4.1.7.2 Primers for site directed mutagenesis
Template Mutation Direction Primer 5’-sequence-3’
pAAV-CMV-
GFP-RIM3γ
NLS (42KKRR
-> AAAA)
fwd GCGACAGCCGCGGCAGCGGCG
pAAV-CMV-
GFP-RIM3γ
NLS (42KK-RR
-> AAAA)
rev GCGCGCCGCTGCCGCGGCTGT
pAAV-CMV-
GFP-RIM3γ
NES (64L-L
-> A-A)
fwd GGACGAGGCGGACGCGAGTGC
TGTGGTCACTGGC
pAAV-CMV-
GFP-RIM3γ
NES (64L-L
-> A-A)
rev GCCAGTGACCACAGCACTCGC
GTCCGCCTCGTCC
Table 4.9: Sequencing primers.(fw: forward; rev:reverse)
4.1.7.3 Sequencing Primers
Template Direction Primer 5’-sequence-3’
pCMV β-Globin Intron fw GAGTCCAAGCTAGGCCCTTT
pAAV-CMV rev TTAGGACAAGGCTGGTGGG
pgex fw GGGCTGGCAAGCCACGTTTGGTG
pgex rev CCGGGAGCTGCATGTGTCAGAGG
Table 4.10: Sequencing primers.(fw: forward; rev:reverse)
4.1.7.4 Genotyping primers
Genotype Primer 5’-sequence-3’ Product size
RIM3γ wild type
GGACCACACTGCAATGCTAA
324bp
ACCAGACTCCAAAGCCCTC
RIM3γ constKO
GGACCACACTGCAATGCTAA
618bp
CCCTTCAGTCTTCCTGTCCA
RIM4γ wild type
GCATGATGGGAAGGAATGCCAAGC
324bp
GTTCAGG-CCAGGGCTTCTCCATGC
RIM4γ constKO
GCATGATGGGAAGGAATGCCAAGC
632bp
CCCTTCAGTCTTCCTGTCCA
Table 4.11: Primers used for genotyping of RIM3 and RIM4 knock-out mice.(fw: forward; rev:reverse; bp: base
pairs)
4.1.7.5 Primers for quantitative real time RT-PCR
Gene Primers Company
RIM3γ Gene expression assay: Mm00805396_m1 Life Technologies
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RIM4γ Gene expression assay:Mm00813040_m1 Life Technologies
β-actin Gene expression assay: Mm00607939_s1 Life Technologies
Synatophysin Gene expression assay: Mm01289818_g1 Life Technologies
Table 4.12: Primers used for quantitative real time RT-PCR
4.1.8 Enzymes
Enzyme Company
GoTaq® Flexi DNA Polymerase Promega
DNase I Roche
Pfu DNA Polymerase Life technologies
Taq DNA Polymerase Life technologies
T4 Ligase Thermo Scientific
Restriction Enzymes Company
EcoRI, SaII, XbaI, MfeI, HindIII, DpnI Thermo Scientific
Table 4.13: List of Ezymes used in this study
4.1.9 Plasmids
Generated plasmids
Name Insert Vector Enzyme
pAAV-SF-TAP SF-TAP pAAV-CMV EcoRI, XbaI
pAAV-TAP-RIM3γ RIM3γ pAAV-SF-TAP XbaI, SaII
pAAV-TAP-RIM4γ RIM4γ pAAV-SF-TAP XbaI, SaII
pgex-RIM4γ RIM4γ pgex EcoRI, SaII
Constructs modified by site directed mutagenesis
pAAV-RIM3γ-mutNLS - pAAV-RIM3γ-GFP -
pAAV-RIM3γ-mutNES - pAAV-RIM3γ-GFP -
Table 4.14: Constructs generated during this study
Plasmids generated prior this study
pLVTHM-GFP, pLVTHM-RFP, pLVTHM-GFP-shRIM3γ, pLVTHM-GFP-shRIM4γ, pLVTHM-
RFP-shRIM3γ, pLVTHM-RFP-shRIM4γ, pLenti-EGFP-RIM3γ and pLenti-EGFP-RIM4γ. These
plasmids are publishes by Alvarez-Baron et al.[Alvarez-Baron et al., 2013].
Plasmids kindly provided by other labs
pEGFP-IQGAP3 Prof. Kozo Kaibuchi (Department of Cell Pharmacology, Nagoya University,
Nagoya, Japan).
pEGFP-C2-IQGAP1 Dr. Dominique Brandt (Pharmakologisches Institut, Universität Marburg,
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Germany).
Rab8-GFP (pEGFP-CMV), Rab6-GFP (GW), Rab11-GFP (GW) Prof. Casper C. Hoogenraad
(Cell Biology, Faculty of Science, Utrecht University, Utrecht, The Netherlands).
pEGFP-N1-plakophilin4 Prof. Ilse Hofmann (Zentrum für Biomedizin und Medizintechnik, Uni-
versität Mannheim, Germany).
pCAG-Syd-1-HA Prof. Peter Scheifele (Biozentrum, University Basel, Switzerland).
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4.2 Methods
4.2.1 Molecular biological methods
4.2.1.1 Polymerase chain reaction
DNA fragments were amplified by polymerase chain reaction (PCR). The PCR reaction mix
contained double stranded DNA of the sequence of interest, single stranded Primers, desoxyri-
bonucleotides (dNTPs) and the required amount of buffers and salt. The reaction was either
preformed with Platinum Taq-polymerase or Pfu-polymerase in order to guarantee proof read-
ing. Exact compositions of PCR reactions are listed below:
PCR reaction mix Volume
10x Polymerase buffer 2μl
Magnesium chloride 25mM 1,2μl
5’ primer (10pmol/μl) 0,5μl
3’ primer (10pmol/μl) 0,5μl
dNTP-Mix (25mM) 0,5μl
DNA Template 2μl (50ng)
Polymerase 0,3μl
Water ad iniectabilia ad 20μl
The reaction was performed in a thermocyler. In the initial step double stranded DNA was
denaturated for 5 minutes at 95°C. Afterwards 30-35 cycles of a denaturation step for 30 seconds
at 95°C, an annealing step for 40 seconds at 50-60°C and an extension step at 68/72°C for 1
minute per kilobase pair was performed. The reaction was completed by a final extension step
at 68/72°C for 10 minutes.
4.2.1.2 Vector generation
For cloning DNA fragments were amplified from plasmid DNA via PCR. PCR reactions were
separated on an agarose gel and the band of interest was cut out and purified (Zymoclean Gel
DNA recovery kit, Zymoresearch). PCR fragments of the correct size were cut with the respective
restriction enzymes for 2 hours at 37°C. In the meantime the vector of interest was cut with
the corresponding restriction enzyme 1 hour at 37°C, and subsequently dephosphorylated with
shrimp alkaline phosphates for 1 hour at 37°C. Following restriction, vector and PCR fragments
were purified (DNA Clean and Concentration kit). Vector and PCR fragments were ligated in
a molar ratio of 1:3 by T4 DNA ligase at room temperature overnight.
4.2.1.3 DNA precipitation
The volume of DNA was adjusted to 500μl and precipitated for at least 15 minutes at –80°C
in the presence of sodium acetate (3,5M, 35μl) and ethanol (100%, 1ml). DNA precipitates
were collected by 30 minutes centrifugation. After centrifugation the supernatant solution was
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removed and the precipitated DNA pellet was washed with 70% ethanol. The solution of 70%
ethanol was centrifuged again to pellet the DNA and the supernatant was removed. The washed
DNA pellet was resuspended in 20μl distilled water for further use.
4.2.1.4 Chemical transformation of bacteria with plasmid DNA
50μl of chemically competent 5-alpha e. coli were incubated with 20μl of the ligation reaction
or 1μl of plasmid DNA for 20 minutes on ice. The transformation reaction was heat shocked for
2 minutes at 42°C and shortly chilled on ice. Afterwards 200μl of LB-media were added to the
reaction mix and incubated for one hour at 37°C on a thermo shaker. Subsequently, 5-alpha
e. coli were plated on agar plates containing 100μg/ml ampicillin for selection of transformated
bacteria.
4.2.1.5 Sequencing
Sequencing PCR reactions were performed with the BigDye Terminator v3.1 cycle sequencing
kit and template specific primers. Reactions were purified (DNA Clean and Concentrator Kit)
and sequencing was carried out using a capillary sequencer. Analysis of sequencing results was
accomplished with the use of SeqMan software.
4.2.1.6 Side directed mutagenesis
Primers (Table 4.9) were designed following the instructions of the QuickChange Primer Design
Program (https://www.genomics.agilent.com/). Mutations were introduce during amplification
of the plasmid carrying the gene with the mutation target site by polymerase chain with the
respective primers containing the desired mutation. To find the optimal conditions nine PCR
reactions with 50ng,100ng, and 200ng of the plasmid carrying the gene with the mutation target
site and varying MgSO4 concentrations were performed with Pfu-polymerase. An initial denat-
uration step at 95°C was followed by 15 cycles of denaturation, annealing at 55°C for 1 minute
and elongation for 2 minutes/kb of the vector at 72°C. The reaction was completed by a final
extension step at 68/72°C for 10 minutes. Non mutated methylated parental DNA templates
were digested by adding 1μl of the restriction enzyme DpnI to each PCR reaction over night
and again 1μl DpnI the next morning for 2 hours at 37°C. After digestion all PCR reaction
were pooled and the DNA concentrated by ethanol precipitation. The concentrated DNA was
transformed into chemically competent 5-alpha e. coli. Bacteria were plated on agar plates
containing 100μg/ml ampicillin for selection of transformed bacteria.
4.2.1.7 mRNA isolation and cDNA sythesis
Total mRNA was obtained from microdissected mouse brain tissue using Dynabeads mRNA
DIRECT Micro Kit according to the manufacturer’s (Life Technologies) instructions. CDNA
was synthesized from purified mRNA by reverse transcription using the RevertAidH Minus First
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Strand cDNA Synthesis Kit and compromised oligo dT primers according to the manufactures
manual. CDNA samples were stored at -20°C.
4.2.1.8 Real time PCR
For quantitative real time PCR the Maxima Probe/Rox qPCR Master Mix (Thermo Fischer)
together with Taqmam gene expression assays (Applied Biosystem) was used according to the
following protocol.
Realtime PCR mix
Reaction component Volume
Master mix 3,0μl
cDNA 1,25μl
Taqman gene expression assay 0,3μl
DEPC- water 1,7μl∑ 6,25μl
Realtime PCR thermal profile
Step Temperature Time Cycle
1 95°C 10min
2 95°C 15sec
3 59°C 60sec
4 72°C 40sec 40 cycles step 2-4
Experiments were performed in triplicates on an ABI Prism 9700HT system (PE Applied Biosys-
tems, Foster City, CA, USA). Gene expression was analyzed as relative gene expression in com-
parison to the internal reference gene synaptophysin. Therefore gene expression was calculated
as 2-Δct(Δ cycle threshold value (ct) = ct of the analyzed gene - ct synaptophysin).
4.2.2 Bioinformatic analysis
Nuclear localization signals in the sequence of RIM3γ were detected with the Nucpred bioinfor-
matical tool (http://www.sbc.su.se/~maccallr/nucpred/cgi-bin/single.cgi). Nuclear export se-
quences within the protein sequences of RIM3γ and RIM4γ were identified via the bioinformati-
cal tool NetNES1.1 server (http://www.cbs.dtu.dk/services/NetNES/). Phosphorylation sites in
the sequences of RIM3γ and RIM4γ were predicted with the programs GPS_3.0_macos_201412
14.dmg for mac (http://gps.biocuckoo.org/ download.php) and http://scansite.mit.edu/.
CHAPTER 4. MATERIAL & METHODS 41
4.2.3 Lentivirus production and in vivo injection
4.2.3.1 Lentiviral vectors
Lentiviral particles were generated by cotransfection of plasmids coding for the virion pack-
aging plasmids Gag and Pol, a transfer vector carrying the gene of interest and an envelop
plasmid expressing the heterologous surface glycoprotein of VSV-G (vesicular stomatitis virus)
in a producer cell line HEK293FT. For the transfer of RIM3γ-GFP and RIM4γ-GFP the third
generation vector plentiN-EGFP and for the transfer of shRIM3-GFP, shRIM4-GFP, shRIM3-
RFP and shRIM4-RFP the second generation transfer vector PLVHTM was used. All lentiviral
particles were produced with the second generation packing plasmid psPAX2 and the envelop
plasmid pMD2.G. The biosafety of human immunodeficiency virus type 1 (HIV-1) based expres-
sion systems is improved by deletion of all viral accessory genes except of Tat and Rev in the
second generation of lentiviral plasmids.
4.2.3.2 Transfection of HEK293T cells
HEK293FT cells growing on 15cm culture dishes with a confluence of 50-60% were transfected
with one of the transfer vectors, psPAX2 and pMD2.G using polyethylenimine (PEI). The trans-
fection mix contained 18,75μg psPAX2, 6,25μg pMD2.G, 25μg transfer vector, 100μg PEI and
500mM NaCl and was directly added to the culture medium. One day after transfection the
culture medium was replaced by fresh DMEM containing 1% penicillin-streptomycin and 10%
fetal calf serum. Viruses were harvested 2 and 3 days after transfection.
4.2.3.3 Viral particle production
The successful transfection of all three viral plasmids leads to the production of lentiviral par-
ticles, that are released by HEK293FT cells and accumulate in the culture media. Two days
after transfection the culture media was collect and cleared from cell debris by filtering through
a 0,45μm syringe membrane filter. Lentiviral particles were concentrated by ultracentrifugation
(Beckman coulter counter, Ti 80) with 34400rpm at 4°C for 2 hours. The obtained viral pellet
was resuspended in 10μl HBSS and stored at -80°C.
4.2.3.4 In vivo Injection of Lentiviral particles
Neonatal lentivirus injections
New born wistar rats were immobilized on ice for 3-5 minutes. 1μl of lentiviral particles were
injected by a microinjection pump with the flow rate of 200nl per second through a hamilton
syringe in the cortex and hippocampus. After the virus injection the syringe was immediately
removed and pups were tattooed for later identification, warmed on a heating pad and re-
turned to the mother. At postnatal day 21 rats were deeply anesthetized with isoflurane and
perfused transcardially with PBS for 5 minutes, followed by 20 minutes of perfusion with 4%
paraformaldehyde in PBS, pH 7.4. After removal, the brain was postfixed in the same fixative
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for 24 h at 4°C. The cerebellum was discarded and the forebrain was cut in 100μm horizontal
sections on a vibratome (Vibratome 1000; Leica Microsystems). Transduced cells were imaged
with a Nikon A1/Ti-E Confocal, using a CFI Plan Apo Lambda 20x 0.75NA objective.
Postnatal day 21 lentivirus injections
21 day old wistar rats were anesthetized with 3 mg/kg xylazine (Rompun, Bayer) plus 100 mg/kg
ketamine (Ketavet, Pfizer), intramuscular. When animals were deeply asleep, the heads of the
rats were stabilized in a stereotactic frame and the scalp was opened in the midline for 5 mm.
To prevent bleeding the periosteal connective tissue was gently removed with the blunt edge of
a scalpel handle. At the coordinates 2,9mm posterior, 3,7mm lateral relative to bregma a whole
was drilled with a small dental drill in the parietal skull plate at both hemispheres. A preloaded
Hamilton syringe attached to a microinjection pump was slowly inserted into the brain through
the opened skull. 0,5μl viral particles were inject with a flow rate of 500nl/second. The needle
was kept place for two minutes moved slowly 1mm higher and again 0,5μl viral particles were
injected with a flow rate of 500nl/second. After two minutes the needle was slowly removed
out of the brain and the skin incision was closed by silk suture. Three weeks after the surgery
rats were were deeply anesthetized with isoflurane and perfused transcardially with PBS for 5
minutes, followed by 20 minutes of perfusion with 4% paraformaldehyde in PBS, pH 7.4. After
removal, the brain was postfixed in the same fixative for 24 hours at 4°C. The cerebellum was
discarded and the forebrain was cut in 100μm horizontal sections on a vibratome (Vibratome
1000; Leica Microsystems). Transduced cells were imaged with a Nikon A1/Ti-E Confocal, using
a CFI Plan Apo Lambda 20x 0.75NA objective.
4.2.4 Cell culture
4.2.4.1 Human embryonic kidney cells
Human embryonic kidney cells (HEK293T and HEK293FT) were grown in Dulbecco’s modified
Eagles medium (DMEM) containing sodium pyruvate supplemented with 10% fetal calf serum
(FCS, Hyclone) and 1% penicillin/streptavidin (100 units/ml penicillin and 100 mg/ml strep-
tavidin). Cells were passaged every 2-3 days at a confluency of 60-80% days and plated in a
dilution of 1:10. Cells were maintained in humidified incubators supplied with 5% C02 at 37°C.
4.2.4.2 Transfection of HEK 293T cells
Calcium phosphate transfection
For colocalization studies of RIM proteins and fluorescence labeled Syd-1 and plakophilin4,
HEK293T cells plated on poly-L-Lysin (0.1 mg/ml in borate buffer) coated coverslip in 24 well
dishes were transfected. For pulldown assays and co-immunoprecipitations RIM proteins and
potential interaction partners HEK293T cells in a 10cm dish were transfected. HEK293T cells
were plated one day before transfection to reach a confluency of 60% on the day of transfection.
2 hours before transfection the culture medium was changed to Iscove’s Modified Dulbecco’s
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Medium (IMDM) supplemented with 5% FCS. DNA and CaCl2 were mixed and 2xHEBES was
added dropwise while shaking, to allow the formation of a fine CaPO4 precipitate containing
the DNA. The precipitate was immediately added to the cell medium and cells were placed
back into the incubator (37°C, 5% C02). The next day culture medium was changed back to
DMEM. Transfected HEK293T cells for colocalization studies were fixed in 4% PFA 48 hours
after transfection and further analyzed by microscopy. HEKs cells in 10cm were harvested 48
hours after transfection.
2x HEBES Buffer
50mM HEPES
280mM NaCl
1,5mM Na2PO4
ph7,1
Transfection mix: 2 x 24-wells
DNA 1μg
250mM CaCl2 50μl
2x HEBES Buffer 50μl
Transfection mix: 1 x 10cm dish
DNA 10μg
250mM CaCl2 600μl
2x HEBES Buffer 600μl
Polyethylenimine transfection
For pulldown assays, co-immunoprecipitations and proteomics affinity-purification mass spec-
trometry approaches RIM proteins and potential interaction partners HEK293T cells in a 10cm
dish were transfected. HEK293T cells were plated one day before transfection to reach a con-
fluency of 60% on the day of transfection. Culture medium was replaced by fresh DMEM (1%
penicillin/streptavidin, 10% FCS) immediately before transfection. DNA was added to 250μl
250mM NaCl and 20μl Polyethylenimine (1μg/μl) were added to a second volume of 250μl 250mM
NaCl. Both the DNA and the Polyethylenimine containing solutions were combined and mixed
thoroughly. The transfection mix was incubated 20 minutes at room temperature and carefully
added to the cells. After overnight incubation at 37°C and 5% C02 the culture medium was
replaced by fresh DMEM. Cells were harvested 48 hours after transfection.
Transfection mix: 1 x 10cm dish
DNA 10μg
150mM NaCl 500μl
Polyethylenimine 20μg
4.2.4.3 Nuclear translocation assay: Leptomycin treatment
HEK293T cells were plated in 24-well culture dishes and transfected one day later with GFP-
RIM3γ by the CaPO4method. Two days after transfection cells were incubated for 1 hour
with 5nM Leptomycin diluted in ethanol or the same amount of ethanol as control. After
the leptomycin incubation the cells were fixed with 4% paraformaldehyde and analyzed by
microscopy (Zeiss Axio Observer.A1, A-Plan 10X 0.25NA objective).
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4.2.4.4 NG108-15 neuroblastoma-glioma cells
NG108-15 cells were grown in Dulbecco’s modified Eagles medium (DMEM) without sodium
pyruvate supplemented with 10% fetal calf serum (FCS, Hyclone) and 1% penicillin/streptavidin
(100 units/ml penicillin and 100 mg/ml streptavidin), 10% HAT (sodium hypoxanthine, aminopt-
erin, and thymidine; Life technologies). Cells were passaged every 2-3 days at a confluence of
60-80% days and plated in a dilution of 1:3,5. Cells were maintained in humidified incubators
supplied with 5% C02 at 37°C.
4.2.4.5 Transfection of NG108-15 cells
NG108-15 cells plated on poly-L-Lysin (0.1 mg/ml in borate buffer) coated coverslip in 24 well
dishes were transfected with lipofectamine 2000 (Life technologies) with RIM proteins and GFP
tagged IQGAP3 for colocalization studies. NG108-15 cells were plated one day before transfec-
tion to reach a confluency of 70% on the day of transfection. Immediately before transfection
culture medium was replaced by reduced serum medium OPTI-MEM (Life technologies). DNA
was added to 50μl OPTI-MEM and 1μl lipofectamine 2000 was added to a second volume of
50μl OPTI-MEM. After 5 minutes incubation at room temperature both the DNA and the
lipofectamine containing solutions were combined, mixed gently and incubated for 20 minutes
at room temperature. 50μl of the transfection mix were added to the culture medium of one
24-well. After 3-4 hours the medium was replaced by fresh DMEM. 48 hours after transfection
NG108-15 cells were fixed with 4% PFA and further analyzed by microscopy.
Transfection mix: 1 x 24-well
DNA 0,5μg
OPTI-MEM 50μl
lipofectamine 2000 0,5μl
4.2.4.6 Primary neuronal cell culture
A pretreatment of coverslips or wells of cell culture dishes is crucial for the optimal adhesion
of neuronal cultures. Coverslips were heated up to 200°C for approximately 12 hours. Baked
coverslips were placed in wells of 24 well cell culture dishes and coated with poly-D-lysine (Sigma,
0.1 mg/ml in borate buffer) overnight at 37 °C. The next day wells were washed 3 times with
sterile water.
Primary neurons were prepared from E16– E19 wistar rat brains. Embryo heads were dissected
and placed in a petri dish with ice-cold calcium and sodium free Hank’s Buffered Salt Solution
(HBSS, Invitrogen). Adhering blood vessels and membranes were removed from the brains
and the cortex and hippocampus of every pup were isolated. Hippocampi and cortices were
separately collected in 15 ml tubes, cut into thin slices and washed 3 times with 5 ml ice-cold
HBSS. After washing HBSS was removed until a volume of 1,8ml in the case of hippocampal
tissue and to 4,5ml for cortical tissue. The thin tissue slices were digested by adding trypsin,
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200μl to hippocampal or 500μl to cortical tissue suspensions for 10 min at 37°C. Subsequently, the
enzyme solution was removed, the preparations were washed three times with HBSS and 200μl
DNAse (1mg/ml) together with pre-warmed 0.8ml Eagle’s Basal Medium (BME, Invitrogen).
The cells were mechanically dissociated by gentle trituration using 1 ml pipette tips. 5ml BME
was added to the dissociated cells and neurons were counted in a Neubauer counting chamber.
According to the cell number BME was added and 50 000 - 70 000 cells were plated in each 24
well. One day after plating the medium was replaced by fresh BME. Neurons were maintained
in humidified incubators supplied with 5% C02 at 37°C. During the whole procedure BME was
supplemented with 2% B27 (Invitrogen), 1% fetal bovine serum (FBS), 0.45% glucose, and
0.2mM L-glutamine.
4.2.4.7 Transfection of primary cultured neurons
Primary cortical and hippocampal neurons were transfected according to the protocol for trans-
fection of hippocampal neurons based on DNA/Ca2+-phosphate coprecipitation descibed by
Köhrmann et al. [Köhrmann et al., 1999]. Neurons were transiently transfected at DIV1-5.
Before transfection the original culture medium was exchanged to Minimum Essential Medium
Eagle (MEM, Invitrogen), during the transfection procedure the original medium was kept in
an incubator with 5% CO2 at 37°C. Per each 24 well 1.5 μg endotoxin free DNA was used. The
DNA needed for the transfection of two 24 wells was added to 60μl 250mM CaCl2 and 60μl
BES buffer was added dropwise while the transfection mix was vortexed for 20 seconds. The
transfection mix was carefully added to the culture medium and the neurons were incubated at
2.5% CO2 for 20 - 40 minutes. Formation of a thin Ca2+-phosphate precipitate was monitored.
When a precipitate was visible neurons were washed twice with HBS and 3 times with BME. In
the end the original medium was added back to the cells.
4.2.4.8 Silencing of primary cultured neurons
Hippocampal neurons were transfected with a plasmid expressing GFP to visualize axons and
dendrites. At DIV 2, 1 day after transfection, 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo-[f]-
quinoxalin-7- sulfonamide (NBQX) was added to the culture media in a final concentration
of 10 or 200nM for 13 days. Control neurons were incubated in unsupplemented media. At DIV
14 neurons were fixed and analyzed using the the Sholl Analysis plug-in for ImageJ software.
4.2.4.9 Cell viability assay
Primary neurons were transfected on DIV5 with plasmids expressing GFP or GFP and the
shRNA against RIM3γ or RIM4γ. Cells were fixed and analyzed on DIV 14. To identify
nonviable cells propidium iodide (PI) was added to the cell culture medium 30 minutes prior
to fixation. For quantification the total number of transfected neurons and PI-positive neurons
were counted per micrograph image (Zeiss Axio Observer.A1, A-Plan 10X 0.25NA objective).
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4.2.5 Microscopy and imaging analysis
4.2.5.1 Microscopy
Transfected primary neurons, HEK293T cells and NG108-15 cells were imaged with a light
microscope (Zeiss Axiovert Observer 1A). For high magnification of cells in culture and in
immunolabeled brain sections, imaging was performed with a confocal microscope (Leica TCS,
Zeiss LSM710 and Nikon Eclipse Ti).
4.2.5.2 Quantification of synapse density
Cultures were transfected at DIV 3 with a plasmid expressing GFP alone (control) or together
with shRNAs against RIM3γ (shRIM3) and RIM4γ (shRIM4) and immunostained at DIV 14
with anti-synapsin 1 and anti-PSD-95 antibodies. Cultured neurons were imaged with a Nikon
A1/Ti-E confocal microscope using a Lambda-S CF1Apo 40X WI 1.25 NA objective. Masks
representing synapsin1/PSD-95 colocalization were created with ImageJ before counting spots
of overlapping synapsin/PSD-95 staining on or adjacent to the transfected neuron.
4.2.5.3 Quantification of Golgi morphology
Hippocampal neurons were transfected at DIV 3 with either shRNAs against RIM3γ (shRIM3)
or RIM4γ (shRIM4), or mutated variants of both shRNAs (mutated shRIM3, mutated shRIM4),
or GFP alone (control). At DIV 14 cultures were fixed and the Golgi apparatus was visualized
by staining with anti-GM130 antibody. Micrograph images (Zeiss Axio Observer.A1, Plan-NEO
FLUAR 40X 0.25 NA objective) of Golgi apparatus were analyzed using ImageJ. To quantify
Golgi dispersion the ratio of the convex area of the Golgi outline and of the Golgi fragments
was measured, and to quantify Golgi condensation the proportion of the neuron covered by the
Golgi apparatus was calculated.
4.2.5.4 Axon quantification
Hippocampal neurons were transfected with either shRNAs against RIM3γ (shRIM3) or RIM4γ
(shRIM4), or mutated variants of both shRNAs (mutated shRIM3, mutated shRIM4), or GFP
alone (control) at DIV 1. Axonal length was measured on DIV5 using the ImageJ plug-in
NeuronJ. Growth velocity was analyzed by life imaging of hippocampal cultures, transfected
on DIV 7, between DIV 8 and DIV 11 and tracking axonal growth cones 24–48 hours after
transfection.
4.2.5.5 Life cell imaging of Rab vesicle traffic
Live cell imaging
Cortical neurons were grown on chambered coverglas (8-well chambered borosilicate coverglas
dish, LabTek). At DIV 1 neurons were cotransfected with either Rab6-GFP or Rab8-RFP or
Rab11-RFP together with shRNAs against RIM3γ (shRIM3) or RIM4γ (shRIM4) or RFP alone.
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4 days after transfection Rab marked vesicular traffic was imaged in living neurons. The cham-
bered coverglas dish was placed in the a heating element with 37°C, attached to a CO2 controller
providing 5% CO2. Fluorescent vesicles were imaged over 10 minutes with a frame rate of 6
images per minute with a Nikon A1/Ti-E confocal microscope using a Lambda-S CF1Apo 20X
1.25 NA objective.
Vesicle tracking and quantification
Vesicles were tracked manually by using the ImageJ Plugin MTrackJ (http://www.imagescience.
org/meijering/software/mtrackj/). Vesicle path length and velocity were quantified with the
MTrackJ plugin. Fractions of mobile and immobile vesicles were quantified with the help of
ImageJ. The obtained image sequences of 10 minutes were first converted in a z-projection to
create an image that contained the total vesicle amount. After subtraction of the background
mobile and immobile vesicles were quantified by counting all particles on 100μm long area of the
axon. An image containing only vesicles that were stable throughout the 10 minutes imaging
time (immobile vesicle fraction) was created by converting the 10 minutes into a summed image
and subtracting the same background as for the quantification of the total vesicle amount.
Mobile vesicles were quantified in the same area as the total vesicle amount. Immobile vesicles
are the difference between total vesicle amount and mobile vesicles.
4.2.6 Immunochemical methods
4.2.6.1 Immunocytochemistry
Primary neurons, HEK293T cells and NG108-15 cells were washed once with PBS and fixed
with 4% paraformaldehyde in PBS for 10–15 minutes at room temperature. After washing 3
times with PBS, cells were permeabilized in 0.3% Triton X-100 in PBS for 10 minutes. Directly
after permeabilization a blocking step was performed by incubating the cells in blocking buffer
(10% goat serum, 1% BSA, 0.1% Triton X-100 in PBS) for at least 30 minutes, after which a
primary antibody containing solution was applied and incubated overnight at 4°C. After three
washes with PBS, fluorochrome-labeled secondary antibodies were applied, and incubated for 45
minutes at room temperature. Finally, cells were washed with PBS and coverslips were mounted
in Moviol and left to dry overnight at room temperature.
4.2.6.2 Immunohistochemistry
Freshly dissected rat or mouse brains were incubated overnight in 4% paraformaldehyde in
PBS at 4°C. After overnight fixation 100μm sagital brain slices were cut on a vibratome Mi-
crom HM650V (Waltham, USA). Brain slices were collected in 12 well culture dishes with 4%
paraformaldehyde in PBS. Freefloating stainings were performed in the 12 well culture dish
wells. Slices were washed once with PBS, blocked 1 hour at room temperature in PBS 10% goat
serum, 0.3% Triton X-100 and labeled with first antibodies in PBS containing 5% goat serum
over night at 4°C. The next morning slices were washed 3 times with PBS and incubated with
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fluorochrome-labeled secondary antibodies in PBS containing 5% goat serum 2 hours at room
temperature. After washing off excess antibody with PBS, slices covered using Moviol mounting
medium.
4.2.7 Biochemical methods
4.2.7.1 RIM3γ and RIM4γ specific antibody production
Specific antibodies against rat RIM3γ and RIM4γ were raised against the N-terminal aminoacid
sequence NH2-FNGEPGPASAGASRNC-CONH2 (RIM3γ) and NH2-CFDDEDAADSRRLKGAI
QR-CO NH2 (RIM4γ) after an epitope analysis (Janin, 1979) by Pineda antibody service
(http:// www.pineda-abservice.de). Antibodies were purified from rabbit immunosera by affin-
ity chromatography on a column to which the synthetic peptide was linked covalently. The
specificity of the antibodies was controlled by antigen blocking. For antigen blocking the puri-
fied RIM3γ and RIM4γ antibodies were diluted 1:100 and 1:100 in PBS containing 10% goat
serum, 1%bovine serum albumin (BSA), and 0.1% Triton X-100 equally divided into two tubes.
The first tube (antigen block) contained glutathione-Sepharose 4B beads bound to glutathione
S-transferase (GST)-RIM3γ and GST-RIM4γ fusion protein. In the second tube (control), the
glutathione-Sepharose 4B beads were bound to GST alone. Both tubes were incubated at 4°C
overnight, spun at 2000 rpm for 2 minutes and supernatants were used for immunoblot analysis.
Incubation with control antibody solution lead to the expected staining in immunoblot analy-
sis, whereas incubation with preblocked antibody solutions abolished the RIM3γ and RIM4γ
specific signal (appendix Fig 8.1). RIM3γ and RIM4γ antibodies were applied in Western blot-
ting, immunocytochemistry, and immunohistochemistry at a concentration of 1:100 and 1:100,
respectively.
4.2.7.2 Western blotting
Cell lysates from brain tissue were prepared from whole mouse brain or microdissected brain
areas. Directly after preparation tissue samples were frozen on liquid nitrogen and either stored
in -80°C or used directly. The frozen tissue samples were homogenized in 2ml/mg tissue phos-
phate buffered saline pH7,4 containing protease inhibitor cocktail (cOmplete, Roche) with the
help of a tissue grinder. Cells in the homogenized tissue samples were lysed by adding 6xLaem-
libuffer (TRIS-hydrochlorid 378mM, 30% glycerol, 12% SDS and 0,06% Bromphenolblue, 10%
β-mercaptoethanol) to the samples and a 1-5 minutes incubation. Proteins were denaturated at
95°C for 5 minutes.
HEK 293T cells were lysed in phosphate buffered saline pH7,4 containing protease inhibitor
cocktail and 1% triton X-100. The lysis reaction was incubated 1 hour at 4°C under rotation.
After the lysis protein lysates were separated from cell debris by centrifugation at 15000rpm,
5 minutes at 4°C. 6x Laemlibuffer was added to the samples and proteins were denatured at 5
minutes at 95°C.
Proteins of the cell lysates were separated by SDS polyacryalmide gel electrophoresis (SDS
PAGE) and blotted to nitrocellulose membrane over night. Membranes were incubated 1,5
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hours in blocking solution of either 5% fish gelatin in PBS or 5% milk powder in TBST to
avoid unspecific binding of antibodies. Proteins of interest were stained with primary antibodies
against the respective proteins. Antibody staining was visualized by incubation with IRDye
anti mouse 800nm or IRDye anti rabbit 680nm IgG (LI-COR) in a diluation of 1:20000 and a
infrared scanning system (Odyssey, Licor). Quantification of western blots was carried using the
analyze gels plugin of the FIJI software.
4.2.7.3 Protein purification from bacteria
GST(glutathione-S-transferase)-fusion proteins were expressed in e.coli BL21 (DE3). Bacteria
expressing the GST-fusion proteins were inoculated in a 5ml liquid LB-culture medium over
night at 37°C. The next morning overnight cultures were added to 500ml fresh LB-medium and
grown until an optical density (OD600) of 0,5 at 600nm was reached. At this OD600 protein
production was induced with 0,1mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) and the
cultures were incubated at 37°C for 3 hours. The bacteria were harvested by centrifugation
at 4°C and lysed for 20 minutes at 4°C under rotation in PBS containing Complete Protease
Inhibitor cocktail and 1% Triton X-100. Glutathione-agarose was added to the protein lysates
and incubated 1 hour at 4°C in order to allow coupling of GST fusion proteins to the glutathione
agarose beads. GST fusion proteins were purified in 3 washing steps. The successful protein
production and the amount of coupled proteins were analyzed by SDS-PAGE and Coomassie
staining.
4.2.7.4 GST Pulldown assay
GST-RIM3γ, GST-RIM4γ, GST-RIM1C2B and GST alone were in expressed in e.coli BL21
(DE3) and bound to glutathione-agarose beads. IQGAP3-GFP, IQGAP1-GFP, and Syd-1-HA
were overepressed in HEK293T cells. 48 hours after transfection HEK 293T cells were washed
once with PBS and lysed in PBS containing Complete Protease Inhibitor cocktail and 1% Triton
X-100 for 1 hour at 4°C. Cell lysates were centrifuged for 2 minutes at 4°C to separate cell debris
from solubilized proteins. To test binding of GST-RIM proteins to potential interaction partners,
agarose coupled GST-RIMs were added to the HEK cell lysates and incubated for 2 hours at
4°C. After the binding reaction protein complexes were washed 3-5 times with PBS containing
1% Triton X-100 and analyzed by western blotting. GFP bound proteins were detected with
GFP antibodies (anti-GFP mouse monoclonal Santa Cruz, 1:1000) and HA tagged proteins with
antibodies against HA (anti-HA mouse Convance, 1:1000).
4.2.7.5 Co-immunoprecipitation
HEK293T cells were transfected with pairs of proteins, of which interaction should be tested,
with polyethylenimine. 48 hours after transfection HEK293T cells were washed once with PBS
and lysed in PBS containing Complete Protease Inhibitor cocktail and 1% Triton X-100 for 1
hour at 4°C. Cell lysates were centrifuged for 2 minutes at 15000 rpm at 4°C to separate cell
debris from solubilized proteins. Protein complexes of the potential interaction partners were
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purified by coupling to magnetic beads bound to antibodies against the flag sequence of the
affinity tag of RIM3γ-TAP, RIMγ4-TAP and RIM1-C2A-C2B-TAP. The precipitated protein
complexes were washed 5 times with PBS containing 1% Triton X-100 and analyzed by western
blotting. TAP tagged proteins were detected with antibodies against flag (anti-flag, mouse,
Sigma, 1:5000) GFP bound proteins with GFP antibodies (anti-GFP mouse monoclonal Santa
Cruz, 1:1000), HIS tagged proteins with antibodies against HIS (anti-HIS, mouse Neuromab
1:200) and HA tagged proteins with antibodies against HA (anti-HA mouse Convance, 1:1000).
4.2.8 Mass spectrometry proteomics approach
4.2.8.1 Protein purification and preparation of tissue fractions
Protein purification from HEK cells
HEK293T cells were transfected with TAP(tandem (streptavidin-flag) affinity purification) affin-
ity tag-tagged RIM3γ and RIM4γ and the TAP tag alone as control with polyethyleneimine.
48 hours after transfection cells were washed once with ice cold PBS and lysed in Lysisbuffer
(50mM Tris HCL (pH7,5), 150mM NaCl, 2%Triton X-100 and Complete proteinase inhibitor
cocktail) for 1 hour at 4°C. Cell lysates were centrifuged at 15000rpm for 2 minutes at 4°C to
separate cell debris from solubilized proteins. The obtained supernatants were incubated 1 hour
with prewashed magnetic beads coupled to flag-antibodies. Bound TAP tagged proteins were
purified by washing the magnetic beads 2 times with a low salt buffer ( 50mM Tris HCL (pH7,5),
100mM NaCl, 2%Triton X-100), 2 times with high salt buffer (50mM Tris HCL (pH7,5), 500mM
NaCl, 2%Triton X-100) and once with PBS.
Preparation of whole brain lysates
Brains of C57 BL/6 wild type mice were prepared freshly and the cerebellum and white matter
were removed. Brains were homogenized in 2mM HEPES buffer (pH7,4) containing 0,32M
sucrose, 50mM EDTA (3ml per animal) in a teflon glass potter with 7 strokes of 900rpm.
Homogenates were solubilized with 20μl Triton X-100/ml for 2 hours at 4°C. The solution was
clarified by centrifugation and the supernatant used for the binding reaction.
Preparation of crude synaptosomes
Brains of C57BL/6J wild type mice were prepared freshly and the cerebellum and white matter
were removed. Brains were homogenized in 2mM HEPES buffer (pH7,4) containing 0,32M
sucrose, 50mM EDTA (3ml per animal) in a teflon glass potter with 7 strokes of 900rpm.
Homogenates were centrifuged with 3000g at 4°C for 15 minutes. The resulting supernatant
was transferred to a new tube and centrifuged at with 15000 rpm at 4°C for 25 minutes. After
the second centrifugation the supernatant was discarded and the obtained synaptosomal pellet
was resuspended in CL144 or lysisbuffer containing 2% Triton X-100 (50mM Tris HCL, 150mM
NaCl, pH 7,5, complete proteinase inhibitor) and incubated for 1 hour at 4°C. The solution was
clarified by centrifugation and the supernatant used for the binding reaction.
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4.2.8.2 Binding assay
Purified TAP-tagged RIM3γ and RIM4γ and the TAP tag alone coupled to magnetic beads
were incubated with either crude synaptosomal fractions or whole brain lysates for four 4 hours
at 4°C. Subsequent to incubation magnetic beads and coupled proteins were washed twice with
low salt buffer, twice with high salt buffer and once with PBS and denaturated at 95°C in 1x
loading buffer (Life technologies). Samples were separated by electrophoresis in a 12% pre-cast
NuPAGE Bis-Tris gel and subsequently visualized by Coomassie Colloidal Blue over night, to
control for the successful binding reaction.
4.2.8.3 In Gel tryptic digestion
Bands of the binding reactions and control reactions on the NuPAGE Bis-Tris gel were cut into
equal small gel pieces and transferred to endotoxin free 1,5ml tubes. 200μl of destaining solution
(Trypsin Profile IGD Kit, Sigma Aldrich) were added to each gel piece and incubated at 37°C.
30 minutes later the solution was removed and discarded and the destaining step was repeated.
The destaining steps were followed by reduction and alkylation of cysteines to irreversibly break
up disulfide bonds. Destained gel pieces were first dried in a centrifugal evaporator for 15-30
minutes. To reduce disulfide bonds to thiol groups, the dried gel pieces were incubated in 100μl
of 20mM Dithiothreitol (DTT) in 100mM ammonium carbonate at 55°C for 30 minutes. The
remaining solution was removed and 100μl of iodoacetamide was added to irreversible alkylate
SH groups. After 30 minutes in the dark the remaining solution was removed and the gel
pieces were incubated in 200μl of 100mM ammonium carbonate containing for 3 minutes. The
supernatant was removed and the gel pieces were first incubated 5 minutes in 50% acetonitrile
and subsequently 5 minutes in 100% acetonitrile. Before trypsin digestion the gel pieces were
dried in a centrifugal evaporator. Each dried gel pieces was incubated with 0,4μg Trypsin
in Trypsin reaction buffer (Trypsin Profile IGD Kit, Sigma Aldrich) over night at 37°C. The
remaining supernatant containing the extracted tryptic peptides was transferred to a new tube
and dried in a centrifugal evaporator. Dried samples were subjected to LC-MS/MS analysis.
4.2.9 Knock-out mouse generation and behavioral experiments
All procedures were performed in accordance with the guidelines of the Bonn University Medical
School Care Committee. Mice were kept in an animal facility, with a maximum of 5 animals per
cage with water and food provided ad libitum, and under the control of an alternating 12-hour
light or dark cycle.
4.2.9.1 Generation of RIM3γ and RIM4γ knock-out mice
Null mice for either RIM3γ or RIM4γ activity were generated utilizing ES cells produced by
the international Knock-out Mouse Project (KOMP) consortium. The KOMP knock-out con-
struct is designed to create three different mouse lines (Fig. 5.19): The line obtained after germ
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line transmission constitutes a “knock-out first” allele, in which insertion of a splice acceptor-
lacZ gene trap cassette disrupts the endogenous RIM3γ and RIM4γ transcripts resulting in
a constitutive knock-out (RIM3γconstKO and RIM4γconstKO). After FLP-mediated excision
of the gene trap cassette a conditional KO is obtained (RIM3γflox and RIM4γflox); and (3)
Cre-mediated recombination results in a null allele (RIM3γKO and RIM4γKO). RIM3γ knock-
out mice were generated from the JM8A3.N1 ES cells carrying the RIM3γ targeting vector
(IKMC Project: 34392; http://www.mousephenotype. org/martsearch_ikmc_project/ mart-
search /ikmc _project/34392). RIM4γ knockout mice were generated from the JM8A3.N1 ES
cells carrying the RIM4γ targeting vector (IKMC Project: 37192; http:// www.mousephenotype.
org/martsearch_ ikmc_project/ martsearch/ikmc_project/37192). Es cells were injected into
Balb/c mice. The resulting chimeric mice were monitored by coat color and genotyped by
PCR. The following primers were used for the RIM3γ constKO line: const KO RIM3γ 5’-
GGACCACACTGCAATG-CTAA-3’ and 5’-CCCTTCAGTC TTCCTGTCCA-3’ product size
618 base pairs; wild type RIM3γ 5’-GGACCACACTG CAATGCTAA-3’ and 5’-ACCAGACTCC
AAAGCCCTC-3’ product size 324 base pairs. The RIM4γ constKO line was genotyped with the
primers: const KO RIM4γ 5’-GCATGATGGGAAGGAATGCCAAGC-3’ and 5’-CCCTTCAGT
CTTCCTGTCCA-3’ product size 632 base pairs; wild type 5’-GCATGATGGGAAGGAATGCC
AAGC-3’ and 5’-GTTCAGGCCAGGGCTTCTCCATGC-3’ product size 324 base pairs. All
analysis were carried out with littermates of heterozygous matings.
4.2.9.2 Gait analysis
Gait analysis of RIM4γ knock-out mice was performed with the CatWalk XT system (Noldus
Information Technology). A cage with used bedding was placed at the end of the walkway to
motivate the mice to cross the walkway without hesitation. While crossing the glass walkway
footprints of mice were recorded with a high speed camera. To obtain comparable data mice
had to cross the walkway within 10 seconds without turning or stopping in between. Mice were
tested 3 times with one week recovery time in between testing days. Only data of mice that
performed 3 consecutive runs meeting the criteria above were included in the quantification of
the gait performance. During episodes of hind limb impairments RIM4γ knock-out mice were
not able to cross the walkway within 10 seconds. Footprints of theses runs were excluded from
the quantification and only used to represent the severity of the phenotype. Quantification of
footprints was performed with the Catwalk XT 9.0 software (Noldus Information Technology).
4.2.9.3 Motor performance on Rotarod
Motorcoordination of mice was tested on a rotating beam (Rota-Rod ENV-575MA Five Station
USB, Med Associates Inc.). Mice were tested at an age of 14-16 weeks once a week for 3
consecutive weeks. Velocity of the rotating rod was accelerated from 4 rounds per minute (rpm)
to 40 rpm within 5 minutes during each testing round and the time until mice fall off the rod
was monitored with a cut off at 5 minutes. Mice were first habituated on the rod for 5 minutes.
After a recovery phase of 15 minutes mice had to perform 3 test rounds with again 15 minutes
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recovery phases in between. The results are the means of 9 tests on 3 days.
5 Results
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Results
RIM3γ and RIM4γ belong to the protein family of Rab3-interacting-molecules (RIM). The large
members of the RIM protein family (RIM1α, RIM1β, RIM2α, RIM2β) are multidomain proteins
enriched at the presynaptic active zone. At the active zone they form a scaffold with numerous
interaction partners and govern thereby several steps of presynaptic neurotransmitter release.
RIM3γ and RIM4γ are much smaller and share only the C2B domain with the large RIMs. Also
their subcellular localization differs from the large RIM proteins. RIM3γ is strongly expressed
in the nucleus and shows a punctate synaptic expression pattern along axons and dendrites.
RIM4γ is absent from the nucleus and shows a diffuse distribution along axons and dendrites.
This already suggests that the function of the small members of the RIM protein family might
differ from the synaptic function of the large RIM proteins, which show a specific presynaptic
localization. First knock-down experiments in primary neuronal cultures revealed that the loss
of RIM3γ and RIM4γ leads to an impairments in neuronal growth [Alvaréz-Baron, 2010]. But
the full impact on neuronal morphology and the molecular mechanisms underlying the function
of γ-RIMs during neuronal growth have not been analyzed yet.
5.1 RIM3γ and RIM4γ’s specific subcellular localizations are
governed by their N-terminal sequence
Studies on the subcellular localization of a protein can reveal its enrichment to cellular organelles
or specialized compartments of a neuron and might thereby give first hints about the molecular
function of a protein. The localization of a protein is on the one hand controlled by intracellular
transport systems and its interaction partners, which target the protein to the desired destina-
tion. On the other hand localization signals within the amino acid sequence of a protein can
determine the subcellular localization of a protein, by for example allowing the integration of
the protein into the plasma membrane or into membranes of cellular organelles. The nucleus of
a cell is the place of gene transcription, this process is controlled by a great variety of proteins,
allowing the cell to adapt its gene expression patterns to exterior conditions. This adaptation
involves the frequent import and export of proteins in and out of the nucleus. The nuclear trans-
port of proteins is tightly regulated by proteins of the nuclear pore complex. One part of this
nuclear pore complex are importin receptors, which are able to recognize nuclear localization
signals within the amino acid sequence of potential cargo proteins and induce their translocation
into the nucleus.
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Figure 5.1: Alignment of the RIM3γ and RIM4γ amino acid sequence reveals a high dregree of
homology between both proteins. Bioinformatical analysis identified a nuclear localization signal in the N-
terminus of RIM3γ and a nuclear export signal in the C2B domain of both γ-RIMs. Multiple sequence alignment
was performed with the bioinformatical program Tcoffe (http://www.ebi.ac.uk/Tools/msa/tcoffee/).
The export of proteins out of the nucleus is regulated in a similar fashion. Exportins in the
nucleus recognize nuclear export signals of export cargos and initiate their transport out of the
nucleus.
Dispite their differing subcellular localization RIM3γ and RIM4γ show a high degree of sequence
homology (Fig. 5.1). A bioinformatic search for nuclear import and export signals within the
sequence of RIM3γ and RIM4γ revealed a nuclear localization signal in the N-terminus of RIM3γ
and a nuclear export signal in the C2B domain of both proteins. To verify the functionality of
the nuclear localization signal identified in the sequence of RIM3γ, expression plasmids for
truncated variants of RIM3γ comprising either the N-terminal sequence or the C2B domain of
RIM3γ were generated. Additionally, the nuclear localization signal of RIM3γ was mutated in
a full-length expression plasmid of RIM3γ by exchanging the nucleotides coding for the nuclear
localization signal. After transfection into NG108 neuroblastoma cells the N-terminal construct
was predominantly located in the nucleus whereas the C2B domain and the mutated version
missing the nuclear localization signal were not able to translocate to the nucleus (Fig. 5.2A).
This proves that the predicted nuclear localization signal in the protein sequence of RIM3γ is
functional and can mediate the nuclear enrichment of RIM3γ.
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Figure 5.2:RIM3γ’s nuclear localization is governed by a nuclear localization signal in its N-terminus.
A, HEK293T cells were transfected with a vector expressing different variants of RIM3γ fused to GFP. The full-
length construct and the N-terminal fragment show a strong nuclear expression whereas the C2B domain and
the construct with a mutated nuclear localization signal are absent from the nucleus. B, Mutations of the last
two amino acids in the nuclear export signal do not change the localization of RIM3γ. Vectors expressing either
RIM3γ or a mutated protein (RIM3 γ-ΔNES) fused to GFP were transfected into primary cortical neurons,
NG108 neuroblastoma cells and HEK29T cells. Both RIM3γ and the its mutated variant, show similar cytosolic
expression levels. C, Incubation of HEK293T expressing RIM3γ-GFP with 5nM Leptomycin, does not lead to
the restriction of RIM3γ to the nucleus.
The nuclear export signal of RIM3γ lies in its C2B domain and is compromised of five amino
acids. Mutations of the nucleotides coding for the two last amino acids of the nuclear export
sequence did not block the export of RIM3γ from the nucleus after overexpression in HEK293T
cells, NG108 cells or primary cortical neurons (Fig. 5.2B). This does not exclude the functionality
of the nuclear export signal, as the first three amino acids could be sufficient to maintain its
function. Additionally, overexpression could mask a decreased nuclear export of RIM3γ as the
protein levels after overexpression exceed by far the endogenous protein levels.
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CRM1 (chromosome region maintenance 1; also referred to as exportin1) is an important nuclear
export receptor, mediating the nuclear export of many proteins. This process can be blocked by
the application of Leptomycin B [Fornerod et al., 1997]. To investigate if the nuclear export of
RIM3γ is actively regulated by CRM1 we incubated HEK 293Τ cells overexpressing RIM3γ for
1 hour with 5nM Leptomycin B and subsequently fixed the cells to analyze the distribution of
RIM3γ. The block of CRM1 mediated nuclear export did not restrict RIM3γ to the nucleus, as
the cytosolic expression levels appeared to be unchanged after incubation with Leptomycin B and
only ethanol as control (Fig. 5.2C). This again suggests, that the nuclear export sequence in the
C2B domain of RIM3 γ is not functional. However to definitively exclude active nuclear export
of RIM3γ in neurons this export needs to be analyzed in a more physiological and quantitative
way.
In summary, RIM3γ and RIM4γ show a more diverse subcellular distribution than the large
RIM protein family members. Whereby the strong nuclear expression of RIM3γ is mediated by a
nuclear localization signal in the N-terminus of RIM3γ. The amino acid sequence of RIM4γ does
not exhibit a nuclear localization signal consistent with its absence from the nucleus. A nuclear
export signal in the C2B domain is conserved between both proteins. Although the functionality
of this sequence could not be proven it suggests that shared functions of RIM3γ and RIM4γ
are mediated by the highly homologous C2B domain whereas isoform specific functions and also
their subcellular localization might be mediated by the differing N-terminal domains.
CHAPTER 5. RESULTS 59
5.2 Characterization of knock-down effects in neurons
ShRNA mediated knock-down of RIM3γ and RIM4γ leads to drastic growth impairments in
cultured primary neurons [Alvaréz-Baron, 2010]. Neurons transfected with shRNAs against
RIM3γ and RIM4γ on DIV3 exhibit only very few short dendrites when analyzed at DIV14.
At this time point control cells transfected only with GFP have already established a complex
dendritic tree. Interestingly, the phenotype could be cross-rescued, as the overexpression of
RIM3γ could restore the growth deficits in RIM4γ-knockdown neurons and vice versa. Already
the overexpression of the C2B domain of RIM3γ or RIM4γ was sufficient to partially restore
the growth deficits. These findings suggest, that the role of RIM3γ and RIM4γ during neuronal
growth is a shared function of both proteins mediated by their C2B domain. However, the knock-
down experiments were performed early during neuronal development, leaving an possible impact
on later developmental stages unresolved. Furthermore, it remained unclear so far if RIM3γ and
RIM4γ’s function is restricted to dendrites or affects also axonal growth.
5.2.1 RIM3γ and RIM4γ are involved in general growth promoting mechanisms
Drastic morphological changes in primary neuronal cultures after genetic manipulations like
shRNA mediated protein knock-down could be a side effect of increased cell death. To rule this
out in the case of RIM3γ and RIM4γ knock-down we labeled control neurons and knock-down
neurons 11 days after transfection with propidium iodide. Propidium iodide is a red fluorescent
DNA-intercalating dye, that is not permeant to living cells and can therefore be used to mark
dead or dying cells. Primary cultured cortical neurons were transfected with either shRNAs
against RIM3γ and RIM4γ together with GFP or GFP alone as control on day in vitro (DIV) 3
and fixed and stained 11 days later. The percentage of viable cells was quantified by counting the
number of neurons, which expressed GFP but were not propidium iodide positive and the total
number of GFP positive cells. The percentage of dead cells did not differ between control and
knock-down neurons (Fig. 5.3D). These results confirm, that the reduced dendritic arborization
observed after the knock-down of RIM3γ and RIM4γ is not an result of increased cell death in
response to the knock-down.
Dendrites and axons share common growth regulatory mechanism but also employ signaling
pathways, which specifically influence dendritic or axonal growth. This allows a neuron to built
up the morphological and molecular distinct compartments of axons and dendrites. In order to
investigate if RIM3γ and RIM4γ’s growth promoting effects are restricted to dendritic growth
or play a role in general growth promoting mechanisms we analyzed the impact of the loss of
the two proteins on axonal growth. Directly after platting cultured primary neurons appear as
round asymmetrical spheres. During the next 24 hours several short processes, the so-called
minor neurites, are formed. About one day after plating neuronal symmetry brakes when one
of the minor processes starts to grow rapidly to become the axon. The other neurites stay short
until day in vitro 4-5 when they start to develop into dendrites. Axonal growth defects can be
therefore easily visualized in primary neuronal cultures at DIV5 when neurons exhibit only one
single long axonal branch and several very short dendritic protrusions.
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Figure 5.3: RIM3γ and RIM4γ knock-down affects early axonal outgrowth. A, Hippocampal neurons
transfected DIV1 expressing GFP (control), shRNAs against RIM3 γ (shRIM3) and RIM4 γ (shRIM4), shRNAs
with few nucleotide exchanges (mutated shRIM3 and mutated shRIM4) and coexpressing the shRNAs with the
respective resistant cDNAs (rescue RIM3 γ and rescue RIM4 γ) were fixed and analyzed by confocal microscopy at
DIV5. B, C, Quantitative analysis of total axonal length (B) and the number of axonal branches (C) showed, that
axonal outgrowth and branching are strongly reduced after knock-down of RIM3γ (shRIM3) and RIM4γ (shRIM4)
as compared to controls. Both parameters are unaffected after cotransfection of either shRIM3 or shRIM4 and
a resistant version of the respective RIM variant (rescue RIM3γ and RIM4γ) or the transfection of mutated
shRNAs against RIM3γ (mutated shRIM3) and RIM4γ (mutated shRIM4) (1-way ANOVA with Bonferoni post
Test, *** p<0.001, ** p<0.01) D, Primary neuronal cultures were transfected on DIV5 with plasmids expressing
GFP (control) or GFP and the shRNA against RIM3 γ or RIM4 γ. Cells were fixed and analyzed on DIV14.
Non-viable cells were identified using Propidium Iodide (PI) staining. Neurons transfected with shRNAs showed
no significant difference in viability compared to GFP transfected control cells (n=8 coverslips, 1-way ANOVA
p=0.69).
The impact of RIM3γ and RIM4γ on axonal growth was investigated by the transfection of
primary cortical neurons on DIV 1 with vectors expressing GFP alone as control or GFP together
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with the respective shRNAs (shRIM3, shRIM4). Analysis of fluorescent micrographs revealed,
that the knock-down of RIM3γ and RIM4γ decreased the total axonal length and the number
of axonal branches (Fig. 5.3A,B,C). These effects were not observed if neurons were transfected
with either a mutated non-functional shRNA or if shRNA-resistant RIM3γ and RIM4γ cDNAs
were coexpressed (constructs were described in [Alvaréz-Baron, 2010] , Fig 5A,B,C). Thus,
RIM3γ and RIM4γ seem to be involved in a general growth regulatory mechanism affecting the
development of dendrites and axons.
Figure 5.4: Absence of dendritic spines and reduction in synapse density in RIM3γ and RIM4γ
knock-down neurons. A, Hippocampal neurons transfected at DIV3 with either a vector expressing GFP
(control) or GFP and the shRNA against RIM3γ (shRIM3) or RIM4γ (shRIM4). All neurons were immunostained
using anti-Synapsin (SYN) and anti-PSD95 (PSD95) antibodies and analyzed at DIV14 by confocal microscopy.
Scale bar = 30µm, *= 5µm. B, Quantification of PSD95/Synapsin co-labeled synaptic punctae on RIM3γ
and RIM4γ knock-down dendrites. RIM3γ-shRNA (shRIM3) and RIM4γ-shRNA (shRIM4) neurons exhibit a
decreased synapse density compared to control. Quantification of Synapsin punctae density was performed using
ImageJ software (n: # branches / # cells, one-way ANOVA *** p<0.001).
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Axonal and dendritic development is not only the simple increase of a cellular or membranous
protrusion it also includes the development of specific axonal and dendritic structures like the
synapse with specialized presynaptic compartments in axons and postsynaptic densities in den-
dritic spines. The impairment in dendritic as well as in axonal growth after the loss of RIM3γ
and RIM4γ suggests, that the small γ-RIMs are involved in general neuronal growth processes.
This raises the question if the loss of RIM3γ and RIM4γ affects also the development of synaptic
structures. To answer this question, primary neuronal cultures were transfected with shRNAs
against RIM3γ and RIM4γ or a control vector at DIV3 and stained 10 days later with antibodies
against the presynaptic protein synapsin and the postsynaptic protein PSD95 (Fig. 5.4A). The
quantification of synapsin and PSD 95 positive synapses revealed a strong reduction in synapse
density in RIM3γ and RIM4γ knock-down neurons (Fig. 5.4B).
Figure 5.5: Synaptic silencing has no effect on neuronal morphology. A, Hippocampal neurons were
transfected with a plasmid expressing GFP at DIV1 to visualize dendrites and axons. From DIV2 to DIV14 the
cells were exposed to 10 nM or 200 nM 2,3- Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo-[f]-quinoxalin-7-sulfonamide
(NBQX). Control cells were incubated in normal media. All neurons were analyzed at DIV14. Scale bar =
100µm. B, Sholl analysis indicated no difference in neurite branching after synaptic silencing. In order to detect
even small changes in distal dendrites Sholl analysis was performed up to 250μm from the center of the neuron.
The large members of the RIM protein family are important regulators of presynaptic neuro-
transmitter release but to date it is unclear if the small γ-RIMs share this function. Thus a
reduction in neuronal activity due to an unknown function of RIM3γ and RIM4γ in synaptic
transmission could be one reason for the growth deficits in RIM3γ and RIM4γ knock-down
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neurons. Excitatory synaptic transmission is mainly mediated by AMPA (α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid) receptors. To test if a reduction in neuronal activity could
lead to the same effects as we observed in neurons deficient for RIM3γ and RIM4γ we si-
lenced neuronal cultures with different concentrations of the AMPA receptor blocker 6-nitro-
7-sulfamoylbenzo(f)quinoxaline-2, 3-dione (NBQX). One day after transfection of hippocampal
cultures with GFP to visualize the cells AMPA receptor mediated synaptic transmission was par-
tially blocked by the application of 10nM NBQX and fully by the application of 200nM NBQX
until the cells were analyzed on DIV 14 [Maclean & Bowie, 2011]. Analysis of cell morphology
on DIV14 revealed, that both the partial and the full block of excitatory synaptic transmission
did not lead to a growth defect in primary neuronal cultures (Fig. 5.5). Therefore, a possible
role of RIM3γ and RIM4γ in synaptic transmission seems not to contribute to their function
during neuronal growth.
5.2.2 RIM3γ and RIM4γ in-vivo knock-down is growth inhibitory
Cultured primary neurons do not form the complex neuronal network present in an intact
brain, where neurons establish complex and interconnected neuronal circuits and specialized
substructures. In order to investigate if the knock-down of RIM3γ and RIM4γ has the same
effect on the growth of a neuron, when a functional neuronal network surrounds it, we sparsely
injected lentiviral particles expressing GFP only as control or the respective shRNAs (shRIM3
or shRIM4) into the ventricle of rats directly after birth (P0). The infected brains were collected
and analyzed 21 days later. Cortical neurons transduced with the shRNA against RIM3γ and
RIM4γ revealed drastic changes in their morphology when compared to control cells expressing
only GFP. Knock-down neurons had only very few short neuronal processes whereas the control
cells had developed a complex dendritic arbor (Fig. 5.6A,B). In accordance with the observed
reduction in synapse density in vitro we detected a reduced numbers of dendritic spines in the
hippocampus and cortex of 21 day old rats, which had been injected with lentiviruses particles
expressing RFP together with a shRNA against RIM3γ directly after birth (Fig. 5.7A,B). To
exclude possible off-target effects leading to the impaired neuronal growth after the knock-down
of RIM3γ or RIM4γ in vivo we performed rescue experiments with a shRNA resistant RIM3γ.
Newly born rats were injected with lentiviral particles expressing RFP alone or RFP together
with the shRNA against RIM3γ or a combination of lentiviral particles expressing either RFP
together with shRNA or GFP together with a resistant version of RIM3γ. As in our previous
experiments we could observe a strong reduction in neuronal growth after knockdown of RIM3γ
when compared to control neurons expressing only RFP. Whereas cells that expressed both the
shRNA and a resistant RIM3γ exhibit a comparable neuronal morphology as control cells (Fig.
5.7C). These results demonstrate that decreasing the levels of RIM3γ and RIM4γ in the first 3
weeks after birth result in a dramatic alteration of neuronal morphology despite their contact
with intact neighboring cells and a normal microenvironment.
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Figure 5.6: In vivo knock-down of RIM3γ and RIM4γ leads to a drastic reduction in dendritic
complexity. A, Lentiviral particles expressing GFP alone (control) or together with shRNAs against RIM3γ or
RIM4γ were injected into the ventricle of P0 rat brains. Brains were analyzed at P21 by immunohistochemistry
with an antibody against GFP. Cortical control neurons displayed a normal morphology, showing regular dendritic
growth. In contrast, neurons transduced with the shRNAs, exhibited a strong deficit in the number of neurites,
indicating a greatly compromised neuronal branching. B, Higher magnification images of control and knock-down
cortical neurons revealed a striking loss in the dendritic arbor of neurons with decreased levels of RIM3γ and
RIM4γ as compared to control.
The reduced length of neuronal processes after the knock-down of RIM3γ and RIM4γ could be
on the one hand caused by defects in neuronal branch development and maturation but on the
other hand by an increase in the retraction of already formed neuronal branches. A contribution
of RIM3γ and RIM4γ in the retraction of dendrites was examined by the injection of lentiviral
particles expressing either RFP alone as control or together with shRNAs against RIM3γ and
RIM4γ in the hippocampus of 21 days old rats. Microscopic analysis 14 days later at postnatal
day 35 revealed no drastic decrease in the dendritic complexity in hippocampal RIM3γ and
RIM4γ knock-down neurons in comparison to control neurons (Fig. 5.7D) pointing to a role for
RIM3γ and RIM4γ during development the of neuronal branches.
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Figure 5.7: In vivo knock-down of RIM3γ reduces spine and synapse number, has no drastic effects in
the adult brain and can be rescued by coexpression of a resistant RIM3γ variant. A, Hippocampal
neurons of P21 rats show that neurons expressing the shRNA against RIM3γ exhibit a reduced number of
dendritic spines in comparison to control cells expressing only RFP. B, Quantification of the loss in spine density
in hippocampal and cortical RIM3γ knock-down neurons (T-test, Hippocampus *** p = 0.0003, cortex ** p =
0.0042). C, Lentiviral particles expressing RFP (control), the shRNA against RIM3γ (shRIM3) alone or together
with a green fluorescent resistant variant of RIM3 (RIM3γ resitant) were injected into P0 rat brains. At P21,
RIM3γ knock-down cortical neurons exhibited the expected loss in arborization, while neurons expressing both
shRNA and the resistant RIM3γ were undistinguishable from control neurons expressing RFP. D, Hippocampal
neurons of P35 rats infected with lentiviral particels expressing a shRNA agianst RIM3γ together with RFP at
P21 show no obvious reduction in their dendritic complexity when compared to control neurons expressing only
RFP.
5.2.3 Effects of RIM3γ and RIM4γ knock-down on intracellular vesicle trafficking
Neuronal growth is strongly dependent on continuous and highly spatially and temporally regu-
lated transport of membrane particles, cellular organelles and proteins. This enormous logistic
effort is mainly provided by vesicular transport throughout the cell. Several cellular organelles
are involved in the organization of the different steps of this vesicular transport. One important
regulator is the Golgi apparatus, it receives newly synthesized proteins from the endoplasmic
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reticulum, sorts them and sends them either directly to the plasma membrane or to the en-
dosomal compartment, a further vesicular sorting system. Unsurprisingly, disruption of Golgi
morphology has been shown to lead to growth impairments in neurons [Beffert et al., 2012, Berto
et al., 2014]. To gain first insights into the question if RIM3γ and RIM4γ are involved in Golgi
apparatus controlled vesicular transport, we analyzed Golgi morphology after the loss of RIM3γ
and RIM4γ in primary neuronal cultures.
Figure 5.8: Structural alteration of the Golgi apparatus in neurons lacking RIM3γ/4γ. A, Confocal
images of GM130 labeled cultured hippocampal neurons, transfected at DIV3 with either shRNAs against RIM3γ
(shRIM3) or RIM4γ (shRIM4), or mutated variants of the both shRNAs (mut. shRIM3, mut. shRIM4), or GFP
alone (control). Cells were fixed at DIV14 and stained against the Golgi marker GM130 (red). B, Quantification
of Golgi dispersion. While Golgi dispersion in RIM4γ knock-down cells is indistinguishable from controls, RIM3γ
knock-down leads to increased fragmentation and dispersion. C, Quantification of Golgi size shows that knock-
down of RIM4γ leads to a smaller, more condensed Golgi apparatus as compared to controls. B, C, These
structural alterations were abolished using the mutated shRNAs against RIM3γ or RIM4γ. Significance: one-way
ANOVA followed by Tukey‘s Multiple Comparison Test, *** p<0.0001.
The structure of the Golgi apparatus of neurons transfected on DIV3 with either a control
vector or shRNAs against RIM3γ and RIM4γ was visualized by staining with antibodies against
the Golgi protein GM130. Whereas in control neurons GM130 staining revealed the typical
ribbon-like structure of the Golgi apparatus, it appeared fragmented into punctate structures
and dispersed throughout the cytoplasm after knock-down of RIM3γ and strongly condensed in
RIM4γ knock-down neurons. Neither Golgi dispersion nor condensation was observed if non-
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functional shRNAs against RIM3γ and RIM4γ with point mutations in the target sequence
against the respective protein (mutated shRIM3 and mutated shRIM4) were transfected (Fig.
5.8A,B,C).
The observed changes in Golgi morphology suggest, that RIM3γ and RIM4γ play a role in
neuronal growth by regulating vesicular traffic. Vesicular traffic between different sorting centers
and also the plasma membrane is governed by small GTPases of the Rab protein family. Rab
proteins act as ’cellular cargo address labels’ marking vesicles for the specific transport routes
between the different sorting centers. This makes Rab proteins ideal markers to study the
vesicular transport routes in living cells. Several Rab proteins and their associated transport
routes have been shown to be crucial for neuronal growth [Villarroel-Campos et al., 2014]. Three
important regulators of vesicular transport during the development of neuronal arbors are Rab8,
Rab11 and Rab6. Rab6 might play a role in neurite outgrowth by regulating intra-Golgi traffic
and traffic from the Golgi to the plasma membrane [Schlager et al., 2010]. Rab8 is also found
on vesicles of the trans-Golgi network and in addition on vesicles of the recycling endosome.
Knock-down expreriments in primary neuronal cultures suggest that Rab8 is crucial for neurite
outgrowth and branching [Huber et al., 1995]. Rab11 is like Rab8 found on vesicles of the
recycling endosome but not present at the trans-Golgi network [Ullrich et al., 1996]. Traffic of
Rab11 positive vesicles has been shown to be important for axonal and dendritic growth. In
dendrites Rab11 was suggested to be involved in the cell surface expression of growth promoting
receptors and thereby to locally regulate branch arborization and elongation [Lazo et al., 2013].
Because of their well established role in neuronal growth we examined if trafficking of Rab11,
Rab8 and Rab6 marked vesicles is affected by the absence of RIM3γ or RIM4γ. Therefore we
transfected primary neuronal cultures with shRNAs against RIM3γ and RIM4γ in combination
with a plasmid expressing either Rab11, Rab8 or Rab6 fused to GFP at DIV3. On DIV7 axonal
traffic of vesicles carrying Rab11, Rab8 and Rab6 vesicles was analyzed by time lapse imaging
for 10 minutes with a frame rate of 10 seconds (Fig. 5.9A). For quantification the vesicles
were tracked manually through the obtained videos of 10 minutes and analyzed in regard to
their velocity, path length and fraction of moving and non-moving vesicles. The quantification
revealed that the knock-down of RIM3γ and RIM4γ impairs transport routes of Rab8 and Rab11
positive vesicles whereas Rab6 vesicle traffic was not significantly changed. The knock-down of
RIM3γ affected Rab8 and Rab11 transport routes with a decrease in the path length of both
vesicle fractions (Fig. 5.9B). The knock-down of RIM4γ had a broader effect as it reduced the
path length and velocity of Rab11 vesicles and changed the number of moving vesicles of Rab8
and Rab11 vesicular transport routes with an increase in Rab11 moving vesicles and a decrease
in Rab8 moving vesicles (Fig. 5.9B,C,D). The number of immobile vesicles was unchanged in
all conditions (Fig. 5.9E).
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Figure 5.9: Changed Rab11 and Rab8 vesicle dynamics after the knock-down of RIM3γ and RIM4γ.
GFP tagged Rab11, Rab8 and Rab6 constructs were coexpressed in rat primary cortical neurons together with
shRNAs against RIM3/4γ and RFP or RFP alone as control. After live cell imaging at DIV7 path length, velocity
and fractions of moving and non-moving of Rab6, Rab8 and Rab11 vesicles were analyzed. A, Exemplar stacks of
confocal images (imaged every 10 sec over 10 minutes) of cortical neurons transfected with Rab11 GFP together
with RFP or the respective shRNA (shRIM3, shRIM4) and RFP overlaid with manual tracks of vesicles over
a time periode of 10 minutes with a frame rate of 10 seconds. B, Quantification of vesicle path length. C,
Quantification of vesicle velocity. D, Quantification of the fraction of moving vesicles per 100μm during a 10
minutes interval. E, Quantification of vesicles that remained a the same position (non-moving vesicles) during
10 minutes imaging per 100μm. Significance: one-way ANOVA followed by Bonferoni post test * p> 0,05 **
p<0.001; n=number of cells.
Taken together, the knock-down of both γ-RIMs drastically decreases neuronal growth in early
developmental stages, affecting dendritic and axonal growth and synapse development. Addi-
tionally, the loss of RIM3γ and RIM4γ impairs Golgi morphology and also vesicular transport of
Rab11 and Rab8 vesicles. This suggest that the small γ-RIMs have a general growth promoting
function during the establishment of neuronal arbors, possibly by regulating vesicular transport
routes. The isofrom specific changes in Golgi morphology and Rab11 and Rab8 vesicle transport
imply, that RIM3γ and RIM4γ are either involved in intracellular traffic at different steps or
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have additional isoform specific functions.
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5.3 Identification of novel γ-RIM binding partners
Protein interactions are the fundament of signal transduction in cells. Signaling cascades of pro-
tein interactions govern all cellular processes form DNA transcription and protein translation to
cellular growth and movement as well as cell specific functions like propagation of vesicle fusion
and regulated secretion of signaling molecules, hormones and neurotransmitters. In order to elu-
cidate the function of a protein it is important to know its interaction partners and the signaling
pathways in which the protein participates. To date very little is known about molecular inter-
action partners of RIM3γ and RIM4γ. The high sequence homology between the C2B domain
of RIM3γ and RIM4γ and all other RIM proteins suggests that the small γ-RIMs might have
common interaction partners with RIM1/2. Consistently it was shown, that RIM3γ and RIM4γ
like the large RIM proteins bind to Liprins and the β-subunit of voltage-gated Ca2+channels
[Wang & Südhof, 2003, Uriu et al., 2010]. However, these suggested interaction rather indicate
a synaptic function than explaining the role of RIM3γ and RIM4γ in neuronal arborization.
5.3.1 Proteomics: affinity purification - mass spectrometry screen for novel
interaction partners
The identification of new γ-RIM specific interaction partners might help to understand their
role in neuronal arborization and to elucidate further γ-RIM functions in the cell. Analysis of
purified protein complexes by mass spectrometry is a well established approach to identify new
interaction partners of a protein. The stability of protein interactions can differ depending on the
presence of cofactors, post translational protein modifications and secondary interactions with
other proteins. Therefore the results of a mass spectrometry proteomic approach can show a high
variation depending on the exact experimental conditions. Taking this into account we performed
multiple independent mass spectrometry experiments with differing experimental conditions to
identify robust but also transient protein interaction partners of RIM3γ and RIM4γ.
5.3.1.1 Affinity purification - mass spectrometry of whole brain fractions and crude
synaptosomal fractions
The brain is composed of multiple different cell types like neurons, astrocytes, oligodendrocytes,
microglia and endothelial cells. Each cell type expresses a specific set of proteins which defines
their cellular identity. Homogenates of whole brain fractions contain this large variety of proteins
found in the brain and thus also all RIM3γ and RIM4γ interaction partners. However, the great
variety of proteins makes it difficult to detect interaction partners that are present in the brain
at only very low amounts. Therefore, we performed a mass spectrometry approach of the whole
brain fraction to identify interaction partners of all cellular compartments of a neuron and of
the crude synaptosomal fraction to identify interactions with less abundant synaptic proteins.
In a first approach expression plasmids of RIM3γ and RIM4γ fused to a GFP-biotin affinity
tag were generated and overexpressed in HEK293T cells. The overexpressed bait proteins were
purified via their biotin tag and incubated with whole mouse brain homogenates solubilized
with Triton X-100, allowing the formation of RIM3γ and RIM4γ protein complexes. After the
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incubation step RIM3γ and RIM4γ and their bound interaction partners were again purified
via the biotin tag. The bound proteins were separated according to their molecular weight
by gel electrophoresis and subsequently digested with trypsin into short peptides, which were
analyzed by mass spectrometry. To control for unspecific binding to the GFP-biotin affinity
tag we performed the same experiment with only GFP-biotin. As an additional control the
C2A-C2B domain of RIM1 was included in the experiment to reduce the background of proteins
showing a general affinity to C2 domains and detect γ-RIM specific interactions (Fig. 5.10A). In
our second screen for RIM3γ and RIM4γ interaction partners we tried to increase the amount of
neuron specific proteins, especially synaptic proteins, by using purified synaptosomal fractions
solubilized with CL114. Cl114 is a detergent of unknown composition, which is able to solubilize
the Triton-X 100 resistant cytomatrix of the active zone. To reduce unspecific bindings to the
bait proteins streptavidin-flag affinity tag (TAP) overexpression plasmids were used instead of
the larger GFP-biotion tag of the first experiment (Fig 5.10B).
Figure 5.10: Affinity purification - mass spectrometry experimental flow. A, Screen for RIM3γ and
RIM4γ interaction partners in whole mouse brain fractions: GFP-biotin labeled RIM3γ, RIM4γ, RIM1 C2A-
C2B-domains or only GFP-biotin were overexpressed in HEK293T cells, purified via the biotin tag and incubated
with Triton X-100 solubilized whole mouse brain homogenates. Bait proteins and bound interaction partners were
purified again via the biotin tag. The purified protein complexes were separated by gel electrophoresis and analyzed
by mass spectrometry. B, Screen for RIM3γ and RIM4γ in crude synaptosomal fractions: streptavidin-flag (TAP)
tagged RIM3γ, RIM4γ, RIM1 C2A-C2B-domains or only streptavidin-flag were overexpressed in HEK293T cells,
purified via the flag sequence and incubated with CL114 solubilized crude synaptosomal fractions. Bait proteins
and bound interaction partners were purified again via the Flag tag. The purified protein complexes were separated
by gel electrophoresis and analyzed by mass spectrometry.
The mass spectrometer is able to resolve the amino acid sequences of the digested peptides.
These peptide sequences are compared with protein databases to identify the composition of the
analyzed protein complex. The obtained results can be displayed in different values character-
izing the probability of the identified protein to be present in the sample. The peptide number
corresponds to the numbers of identified peptides from one protein and determines the sequence
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coverage of the protein. Peptide spectrum matches (PSM) are the number of mass spectrometer
spectra, which can be related to one protein. The protein score is composed of the number and
probability of peptide identifications corresponding to one single protein. To eliminate proteins
bound to the beads or the affinity tag of bait proteins we subtracted proteins that were as well
found in mass spectrometry data of the control reactions (GFP-biotin, steptavidin-flag). Pro-
teins which were detected in control and γ-RIM binding reactions but had more than a twofold
higher protein score in the datasets of RIM3γ or RIM4γ were still taken into account. Further-
more, we excluded proteins from our analysis that were also present in the mass spectrometry
data of RIM1 C2A-C2B-domains binding reactions. This approach lead to the identification
of 50 potential novel RIM3γ interaction partners and 44 novel RIM4γ interaction partners in
whole brain fractions, whereby 38 of these proteins were found in the data sets of both proteins
(see appendix table 8.1). The great overlap of both data sets suggests that the γ-RIMs have
shared functions, this is consistent with the observed growth deficit after the knockdown of
RIM3γ as well as RIM4γ. The novel binding partners were grouped into functional categories
by literature research. The largest groups of identified proteins from whole brain homogenate
could be associated to signaling cascades related to growth and neuronal development (22-20%),
adhesion molecules (21-18%), proteins involved in intracellular traffic (16-21%) and cytoskele-
tal proteins (16-17%) (Fig 5.11A). These functional categories were represented in RIM3γ and
RIM4γ data sets to similar amounts whereby cytoskeletal proteins were more abundant in the
data of RIM4γ. The novel RIM3γ and RIM4γ interaction partners overlapped mostly in the
groups of intracellular vesicle and protein traffic with 100% overlap. In lower amounts we found
synaptic proteins and two channel proteins. As specific interaction partners of RIM3γ we could
identify nuclear proteins like importins and the two calcium binding proteins reticulocalbin1 and
2 in whole brain fractions (Fig 5.11A, appendix 8.1). Importins are nuclear import receptors;
they recognize nuclear localization signals of target proteins and initiate their transport into the
nucleus. The sequence of RIM3γ compromises such a nuclear localization signal and is actively
transported into the nucleus (chapter 5.1). Thus the identified importins might mediate the
nuclear translocation of RIM3γ. The relatively low amount of synaptic proteins with only 10-
6,5% could be on the one hand due to a low level of synaptic proteins in the used whole brain
fractions. On the other hand the whole brain fractions were solubilized with the detergent Triton
X-100, a detergent that is not able to break up the tight cytomatrix of the presynaptic active
zone leading again to lower levels of active zone specific protein in the whole brain fraction.
Proteins identified from the synaptosomal homogenate were analyzed in the same manner as
described above. Percentages of identified protein categories reveal that the use of crude synap-
tosomal fractions drastically increased the amount of synaptic interaction partners. Additionally
the second experimental strategy strongly reduced the amount of proteins identified as shared
interaction partners of RIM3γ and RIM4γ and revealed a larger fraction of RIM3γ or RIM4γ
specific binding proteins. In this second screen we identified 74 novel RIM3γ interaction partners
and 34 novel RIM4γ interaction partners, of theses 98 proteins only 9 were found in the data
sets of RIM3γ and RIM4γ (see appendix table 8.2). Grouping of the novel interaction partners
into functional categories upon literature research revealed as largest group synaptic proteins
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(18-26,4%) followed by cytoskeletal proteins (12-23,5%) and proteins involved in intracellular
traffic (31-22%). In lower amounts we found adhesion molecules (5,5- 14,7%), channel proteins
(18-6%) and nuclear proteins (13-6%) (Fig 5.11B).
Figure 5.11: Functional categories of novel interaction partners suggest a role in vesicular traffic and
remodeling of the cytoskeleton. A,B, First 3 columns show categories and percentages of proteins identified
as novel interaction partners of RIM3γ (yellow), of RIM4γ (orange) and shared γ-RIM binding partners (grey).
The last column represents all detected proteins: grey represents the proteins found in the data sets of RIM3γ
and RIM4γ, yellow RIM3γ specific proteins and red RIM4γ specific proteins. A, Proteins detected in whole brain
homogenates solubilized with Triton X-100. B, Proteins identified in crude synaptosomal fractions solubilized
with Cl114.
As RIM3γ specific interaction partners we could again identify one member of the importin
family and the calcium binding protein reticulocalbin 2. The composition of the identified func-
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tional categories supports that the small γ-RIMs might have a functional role at the synapse
and an additional role in the promotion of neuronal growth by regulating intracellular traffic
and the remodeling of the cytoskeleton. According to literature research we selected a subset
of proteins from the whole set of novel RIM3γ and RIM4γ interaction partners that had a high
protein score and additionally seemed to be promising candidates to be involved the molecu-
lar mechanism underlying the function of RIM3γ and RIM4γ in neuronal growth. These most
promising candidates are listed in the table below (table 5.1). Variations in the calibration
of the mass spectrometer can cause high variations in the protein scores of identified proteins
explaining the much lower values in the second experiment. In whole mouse brain homogenates
we found the adhesion molecules δ-catenin, plakophilin2 and plakophilin4 with relatively high
protein scores. These proteins belong to a subfamily of armadillo repeat proteins that has been
associated with the regulation of dendritic growth possibly by an involvement in the remodeling
of the cytoskeleton [Elia et al., 2006, Keil & Hatzfeld, 2013]. In the synaptosomal fraction we
only detected the more distantly related armadillo repeat protein 3. In both tissue fractions
a large group of proteins involved in intracellular protein and vesicle transport was identified.
Interesting candidates that might explain the function of RIM3γ and RIM4γ in neuronal growth
and also the changes in Golgi morphology in RIM3γ and RIM4γ knock-down neurons are mem-
bers of the Exocyst complex. The Exocyst complex is involved in the site directed fusion of
several vesicular transport routes ensuring the correct delivery of vesicular cargos to the correct
fusion site. In whole brain homogenates we identified Exocyst complex component 1 (sec3)
and Exocyst complex component 4 (sec8) as novel binding partners of both γ-RIMs and in
crude synaptosomes Exocyst complex component 3 (sec6) as RIM3γ interacting protein. Fur-
ther important regulators of intracellular vesicular traffic are Rab proteins. In accordance to the
observed changes in intracellular traffic of Rab marked vesicles after the knock-down of RIM3γ
and RIM4γ we found various Rab proteins in the synaptosomal fractions. The correct remod-
eling of the cytoskeleton is a crucial mechanism during neuronal growth. From synaptosomes
and the whole brain fraction we could identify two members of the IQGAP family. IQGAPs are
involved in the crosstalk between actin and microtubules and have been shown to play an impor-
tant role in the development of axons and dendrites. As further cytoskeleton regulating proteins
we identified the CDC42 effector protein 1 in whole brain fractions as interaction partner of
RIM4γ and the CDC42 effector protein 5 as interaction partner of RIM3γ. Synaptic proteins
were mainly detected in the synaptosomal fractions. One interesting candidate detected in whole
brain fractions is the synapse defective protein Syd-1. Syd-1 is involved in the early stage of
synapse assembly and contributes to the recruitment of the RIM binding partner Liprin-α to
the active zone [Owald et al., 2012]. Syd-1 was not found in synaptosomal fractions however
several other members of the active zone like RIM1, the large scaffolding proteins Bassoon and
piccolo and proteins of the SNARE complex for instance SNAP25. Importins were identified
in both screens as specific interaction partners of RIM3γ. Protein interactions resolved in a
proteomics approach might not always be primary interactions but can also be secondary and
tertiary interactions, this depends strongly on the sensitivity of the protein interaction to the
experimental conditions like protein abundance in the used tissue fraction, composition of the
used buffers and sensitivity to trypsin digestion. Therefore the overlapping patterns of protein
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categories can already give an idea in which cellular functions RIM3γ and RIM4γ might be
involved. Further it has to be taken into account that peptides of trypsin-digested proteins
show different protein specificity, depending on the sequence homology of for example different
members of the same protein family. Thus a peptide with a relatively low specificity could be
correlated with several protein family members. Taken together the large fraction of proteins
directly involved in neuronal growth or in cellular processes underlying neuronal growth support
a functional role of RIM3γ and RIM4γ in neuronal development, whereby the composition of
the functional categories of the identified binding partners differed among both γ-RIMs. This
suggests that RIM3γ and RIM4γ have isoform specific function and might contribute differen-
tially to growth regulating processes. The identified synaptic proteins propose an additional
synaptic function in accordance to the presynaptic role of the large RIM proteins.
gene ID identified protein
protein score RIM3γ protein score RIM4γ
whole
brain
synaptosomes whole
brain
synaptosomes
Adhesion molecules
70882
Armadillo
repeat-containing protein
3
34
1500
Catenin
(cadherin-associated
protein), delta 1
502 285
5318 Plakophilin2 769
8502 Plakophilin4 129 442
Intracellular protein and vesicle traffic
55763
Exocyst complex
component 1 (Sec3)
491 164
211446
Exocyst complex
component 3 (Sec 6)
35
60412
Exocyst complex
component 4 (Sec8)
404 291
104886
Ras-related protein
Rab-15
31
19338
Ras-related protein
Rab-33B
57
270160
Ras-related protein
Rab-39A
19 19
67295
Ras-related protein
Rab-3C
57
19341
Ras-related protein
Rab-4A
57
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19346
Ras-related protein
Rab-6A
57
cytoskeletal and cytoskeleton regulating proteins
11135
CDC42 effector protein
(RhO GTPase binding) 1
484
58804 Cdc42 effector protein 5 30
10788
Ras
GTPase-activating-like
protein IQGAP2
32
128239
IQ motif containing
GTPase activating
protein 3 (IQGAP3)
158 603
synaptic proteins
12217 Bassoon 35 37
26875 Piccolo 30
116837
Regulating synaptic
membrane exocytosis
protein 1
68 121
85360
Synapse defective 1, Rho
GTPase, homolog 1
(syd-1)
246
20614
Synaptosomal-associated
protein 25
51
nuclear proteins
79711 Importin 4 150
3843 Importin 5 188
10526 Importin 8 119
76582 Importin-11 33
Calcium binding proteins
5954
Reticulocalbin 1,
EF-hand calcium binding
domain
658
26611 Reticulocalbin-2 396 88
Table 5.1: Novel RIM3 and RIM4 interaction partners repeatedly identified in whole brain and synaptsomal
fractions.(Protein score= the number and probability of peptide identifications corresponding to one single protein)
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5.3.1.2 Comparative mass spectrometry analysis of RIM3γ and RIM4γ binding partners in
whole brain and crude synaptosomal fractions
The experimental conditions of the two above described proteomic approaches, did not only dif-
fer in the used tissue fractions, detergents and purification tags of bait proteins but also in the
used mass spectrometers. To obtain more comparable results, which only differ in the cellular
fraction and in the used detergents we repeated the experiment in a combined approach. In this
experimental strategy we combined a search for novel interaction partners in whole brain frac-
tion solubilized with Triton X-100, crude synaptosomes solubilized with Triton X-100 and crude
synaptosomes lysed with the detergent CL114. All tissue samples were obtained from one brain
preparation to exclude variations within the tissue fractions. Bait proteins (streptavindin-flag
tagged RIM3γ and RIM4γ) used for the binding reactions with the three protein homogenates
were purified from one batch of HEK cells to ensure the same amount of bait protein in all exper-
iments. After incubation of the flag purified bait proteins with the different tissue homogenates
protein complexes were purified via the flag tag and separated by gel electrophoresis on the same
gel. Also the trypsin digestion of all samples was carried out in one experimental procedure be-
fore peptides were analyzed by LC-MS/MS (Liquid chromatography–mass spectrometry-mass
spectrometry) (Fig 5.12A). After analysis of the mass spectrometry data by literature research
and subtraction of unspecific binding partners as described above (5.3.3.1) we grouped identified
proteins of each binding reaction in the functional categories cytoskeleton regulating proteins,
kinase and phosphatases, transcriptional proteins and nuclear proteins, proteasomal proteins,
synaptic proteins, channel proteins, Ca2+-sensors and adhesion molecules.
The percental distribution in functional categories revealed similar results for the whole brain
fraction and synaptosomes lysed with Cl114 regarding cytoskeletal proteins and proteins in-
volved in intracellular traffic. Synaptosomes lysed with Triton X-100 however revealed only a
small percentage of cytoskletal proteins and proteins involved in intracellular traffic. Overall we
found only a small fraction of synaptic proteins in synaptosomes and whole brain homogenates,
whereby the use of the detergent Cl114 slightly increased the amount of this group in the
crude synaptosomal fractions (Fig 5.12A-C, appendix table 8.3). In this combinatory screen
for novel γ-RIM interaction partners we could not exactly reproduce the results of he first two
experiments, however a comparison of the identified proteins in all experiments reveals sev-
eral protein complexes or protein families that were found in multiple experiments. We could
repeatedly identify cyclin dependent kinases, calcium/calmodulin dependent kinases, IQGAP
proteins, CDC42 effector proteins, Fascins, microtubule associated proteins, kinesins, members
of the Exocyst complex, GIT1, rab proteins, Ephrin receptors, synaptosomal associated pro-
teins, synaptogyrins, synaptotagmin, synapsin, voltage dependent anion channels, importins
and reticulocalbins (see appendix table 8.4 for details). The repeated identification of these pro-
tein families proposes strongly that they might indeed interact with RIM3γ and RIM4γ in vivo.
Furthermore, the proteins detected in several experiments were associated with the functional
categories adhesion molecules, intracellular traffic, cytoskeleton, synaptic proteins and nuclear
proteins.
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Figure 5.12: Results of combinatory mass spectrometry approach. A, Experimental strategy: RIM3γ
and RIM4γ fused to a streptavidin-flag tag (TAP) were overexpressed in HEK 293T cells and incubated with
whole brain homogenates solubilized with Triton X-100, synaptosomal fractions solubilized with Triton X-100,
synaptosomal fractions solubilized with CL114. All cell lysates were obtained from one tissue preparation. After
the incubation step the formed protein complexes were purified via the flag tag of the bait proteins and further
analyzed by gel electrophoresis and mass spectrometry. B, Functional categories and percentages of potential
RIM3γ and RIM4γ interaction partners detected in lysates of whole brain homogenates, C, proteins identified in
synapsomal fractions lysed with Triton X-100, D, proteins identified in synaptosomal fractions lysed with CL114.
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These categories were most prominent in all screens for novel γ-RIM interaction partners, sug-
gesting that these novel interactions might have functional relevance in the molecular mechanism
underlying the growth promoting effect of RIM3γ and RIM4γ. In the last combinatory affinity
purification mass spectrometry experiment we identified a large number of kinases. To get first
insight in the question if a phosphorylation by these kinases might have a physiological rele-
vance we performed a bioinformatic search for phosphorylation sites in the amino acid sequences
of RIM3γ and RIM4γ. This analysis revealed a phosphorylation sites in the sequence of both
γ-RIMs by the repeatedly identified kinases Cyclin dependent kinase 5 (CDK5) and Calcium
calmodulin dependent kinase 2 (CAMKII) (table 5.2).
RIM3γ
Kinase Site Sequence
CAMKII S104 SRVTRQGSRESTDGS
CAMKII L298 RRLSQSSLESATSPS
CDK5 T181 VIEARGLTPKPGSKS
RIM4γ
Kinase Site Sequence
CAMKII S63 SRTLRQASHESIEDS
CAMKII S254 GPLLRQASQLSLEST
CDK5 S190 QVLLFPESPQGKVLQ
Table 5.2: In affinity-purification mass spectrometry screen for novel -RIM interaction partners identified kinases
and predicted binding sites (http://scansite.mit.edu/).
Taken together, besides a general variation in the results of individual experiments we were
able to reproduce the results regarding functional categories and even to identify a cluster of
proteins that are promising candidates to understand the cellular function of RIM3γ and RIM4γ
repeatedly in multiple experiments. In addition by changing the tissue fraction and detergent
properties we were able to increase the amount of potential synaptic interaction partners.
5.3.2 Analysis of potential novel γ-RIM binding proteins
5.3.2.1 The adhesion molecule plakophilin4
Plakophilin4 was identified as potential interaction partner of RIM3γ and RIM4γ in the first
proteomic approach performed with Triton X-100 solubilized whole mouse brain homogenates.
Plakophilin4 also known as P0071 belongs to a subfamily of armadillo repeat proteins composed
of p120catenin, δ-catenin/NPRAP, ARVCF and the more distantly related plakophilins1-3. Ar-
madillo repeat proteins, are characterized by a central domain of a series of approximately 40 -
45 amino acid long repeated sequence motifs, called arm-repeats. This sequence repeats built the
scaffold for various protein interactions, which allow armadillo repeat proteins the involvement
in several cellular processes like intracellular signaling, cell adhesion and cytoskeletal remodeling
[Peifer & McCrea, 1992]. Plakophilin4 and related proteins were first identified as components of
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adherens junctions, where they cluster and stabilize cadherins and control thereby intercellular
adhesions. In addition to this local function at the plasma membrane plakophilins have been
shown to be present in the cytosol, where they are involved in the regulation of RhO GTPases
during several cellular processes like cell motility, cell division and neurite outgrowth [Elia et al.,
2006, Kim et al., 2007, Martinez et al., 2003].
Figure 5.13: Plakophilin4 is present in the same cellular compartments as RIM3γ and RIM4γ in
HEK293T cells. A, overexpression of plakophilin4, RIM3γ and RIM4γ fused to GFP in HEK293T cells show
the specific expression patterns of the three proteins. All proteins show a diffuse cytosolic expression. Aditionally
plakophilin4 is enriched at the plasma membrane, RIM3γ is in the nucleus and RIM4γ to lamelipodia of the cell.
B, HEK293T cells were transfected with plakophilin4 fused to GFP together with either RIM3γ and RIM4γ.
Antibody stainings against RIM3γ and RIM4γ two days after transfection reveal that all three proteins reside in
the cytoplasm and do not alter the localization of each other.
Plakophilin4 is most closely related to δ-catenin and shows like δ-catenin a high expression level
in neuronal tissue. δ -catenin is involved in the regulation of dendritic morphology and dendritic
spine number by is interaction with RhoGTPases [Kim et al., 2007, Martinez et al., 2003]. A
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specific function of plakophilin4 in neuronal growth was not shown yet however a screen for
interaction partners of plakophilin4 revealed a high number of cytoskeletal proteins and also a
large fraction of proteins involved in vesicular and intercellular traffic [Keil & Hatzfeld, 2013, Keil
et al., 2013]. The identified interaction partners suggest that plakophilin4 like δ -catenin plays an
important role in neuronal outgrowth and makes it to an interesting potential γ-RIM interaction
partner, which might help to elucidate the specific function of RIM3γ and RIM4γ in neuronal
growth. As a first step to examine if RIM3γ and RIM4γ interact in vivo we tested in human
embryonic kidney cells (HEK293T) if their subcellular localization is altered by the coexpression
of plakopilin4 in the same cell and if they are present in the same subcellular compartments. The
overexpression of only plakophilin4-GFP revealed an enrichment of plakophilin4 at the plasma
membrane and a diffuse cytsosolic distribution. γ-RIMs fused to GFP exhibit diffuse expression
in the cytoplasm of HEK 293T cells. RIM3γ is additionally enriched in the nucleus whereas
RIM4γ localizes to lamelipodia (Fig 5.13 A). After overexpression of plakophilin4-GFP together
with either RIM3γ or RIM4γ and antibody stainings against RIM3γ and RIM4γ a colocalization
was mainly observed in the cytosol (Fig 5.13 B). The potential interaction between plakophilin4
with RIM3γ or RIM4γ was further characterized in vitro by co-immunoprecipitation. RIM3γ
and RIM4γ fused to a flag-streptavidin affinity purification tag (TAP) were coexpressed in
HEK293T cells together with plakophilin4 fused to GFP. After 48 hours the cells were lysed and
RIM3γ-TAP and RIM4γ-TAP together with bound partners were purified via their flag tag.
The purified protein complexes were seperated by gel electrophoresis and analyzed by western
blotting (Fig 5.14A).
Figure 5.14: In vitro binding of plakophilin4 to RIM3γ and RIM4γ. A, Co-immunoprecipitation (Co-IP)
experimental procedure: RIM3γ and RIM4γ fused to a streptavidin-flag affinity tag (TAP) were coexpressed with
plakophilin4–GFP in HEK293Tcells. After cell lysis the formed protein complexes were purified via the flag tag of
RIM3γ and RIM4γ and separated by gel electrophoresis. A positive binding was detected on the western blot by
immunostaining against GFP. B, Immunoblotting of Co-IP reveals an in vitro binding of plakophilin4 to RIM3γ
and RIM4γ and no binding to both controls (TAP and RIM1 C2A-C2B-domain-TAP). Number of individual
experiments n=2.
Plakophillin4-GFP was detected on the western blot by antibody staining against the GFP tag.
To control for unspecific binding the experiment was performed with only the TAP tag alone
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and to control for a general binding affinity of plakophilin4 for C2 domains with the RIM1-C2A-
C2B-domains fused to TAP. Both control reactions were negative, whereas binding reactions of
plakophilin4 and RIM3γ and RIM4γ revealed a plakophilin4 specific band on the western blot
(Fig 5.14B). Therefore, the results of the co-immunoprecipitation support the identification of
plakophilin4 as novel γRIM binding partner.
5.3.2.2 The cytoskeleton regulator IQGAP3
The correct interplay between actin and microtubules is one important aspect during initial
neuronal growth but also later when neurons grow in response to external and internal signaling
cascades. In our mass spectrometry approach we found IQGAP3, a protein, which has been
shown to regulate the cross talk between microtubules and actin filaments. IQGAP3 was recently
shown to regulate neurite outgrowth in response to Rac1 and CDC42 signaling [Wang et al., 2007]
making an interesting potential interaction partner of RIM3γ and RIM4γ. IQGAP3 belongs to
the IQGAP (IQ domain-containing GTPase-Activating Protein) family consisting of IQGAP1-
3. All IQGAPs posses a calponin homology domain (CHD) responsible for their interaction
with actin, several IQ repeats, an IQ motif, which is associated with calcium/calmodulin and a
RasGAP related domain (GRD) (Fig 5.16A). The GRD has not been shown to facilitate GTPase
activity, it rather interacts directly with and stabilizes Rac1 and CDC42 [Brill et al., 1996]. This
is consistent with the finding that IQGAPs function in various cellular processes by remodeling
actin filaments and microtubules. Interestingly all IQGAPs have been shown to be involved in
aspects of dendritic or axonal growth [Swiech et al., 2011, Wang et al., 2007].
We first tested in mouse neuroblastom cells (NG108 cells) if IQGAP3 localizes to the same
cellular compartments as RIM3γ and RIM4γ which would spatially allow their interaction.
After overxpression of IQGAP3-GFP in NG108 cells, IQGAP3 revealed a strong localization
to the plasma membrane at growing tips of the cell and a diffuse cytosolic distribution. When
IQGAP3 was coexpressed with RIM3γ and RIM4γ, all three proteins resided in the cytopplasm
of NG108 cells. (Fig 5.15).
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Figure 5.15: IQGAP3 colocalizes with RIM3γ and RIM4γ in the cytoplasm of NG108 cells. A, Over-
expression of IQGAP3-GFP (left panel) in mouse neuroblastoma cells (NG108 cells) reveals a diffuse cytosolic
expression in addition to an enrichment at growing tips of the cell. Middle and right panel show a diffuse distribu-
tion of RIM3γ and RIM4γ in cytoplasm after overexpression and antibody labeling. RIM3γ is in addition strongly
enriched in the nucleus. B, Coexpression of IQGAP3-GFP and RIM3γ and RIM4γ, reveals a colocalization of
IQGAP3 and the γ-RIMs in the cytosol of NG108 cells.
In a GST (glutathione-S-transferase)-pulldown assay, GST-RIM3γ and GST-RIM4γ coupled to
glutathione agarose were incubated with HEK23T cell lysates expressing IQGAP3-GFP. After
purification of the GST-γ-RIMs coupled to agarose beads together with their bound interaction
partners, the formed protein complexes were separated by gel electrophoresis and analyzed by
western blotting (Fig 5.16B). Due to the high sequence homology in the C2B domain of all RIM
protein family members the binding reaction was also performed with GST-RIM1-C2B. To con-
trol for unspecific interactions the same binding reaction was performed with glutathione-agarose
alone and only GST coupled to glutathione-agarose. Immunoblotting against GFP showed a spe-
cific binding of IQGAP3-GFP only to GST-RIM3γ, GST-RIM4γ and GST-RIM1-C2B but not
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to the controls (Fig. 5.16C). To further confirm the potential interaction between IQGAP3 and
RIM proteins we performed Co-immunoprecipitaions. To this end RIM3γ, RIM4γ and RIM1-
C2A-C2B-domains fused to an streptavidin-flag (TAP) tag were coexpressed in HEK293Tcells
together with IQGAP3-GFP. The in vivo formed protein complexes were purified with magnetic
beads coupled to antibodies against the flag sequence of the bait proteins affinity tag. After sepa-
ration by gel electrophoresis and immunoblotting a positive binding was detected with antibody
labeling against GFP.
Figure 5.16: Biochemical analysis of the potential interaction between IQGAP3 and RIM3γ and
RIM4γ. A, Protein domains of IQGAP3, IQGAP1 and the tested interaction partners RIM3γ, RIM4γ and the
C2A-C2B domain of RIM1. B, Schematic representation of GST-pulldown assays: RIM3γ–GST and RIM4γ–GST
were expressed in e. coli and purified via coupling to glutathione-agarose. HEK293T cell lysates expressing
IQGAP3-GFP were incubated with the purified agarose coupled γ-RIMs. Protein complexes were analyzed by gel
electrophoresis and western blot. C, GST-pulldown assay with IQGAP3-GFP reveals a binding of IQGAP3 to
GST-RIM3γ, GST-RIM4γ and GST-RIM1 C2B-domain whereas the control reactions with uncoupled agarose and
GST-agarose do not show a signal. Number of individual experiments n=3. D, Co-immunprecipitaion of RIM3γ-
streptavidin-flag (TAP), RIM4γ-TAP and RIM1 C2A-C2B-domain-TAP and IQGAP3-GFP with magnetic beads
coupled to a flag antibodies further confirm a binding of IQGAP3 to RIM3γ and RIM4γ. Number of individual
experiments n=3. E, IQGAP1 shows no binding affinity to RIM3γ-TAP, RIM4γ-TAP and RIM1 C2A-C2B-
domain-TAP in co-immunoprecipitation assays. Number of individual experiments n=2.
Theses experiments confirmed a binding of IQGAP3 to RIM3γ and RIM4γ and no binding to
the TAP tag alone. However the in pulldown assays observed binding of IQGAP3 to RIM1-C2B-
C2A-domains could not be reproduced in in co-immunoprecipitations (Fig. 5.16,D). Collectively
these results suggest an interaction of IQGAP3 with RIM3γ and RIM4γ does take place in living
cells. The positive binding to RIM1 in pulldown assays implies, that either IQGAP3 might
show in addition a general affinity to C2B domains or exhibits a rather transient interaction
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with RIM1. IQGAP3 shows a high structural homology to IQGAP1 (Fig 5.16A). Therefore we
tested in co-immunoprecipitations if also IQGAP1 exhibits an binding affinity towards RIM3γ
and RIM4γ. Both γ-RIMs and also the control construct of RIM1 C2A-C2B-domains did not
show any in vitro binding affinity to IQGAP1 (Fig. 5.16E). This further supports the specificity
of the interaction between IQGAP3 and RIM3γ and RIM4γ. Taken together IQGAP3 and the
γ-RIMs colocalize in the cytosol of neuroblastoma cells. Additionally, biochemical binding assays
showed that RIM3γ and RIM4γ interact in vitro with IQGAP3. This interaction is specific for
IQGAP3 as no interaction with IQGAP1 could be observed supporting a possible role of RIM3γ
and RIM4γ in the remodeling of the cytoskeleton during neuronal growth.
5.3.2.3 The presynaptic protein Syd-1
Down regulation of RIM3γ and RIM4γ also affects the correct formation of synaptic structures
(chapter 5.2.1), which could be on the one hand caused by the disruption of general growth
promoting mechanisms but also on the other hand by a potential synaptic function of RIM3γ
and RIM4γ. In the mass spectrometry approach of lysates from whole brain homogenates
the synapse-defective-1 protein (Syd-1) was identified as one potential interaction partner of
RIM3γ. Genetic approaches identified Syd-1 as one of three core molecules of the presynaptic
active zone in flies and worms [Patel et al., 2006]. Presynaptic assembly includes local changes
of the actin cytoskeleton followed by the recruitment of the synapse specific protein network.
Syd-1 was shown to interact with this actin network at nascent synapses and to be crucial
for the concomitant assembly of the presynapse [Chia et al., 2012]. Consistently, the loss of
Syd-1 disrupts the localization of multiple presynaptic proteins. In addition Syd-1 coordinates
pre- and postsynaptic assembly by interacting with the presynaptic adhesion molecule neurexin,
which induces the postsynaptic assembly via its postsynaptic interaction partner neuroligin
[Owald et al., 2012]. Because of the reduced synapse number in RIM3γ and RIM4γ knock-down
neurons Syd-1 is an interesting potential interaction partner. To gain first insights into the
potential interaction between Syd-1 and RIM3γ and RIM4γ we analyzed if the three proteins
are colocalized in the same subcellular compartments when overexpressed in HEK293T cells.
Overexpressed Syd-1 shows a prominent nuclear localization and a diffuse cytosolic distribution.
The same is the case for RIM3γ, when overexpressed in HEK 293T cells. RIM4γ in contrast is
absent from the nucleus and diffusely distributed throughout the cytoplasm (Fig. 5.17A). The
coexpression of RIM3γ and SYD-1 did not change the localization of both proteins (Fig. 5.17B).
However the coepxression of RIM4γ and Syd-1, did lead to the translocation of Syd-1 out of the
nucleus indicating a functional interaction (Fig. 5.17B).
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Figure 5.17:RIM4γ changes the subcellular localization and Syd-1 whereas RIM3γ and SYD-1 reside
in nucleus and cytoplasm of HEK293T cells. A, Overxpression of SYD-1 fused to GFP and RIM3γ and
RIM4γ in HEK293T cells. The cells were fixed 48 hours after transfection and immunostained with antibodies
against RIM3γ and RIM4γ. B, Coexpression of RIM4γ together with SYD-1 leads to a translocation of Syd-1
out of the nucleus, whereas the coexpression of RIM3γ had no effect on the localization of Syd-1.
Next, we investigated the possible interaction between Syd-1 and the γ-RIMs in GST (glutathione-
S-transferase)-pulldown assays and immunoprecipitations. Because of the high sequence homol-
ogy of the C2B domains of RIM1, RIM3γ and RIM4γ we included the C2A-C2B domain of
RIM1 in the biochemical interaction studies. In the GST-pulldown assay GST-RIM3γ, GST-
RIM4γ, GST-RIM1-C2B-domain and GST coupled to glutathione agarose were incubated with
HEK293T cell lysates expressing Syd-1 fused to a HA (human influenza hemagglutinin) affinity
tag. After the incubation step protein complexes were purified, separated by gel electrophoresis
and analyzed by western blot. Syd-1 was pulled down from the HEK cell lysates with all three
RIM proteins, whereas GST alone was not able to bind Syd-1 (Fig. 5.18A). In a pulldown assay
the analyzed interaction takes place in an artificial buffer solution. To test if the interaction
between Syd-1 and RIM proteins would also take in place under more physiological conditions
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in living cells co-immunoprecitipitations were performed. Syd-1-HA was coexpressed together
with RIM3γ, RIM4γ and RIM1-C2A-C2B fused to a streptavidin-flag (TAP) affinity tag, af-
ter 48 hours the protein complexes were purified with magnetic beads coupled to antibodies
against HA. The purified protein complexes were analyzed by gel electrophoresis and western
blot. Immunostaining of the western blot with flag antibodies revealed, that syd-1 immunopre-
cipitated RIM3γ, RIM4 γ and RIM1-C2A-C2B (Fig. 5.18B). This further validates the potential
interaction between the RIM proteins and Syd-1. Taken together the colocalization studies in
HEK293T cells showed, that SYD-1 and γ-RIMs are expressed in the same cellular compart-
ments and might influence the localization of each other. Further we could verify the potential
interaction between Syd-1 RIM3γ, RIM4γ and the C2B domain of RIM1 in biochemical bind-
ing studies. However, if this in vitro interaction has a functional role in synapse assembly and
function needs to be analyzed further.
Figure 5.18: Biochemical analysis of the potential interaction between Syd-1 and RIM3γ and RIM4γ.
A, GST pulldown: GST-RIM3γ, GST-RIM4γ and the C2B domain of RIM1 coupled to glutathione-agarose were
incubated with HEK cell lysates overexpressing Syd-1-HA. Immunostainigs of the western blot with antibodies
against HA reveals a binding of Syd-1 to all three RIM proteins. Number of individual experiments n=3. B,
Coimmunoprecipitation: RIM3γ-TAP and RIM4γ-TAP and the RIM1 C2A-C2B-domain-TAP were coexpressed
with Syd-1-HA in HEK293T cells. Protein complexes were purified with HA antibodies coupled to magnetic
beads. The western blot shows a binding of all three RIM proteins to Syd-1. Number of individual experiments
n=2
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5.4 RIM3γ and RIM4γ knock-out mice
Loss of function studies with shRNA mediated knock-down of a protein of interest are technically
restricted to single cells or subsets of cells and specific time points during development. Genetic
knock-outs in contrast give the opportunity to study gene and protein function in vivo through-
out the development and at specific developmental stages. In addition conditional knock-outs
allow to study the loss of gene function in specific cell types or brain regions. To get a better
understanding of the functional role of RIM3γ and RIM4γ in living animals during different de-
velopmental stages and different physiological and pathological conditions we set out to generate
conditional and constitutive RIM3γ and RIM4γ knock-out mice.
5.4.1 Generation of RIM3γ and RIM4γ knock-out mice
RIM3γ and RIM4γ knock-out mice were generated with embryonic stem cells produced by the
international Knock-out Mouse Project (KOMP) consortium.
Figure 5.19: Generation of constitutive and conditional RIM3γ and RIM4γ knock-out mice. A,
Schematic representation of RIM3γ knock-out strategy. RIM3γ wild type alleles lead to normal protein expression
of RIM3γ. Introduction of the gene trap cassette in the intro region between exon 3 and 4 leads to splicing of
RIM3γ after exon 3 and ablation of protein expression (RIM3γconstKO). Recombination by FLP-recombinase
leads to excision of the gene trap and a normal expression of the protein (RIM3γflox). Recombination of RIM3γflox
by Cre-recombinase to the excision of exon 4 and no protein expression (KO RIM3γ). B, RIM4γ targeting vector.
Introduction of the gene trap cassette in the intro region between exon 1 and 2 leads to splicing of RIM4γ after
exon 3 and ablation of protein expression (RIM4γconstKO).
The embryonic stem cells carried the targeting vector against either RIM3γ or RIM4γ, de-
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signed to create three different mouse lines (Fig. 5.19). The first line obtained after germ line
transmission constitutes a “knock-out first” allele, in which insertion of a splice acceptor-lacZ
gene trap cassette disrupts the endogenous RIM3γ and RIM4γ transcripts resulting in a con-
stitutive knock-out (KO) (RIM3γconstKO and RIM4γconstKO). After recombination with a
FLP-recombinase expressing mouse line, the FLP-recombinase expression leads to excision of
the gene trap cassette and generation of a conditional knock-out (RIM3γflox and RIM4γflox).
The conditional knock-out should express wild type levels of RIM3γ or RIM4γ, but can be con-
verted into a null allele by Cre-mediated recombination (RIM3γKO and RIM4γKO) (Fig. 5.19).
This system allows to generate a constitutive knock-out, that can be used to study the functional
impact on a whole organism caused by the gene ablation from beginning of its development. In
addition the conditional knock-out gives the opportunity to ablate the gene of interest at specific
time points during development and in the mature organism in specific brain regions or specific
neuronal populations
The ’knock-out first’ strategy leads in a first step to a conditional knock-out, allowing to analyze
the impact of the constitutive genetic ablation of either RIM3γ or RIM4γ on the mouse organism.
In the following section results of the characterization of this knock-out-first RIM3γ and RIM4γ
mouse lines are shown. In order to verify that insertion of the splice acceptor-casette indeed
abolishes RIM3γ and RIM4γ expression we characterized transcript and protein levels in brains
of wild type and heterozygous and homozygous RIM3γconstKO (RIM3γ-/-) and RIM4γconstKO
(RIM4γ-/-) mice. The level of transcripts was assessed by quantitative real time RT-PCR.
RIM3γ transcripts levels were reduced to about 60% in heterozygous and almost abolished
in homozygous RIM3γ-/- mice in the hippocampus, cerebellum and cortex. In heterozygous
RIM4γ mice transcript levels in hippocampus and cortex showed no significant differences to
wild type levels, only in the cerebellum transcript levels were significantly reduced. However
homozygous RIM4γ-/- mice exhibited a reduction of RIM4γ transcript to about 30% of wild
type levels in all tested brain regions (Fig 5.20 A,B). To analyze if these reduced levels of
transcripts also lead to the ablation of the protein quantitative immunoblotting of homogenates
from hippocampus, cerebellum and cortex were performed. Staining of the immunoblots with
RIM3γ and RIM4γ specific antibodies revealed, that the gene trap had successfully disrupted
RIM3γ and RIM4γ protein expression (Fig 5.20 C,D). Protein levels were reduced in both γ-RIM
knock-out mouse lines, however the effect was more distinct in RIM3γ knock-out mice especially
in the hippocampus (Fig 5.20C-F). Collectively these data show that the gene trap introduced
in intron regions of RIM3γ and RIM4γ successfully abolishes the expression of both genes.
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Figure 5.20: RIM3γ and RIM4γ knock-out abolishes RIM3γ and RIM4γ gene transcription and
protein expression. A,B, Quantitative real time RT-PCR of wild type, heterozygous and homozygous
RIM3γconstKO and RIM4γconstKO mice reveals reduced gene transcript levels.(n=10 animals per group) C,D,
Immunoblots of RIM3γconstKO and RIM4γconstKO mice, show a reduction in protein expression in hippocam-
pus (HC), cerebellum (CB) and cortex. To control for the specificity of the RIM3γ and RIM4γ antibody signal on
the immunoblots HEK cell lysates overexpressing the respective γ-RIM were included in the analysis (RIM3γOE,
RIM4γOE). E,F, Quantification of RIM3γconstKO (n=5 animals per group) and RIM4γconstKO (n=10 animals
per group) immunoblots. Significance: two-way ANOVA Bonferoni post Test * = p <0,05 ** <=p 0,01 *** =
p<0,001.
5.4.2 RIM3γ and RIM4γ knock-out mice are viable and born at mendelian ratios
Pups of heterozygous RIM3γ and RIM4γ breedings are viable and undistinguishable upon their
genotype. Genotypes of heterozygous offspring showed no significant deviation from the expect
mendelian distribution in both lines, with about 25% wild type, 50% heterozygous and 25%
homozygous knock-out litters (Fig. 5.21A,B).
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Figure 5.21: Genotype distribution of pups produced by heterozygous RIM3γ and RIM4γ breeding
pairs. A,B) Genotype frequency of 34 heterozygous RIM3γ mating pairs (A) and 38 heterozygous RIM4γ
mating pairs (B). Columns represent the percentage of the registered genotype of offspring and dashed lines the
expected frequency based on Mendelian inheritance. Numbers in the columns represent numbers of pups for each
genotype. Chi-squared statistics reveal no significant deviations from expected Mendelian ratios.
During the first 3 weeks after birth pups deficient for RIM3γ or RIM4γ develop normal and
gain weight to the same extend as wild type litter mates. However, around the time of weaning
RIM4γ -/- mice suddenly start to loose weight. In order to characterize the onset and extend of
the weight loss heterozygous and homozygous RIM4γ -/- and wild type littermates were weighed
every five days from postnatal day 5 until an age of 35 days. Around postnatal week 3 RIM4γ
-/- mice experience a drastic weight loss up to two grams. Afterwards they gain again in weight
but do not reach the wild type level until postnatal day 35 (Fig. 5.22A,B). RIM3γ -/- mice in
contrast show no changes in weight compared to wild type and heterozygous litter mates (data
not shown).
Figure 5.22: Reduced body weight in RIM4γ -/- mice. A, Weight reduction in RIM4γ -/- mice becomes
evident around postnatal day 21 (significance: two-way ANOVA followed by Bonferoni post test, ***p< 0,001,
+/+ n= 5 animals, +/- n= 5 animals, -/- n= 5 animals). B, Heterozygous(+/-) and homozygous(-/-) RIM4γ
knock-out mice at an age of six weeks. Due to reduced body weight the full knock-out appears smaller than the
heterozygous littermate.
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5.4.3 RIM4γ knock-out mice show a strong motor phenotype
At the same as the strong weight reduction becomes evident (postnatal week 3) constitutive
RIM4γ-/- mice develop episodes of strong hind limb impairments. The duration and frequency
of these events was analyzed by video monitoring of two six weeks old RIM4γ -/- mice over
five days. During these five days once every 24 hours a 1-4 hours episode of strong movement
impairments was observed (Fig 5.23A).
Figure 5.23: RIM4 knock-out (-/-) mice show episodic motor defecits. A, Time line of five-day video
monitoring of RIM4 γ -/-. Episodes of motor deficits (ataxia and dyskenisia) over 1-4 hours were observed once a
day. B, Movie of 15 seconds, displayed in images every 5 second of the ataxia /dyskenisia episodes in a five week
old RIM4γ -/- mouse. C, Images of a 15 second movie showing a RIM4γ -/- mouse (8weeks) experiencing strong
epileptic like seizures.
These episodes were composed of rapid uncontrolled movements of the hind limbs and sometimes
even front limbs disrupted by phases of immobility, during which the hind limbs appeared
stretched out and rigid (Fig 5.23B). Apart from these episodes the animal behaved normally
and showed now obvious motor abnormalities. Rarely a phenotype resembling epileptic seizure
like behavior was observed in some RIM4γ -/- mice (Fig 5.23C). This strong phenotype was not
observed during the 5 day video monitoring. Taken together, RIM4γ -/- mice experience weight
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loss at an age of 3 weeks at the same time when they develop a strong motor phenotype.
Figure 5.24: Paw prints of RIM4γ -/- mice. A,B, Cat walk analysis of 3 RIM4γ -/- mice showing no obvious
phenotype and 3 wild type litter mates A, Quantification of the paw print length reveals no reduction in the
print length of RIM4γ -/- mice. B, Quantification of the maximal paw contact area shows a significant reduction
in the maximal contact area of the left hind paw in RIM4γ -/- mice during a behavioral inconspicuous phase. C,
Paw prints and paw print intensities of a 7 weeks old wild type animal. C, Paw prints and paw print intensities
of a 7 weeks old RIM4γ -/- mouse during a behavioral inconspicuous phase (upper panel) and a episode of strong
motoric hind limb impairments (lower panel). Significance: two-way ANOVA **p < 0,01, ***p < 0,001 n= 3
animals per group with 3 trials per mouse.
Gait disorders can be characterized by several motor tests. The CatWalk system is a video based
automated gait analysis system developed to evaluate footfall and gait changes in rodents. The
CatWalk system consists of an enclosed walkway on a glass plate that is crossed by a mouse
from one side of the walkway to the other. Green light enters on the long edge of the glass
plate and is completely internally reflected. Only when a mouse’s paw makes contact with the
glass plate the light is scattered and can escape. The enlightened paw prints are captured by
a camera underneath the walkway. RIM4γ -/- mice experience episodes of strong hind limb
motor abnormalities, besides theses episodes they appear to walk normally and show no obvious
changes in gait. To characterize the motoric hind limb phenotype and identify weaker gait
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abnormalities during behavioral inconspicuous phases RIM4γ -/- mice and wild type littermates
were analyzed by the CatWalk system. RIM4γ -/- mice experiencing an episode of hind limb
impairments were not able to traverse the complete distance of the walk under two minutes,
whereas a healthy mouse crosses the walkway in 5-15 seconds. The hind limbs of RIM4γ -/-
mice suffering from hind limb impairments barely contacted the glass plate and animals could
only push themselves forward by using their front limbs (Fig 5.24D lower panel). For further gait
analyzes only RIM4γ -/- mice showing no obvious motor deficits were examined on the Catwalk
system (Fig 5.24D upper panel). Quantification of the print length and maximal contact area of
all four paws revealed, that RIM4γ -/- mice also suffer from mild gait impairments when they
show no obvious motor phenotype. RIM4γ -/- mice showed no significant reduction in print
length but in contact area of the left hind paws made with the walk way (Fig. 5.24A,B). This
could be either caused by a weakened musculature or by coordination difficulties or both.
Figure 5.25: Coordinative disturbances in RIM4γ -/- mice in a behavioral inconspicuous phase.
A, Footfall pattern of a wild type littermate shows a regular step sequence (upper panel), whereas the step
sequence of a RIM4γ -/- mouse shows a step sequence disrupted by irregular paw placements (lower panel). B,
Quantification of the regularity index (number of normal step sequences x 4 / number of paw placements) reveals
a higher irregularity of paw placements in RIM4γ -/- mouse. Significance: ttest * p=0,03, n=3 animals per group
with 3 trials per mouse.
Mice walking on their four paws use specific step patterns. Deficits in coordination can disrupt
these patterns. Therefore coordinative abilities can be characterized by the regularity of step
patterns. Common step sequence patterns are defined as cruciate (right front - left front - right
- hind - left hind paw or starting with left front) alternate (right front - right hind - left front
- left hind or starting with left front) or rotate (left front - right front - right hind - left hind).
A measure of interpaw coordination is the regularity index of these footfall patterns, it can be
calculated as the number of normal step sequence patterns relative to the paw placements. A
healthy fully coordinated animal walking only in the four predefined patterns shows a regularity
index of 100% (Fig. 5.25A). Footfall patterns of RIM4γ -/- mice were disrupted by irregular
step sequences, which could not be related to the predefined step sequence patterns (Fig 5.25A
lower panel, B). Wild type littermates in contrast crossed the walkway in regular step sequences
with an average regularity index of 96% (Fig 5.25A upper panel,B).
Another behavioral test for motor coordination and physical endurance of rodents is the rotarod
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test. It is composed of a turning cylinder the rotational speed of which can be adjusted from 4
to 40 rotations per minute (rpm). In the test motor skills are assessed by recording the duration
and the maximum velocity reached before the mouse falls from the cylinder. The ability of a
mouse to stay on the rotating rod during accelerating speed depends on coordination and grip
strength of the mouse. We tested the ability of 6 RIM4γ -/- mice and 6 wild type littermates
to stay on the rotating rod when the velocity was increased from 4 to 40 rotations per minutes
(rpm) during five minutes. The animals were placed on the rotating rod at a speed of 4 rpm,
when all animals were walking stablely on the turning cylinder the speed was accelerated. In a
first trail the animals were habituated. After habituation mice were tested in 3 subsequent trials
with a 15-minute break in between. All animals were tested on 3 different days with one-week
recovery time between testing days.
Figure 5.26: RIM4γ -/- mice exhibit a reduced ability to stay on the rotating rod. A, 6 RIM4γ -/-
mice and 6 wild type littermates were tested on 3 days, 3 times for 5 minutes with an accelerating speed from
4 to 40 rpm. 3 trials of 3 RIM4γ -/- mice experiencing strong hind limb impairments (-/- HLP) were included
in the quantification to show the drastic impairments in motor skills. Significance: one-way ANOVA followed by
Bonferoni post test, **p<0,01, ***p<0,001
To illustrate the strong differences in motor performance of RIM4γ -/- mice suffering from
hind limb impairments and RIM4γ -/- mice showing no obvious motor impairments, 3 trials of
RIM4γ -/- animals experiencing an episode of strong hind limb impairments were include in the
quantification. Wild type animals mostly stayed on the rod the complete trial and were still
walking stabely after 5 minutes at a speed of 40 rpm. RIM4 γ -/- mice were not able to complete
the trial and fell of the rotating rod after about 2 minutes at a speed of 20 to 25 rpm. During
strong episodes of hind limb impairments RIM4γ -/- mice could not stay on the rotating rod
for longer than 15 seconds (Fig 5.26). These results together with the irregular footfall patterns
observed in RIM4γ -/- mice suggests that RIM4γ -/- mice suffer from coordinative disturbances
also during behavioral inconspicuous phases.
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5.4.4 RIM3γ and RIM4γ knock-out mice show no obvious changes in neuronal
structures
Knock-down of RIM3γ and RIM4γ at early developmental stages in neuronal cultures and in
vivo leads to strong reduction in neuronal branching. This implicates that a knock-out of
these proteins might lead to the same impairments in neuronal branching or even disturb the
correct development of brain structures. In addition the observed phenotype in RIM4γ -/-
mice indicates, that RIM4γ -/- mice suffer from neurological deficits accompanied or caused by
morphological changes in the brain. Changes in the cerebellar architecture have been associated
with mouse models of episodic ataxia and dyskenisia [Mark et al., 2011].
Figure 5.27: No obvious structural changes in cerebellar and hippocampal architecture in RIM3γ
-/- and RIM4γ -/- mice. A,B, NeuN staining in the cerebellum and hippocampus of RIM4γ -/- and RIM3γ
-/- mouse display no obvious differences in comparison to wild type littermates.
Interestingly, levels of RIM4γ protein expression are highest in the cerebellum [Alvaréz-Baron,
2010]. The correct layering and morphology of hippocampus and cerebellum was analyzed in
RIM3γ -/- and RIM4γ -/- mice and wild type littermates by staining neuronal cell layers with
antibodies against the neuron specific protein NeuN (Fig 5.27). Comparison of the cerebellar and
hippocampal morphology after NeuN immunostaining revealed no obvious differences between
RIM3γ -/-, RIM4γ -/-mice and wild type littermates. However milder changes in the cellular
morphology that do not affect the overall structure of a brain are not detected by this method.
5.4.5 Neuronal activity influences gene expression of RIM3γ and RIM4γ
During increased neuronal activity neurons undergo changes in molecular composition and struc-
ture in order to adjust their synaptic strength. This neuronal plasticity has been associated with
a variety of physiological processes like learning and memory but also pathological processes like
epileptogenesis [Milner et al., 1998, Bausch et al., 2006]. In order to investigate if RIM3γ and
RIM4γ gene expression is differentially regulated during neuronal activity we performed quanti-
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tative real time RT PCR on mouse hippocampal tissue samples at four different time points after
the induction of status epilepticus (SE). SE was induced by the application of pilocarpine, 40
minutes after onset SE was relived by the administration of diazepam. 12, 24, 36 and 72 hours
later animals were sacrificed and hippocampal subregions dentate gyrus (DG), cornu amonis 1
(CA1) and cornu amonis 3 (CA3) were microdissected. Quantitative real time RT PCR revealed
a significant down regulation of RIM3γ 36 and 72 hours after SE in the DG (Fig. 5.28A). In
contrast, RIM4γ was strongly upregulated already 12 hours after SE in all hippocampal sub-
regions. In CA3 this upregulation was most prominent and still detectable 24 hours after SE
(Fig. 5.28B). These results suggest that RIM3γ and RIM4γ are involved in the modulation of
neuronal transmission or remodeling of neuronal structures after changes in the network activity.
Figure 5.28: Changes in gene transcription of RIM3γ and RIM4γ after induction of status epilepti-
cus (SE). A,B, 8 week old wild type mice were subjected to pilocarpine induced SE and hippocampal subregions
dentate gyrus (DG) cornu ammonis 1 (CA1) and cornu ammonis 3 (CA3), were microdissected 12, 24, 36 and 72
hours after SE. Gene expression levels are displayed as relative increase in comparison to basal gene expression
levels of sham injected animals normalized to 1. A, Quantification of real time RT PCR reveals a downregulation
of RIM3γ mRNA levels 36 and 72 hours after SE in DG. B, Quantification of real time RT PCR reveals an upreg-
ulation of RIM4γ in all hippocampal subregions 12 hours after SE and CA3 also 36 hours after SE. Significance:
two-way ANOVA followed by Bonferoni post test * = p < 0,05 *** = p < 0,001, n=5 for all groups.
6 Discussion
98
Discussion
At the presynapse the large members of the RIM protein family are centrally involved in the
network of active zone proteins [Mittelstaedt et al., 2010]. Through multiple interactions within
this network of active zone proteins they participate in several steps of neurotransmitter release
and regulate thereby its speed, efficiency and synchrony [Südhof, 2013]. In contrast very little
is known about the function of the small γ-RIMs which are composed of only the RIM specific
C2B domain and an isoform specific N-terminus [Wang & Südhof, 2003]. First, shRNA medi-
ated knock-down experiments resulted in a strong growth deficit in primary cultured neurons,
suggesting a role of RIM3γ and RIM4γ in neuronal growth and development [Alvarez-Baron
et al., 2013]. In this study we set out to analyze the molecular mechanism underlying the role
of RIM3γ and RIM4γ during neuronal growth and to identify a possible synaptic function in
accordance to the large RIM proteins.
6.1 Subcellular localization of RIM3γ and RIM4γ
Eukaryotic cells are compartmentalized, allowing molecular pathways within the cell to occur
more efficiently and in a well orchestrated fashion. During development cellular organelles and
functional compartments can change their protein composition to adapt their functionality to
changing external conditions. Thus, a distinct subcellular localization pattern of a protein might
give first hints on its cellular function.
In accordance to its well-established role at the presynaptic neurotransmitter release site RIM1
shows a specific synaptic localization. RIM3γ and RIM4γ in contrast do not show an exclusive
synaptic expression pattern. RIM4γ is present at pre- and postsynaptic compartments but
shows no specific localization to these structures and is rather diffusely distributed throughout
axons and dendrites. RIM3γ is localized to pre- and postsynaptic compartments and shows
in addition a strong enrichment in the nucleus. In this study we identified bioinformatically a
nuclear localization signal in the N-terminal sequence of RIM3γ whereas such a signal was not
present in the sequence of RIM4γ. By mutating all four amino acids coding for this nuclear
localization signal we could prove its functionality and show that this sequence is responsible
for the localization of RIM3γ to the nucleus (Fig5.2).
The only protein interaction domain shared between the small γ-RIMs and RIM1α is the C2B
domain. Even though the precise molecular mechanisms determining the presynaptic localization
of RIM1 are not fully resolved so far, the C2B domain of RIM1 was suggested to be involved
in targeting RIM1 to the active zone. In C. elegans the Liprin-α homolog SYD-2, a binding
partner of RIM1’s C2B domain, was shown to be an important regulator in the formation of the
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presynaptic active zone [Zhen & Jin, 1999, Schoch et al., 2002]. Accordingly, shRNA mediated
knock-down of Liprins-α in primary cultured neurons leads to reduced RIM1 levels at the synapse
indicating that the C2B of RIM1 domain contributes to its localization to the synapse [Spangler
et al., 2013]. This suggests, that the C2B domain of RIM3γ and RIM4γ might be involved in
a similar manner in the localization of RIM3γ and RIM4γ, whereas the N-terminal sequences
could target the γ-RIMs to non-synaptic localizations. However, the C2B domain of RIM3γ
and RIM4γ was also suggested to be important for the growth promoting effects mediated by
RIM3γ and RIM4γ. The strong reduction in neuronal growth after the shRNA mediated knock-
down of RIM3γ and RIM4γ can be partially rescued by overexpressing only the C2B domain of
the respective γ-RIM [Alvarez-Baron et al., 2013]. Thus, depending on interactions with other
proteins the C2B domain of RIM3γ and RIM4γ might be on the one hand involved in targeting
the γ-RIMs to the synapse and on the other hand in mediating their growth promoting effects.
In our affinity purification - mass spectrometry screen for novel γ-RIM binding proteins sev-
eral importins were detected as interaction partners of RIM3γ. This and the identification of
RIM3γ’s nuclear localization signal indicates an active recruitment of RIM3γ into the nucleus.
Synapses can adapt their strength in response to increased or reduced network activity, leading
to structural changes for exmaple in the protein composition at the active zone [Lazarevic et al.,
2013]. An adaptation of synaptic strength can be dependent on changes in gene transcription to
meet the changed demand in synapse specific proteins [Cohen & Greenberg, 2008, Ch’ng et al.,
2012]. The strong nuclear localization of RIM3γ together with its localization at the synapse
suggests a possible function of RIM3γ in synapse to nucleus signaling and in the activity de-
pendent regulation of gene transcription. Signaling form the synapse to the nucleus can occur
through a variety of mechanisms including rapid electrochemical, regenerative calcium waves
along the endoplasmic reticulum as well as active transport of soluble proteins from the synapse
back to the nucleus [Ch’ng & Martin, 2011]. The active transport of proteins from the synapse
to the nucleus is mediated by importins. During increased neuronal activity synaptic bound
α-importins are released, bind to the nuclear localization signal of potential cargos and initiate
their translocation to the nucleus in cooperation with β-importins [Jeffrey et al., 2009]. Once in
the nucleus the synaptic cargos can induce alterations in transcriptional programs allowing the
cell to answer the changed protein demand at the synapse. An involvement of RIM3γ in the
activity dependent signaling from synapse back to the nucleus and the signals that trigger the
shuttling of RIM3γ in and out of the nucleus need to be addressed in future studies.
6.2 The growth reduction in RIM3γ and RIM4γ knock-down
neurons involves changes in vesicular traffic
The growth of axons and dendrites is regulated by common but also by axon and dendrite specific
mechanisms. The shRNA mediated knock-down of RIM3γ and RIM4γ in primary neuronal
cultures at DIV 1 resulted in impairments in axonal and dendritic growth. This suggests that
RIM3γ and RIM4γ are involved in general growth promoting processes crucial for axon and
dendrite development. Neuronal growth and polarization are not only the simple extension of
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neuronal branches; these processes involve also the establishment of highly specified neuronal
structures, like synapses. Thus, if the maturation of neuronal processes is inhibited one would
expect in addition to a reduction of the process length an immaturity of these short preserved
branches. This could be verified in the case of RIM3γ and RIM4γ knock-down neurons. The
few short branches that were formed in RIM3γ or RIM4γ knock-down neurons had significantly
less synapses and dendritic spines. The findings were not observed when a mutated versions
of the shRNAs against RIM3γ and RIM4γ with single nucleotide exchanges in the binding site
of RIM3γ and RIM4γ were transfected and could be rescued by the coexpression of a shRNA
resistant version of the respective γ-RIM confirming the specificity of the knock-down (Fig. 5.4).
Neurite outgrowth can be stimulated by neuronal activity and the concomitant depolarization
of neurons. Especially dendritic growth is profoundly regulated by synaptic activity in order to
connect the different brain regions correctly [Solem et al., 1995, Wong & Ghosh, 2002]. Taking a
possible synaptic role of RIM3γ and RIM4γ in account, impairments in neurotransmitter release
due to the loss of RIM3γ and RIM4γ could therefore induce the reduction in neuronal growth.
However silencing neuronal activity in primary neuronal cultures had no influence on neurite
outgrowth and dendritic complexity (Fig5.5). Thus, possible changes in neurotransmitter release
due to the loss of RIM3γ or RIM4γ are most likely not responsible for the growth inhibition of
neuronal branches. Additionally, if the growth deficit in RIM3γ and RIM4γ knock-down neurons
were caused by a reduced network activity the effect should be abolished, if the cell is surrounded
by a network of wild-type neurons. However, the in vivo knock-down of RIM3γ and RIM4γ in
single neurons surrounded by wild-type neurons in the hippocampus and cortex of rats one
day after birth still led to a reduction in neuronal growth (Fig5.6). This reduction in neuronal
growth was not observed when the shRNA against RIM3γ was introduced in cortical neurons of
21 days old rats (Fig 5.7). Thus, the growth promoting effect of RIM3γ and RIM4γ seems to
be restricted to development of neuronal processes with no influence on the maintenance of the
dendritic tree.
One of the most important cellular processes during neuronal growth is the sorting and transport
of new proteins and membrane particles to nascent neuronal compartments. New proteins are
synthesized in the endoplasmic reticulum and transported to the Golgi apparatus, the main
cellular organelle regulating vesicular transport and protein distribution. Consequently, the
correct functionality of the Golgi apparatus and the associated protein sorting and distribution is
crucial for neuronal growth. Despite a generally high structural stability of the Golgi apparatus
various physiological and pathophysiological processes can induce fragmentation of the Golgi
structure. For instance it was shown that the accumulation of mutated proteins in the Golgi
leads to the disruption of the Golgi structure in several neurodegenerative diseases [Fan et al.,
2008]. During neuronal growth the Golgi apparatus undergoes structural remodeling. In early
stages of neuronal growth the Golgi is first oriented towards the axons and later when dendritic
development starts it reorients itself towards the main dendrite and sends out Golgi outpost
into the growing dendrites. Golgi outposts are suggested to be important regulators in local
branch induction of dendrites [Horton et al., 2005, Ye et al., 2007, Yadav & Linstedt, 2011].
Interestingly, RIM3γ and RIM4γ knock-down neurons exhibit alterations in the structure of the
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Golgi apparatus. Knock-down of RIM3γ leads to a fragmentation and dispersion of the Golgi
apparatus throughout the neuron, whereas knock-down of RIM4γ leads to a condensation of the
Golgi apparatus in the center of the soma and to a reduction of the total Golgi size (Fig. 5.8).
Golgi condensation associated with changes in neuronal morphology was for example observed
after the overexpresssion of the microtubule plus end tracking protein CLASP2 [Beffert et al.,
2012]. After overexpresion of CLASP2 in neuronal cultures the amount of densely packed,
smaller Golgi was increased in comparison to wild type neurons. In contrast to the observed
finding in RIM4γ knock-down neurons CLASP2 overexpressing neurons show an increase in axon
length and exhibit multiple axons [Beffert et al., 2012]. CLASP2 might lead to an stabilization of
the cytoskeleton that promotes neurite outgrowth but impairs the changes in Golgi morphology
to induce dendritic branching, whereas in RIM4γ knock-down neurons the functionality of the
Golgi apparatus seems to be further impaired leading to the complete inhibition of axonal and
dendrite growth.
TTC3, a gene located in the close proximity of the Down critical region on human chromosome
21, was recently shown to inhibit neurite growth through the induction of actin polymerization.
Overexpression of TTC3 in primary neuronal cultures impairs neurite extension and leads to
a fragmentation of the Golgi apparatus, similar to the observed changes in Golgi morphology
after knock-down of RIM3γ [Berto et al., 2014]. Actin remodeling is a key feature of neuronal
growth [Neukirchen & Bradke, 2011]. Local actin instability in the growth cone allows for the
penetration of microtubules that direct membrane flow from the Golgi into the growing tip
leading to the formation of a new neuronal branch. Thus, depolarization of the actin network
might lead to a disruption of the Golgi structure in differentiating neurons. The observed
fragmentation of the Golgi apparatus and reduction in neuronal growth after overexpression of
the actin polymerizing protein TTC3 suggest that the correct balance of actin depolymerizing
and polymerizing forces are required to guarantee neuronal growth as well as structural stability
and correct membrane flow of the Golgi apparatus. The similar effects on neuronal growth and
Golgi morphology of microtubule and actin filament regulating proteins indicate that RIM3γ and
RIM4γ’s role during neuronal growth involves the correct regulation of cytoskeletal structures.
This is further supported by the identification of several cytoskeleton regulating proteins in our
affinity-purification mass spectrometry screens for novel γ-RIM binding partners (Fig 5.11, Fig.
5.12).
A further important factor regulating the structure of Golgi morphology is the continuous and
correct amount of membrane supply from the endoplasmic reticulum (ER). The incorporation
of vesicles arriving from the ER requires the cis-Golgi protein GM130. Knock-down of GM130
leads to a disruption of the membrane supply from the ER and breakdown and of the Golgi
structure [Marra & Salvatore, 2007]. Thus, an impairment in the incorporation of membrane
vesicles send out from the ER could lead to the dispersion of the Golgi apparatus in RIM3γ
knock-down neurons and in the case of RIM4γ a reduced membrane input from the ER to the
condensation of the Golgi apparatus. Both the condensation and dispersion of the Golgi could
additionally disrupt the supply of proteins and membrane at sites of neuronal growth and would
explain why axons and dendrites and smaller structures like synapses are affected to the same
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degree.
In accordance, changes in vesicular transport of Rab8 and Rab11 marked vesicles were observed
in RIM3γ and RIM4γ knock-down neurons while vesicular traffic of Rab6 marked vesicles was
unaffected (Fig. 5.9). Here again effects of the two γ-RIMs differed as RIM4γ had overall a
stronger effect on vesicular transport than RIM3γ. Rab proteins are thought to act as cellular
cargo address labels of the various membrane transports routes within a cell. They are involved
in the recruitment of the correct cargos to transport vesicles of specific transport routes and
also support the traffic itself by interacting with the cytoskeleton. Furthermore, Rab proteins
regulate the corresponding transport routes by controlling vesicle budding at the site of origin
and vesicle fusion at the desired destination [Zerial & McBride, 2001]. The three analyzed
Rab proteins participate in different aspects of vesicular transport routes and have all been
implicated in neuronal growth [Huber et al., 1995, Schlager et al., 2010, Lazo et al., 2013]. Rab8
and Rab6 are both localized to the trans Golgi network (TGN) on vesicles leaving the Golgi
to travel to the plasma membrane. Rab8 additionally localizes to the recycling endosomes. In
a popular model of polarized vesicle traffic, the traffic of rhodopsin in retinal photoreceptors,
it was shown that Rab6 and Rab8 seem to interfere with TGN vesicular transport at different
stages [Shetty et al., 1998, Deretic et al., 1995]. In this system Rab6 is recruited to vesicles
transporting rhodopsin at earlier stages of the transport process than Rab8 and might be a part
of the sorting machinery that controls post Golgi vesicle budding [Deretic & Papermaster, 1993].
Rab8 is not needed for budding or the motility of exocytic carriers but required for docking and
fusion of vesicles send out from the TGN to the plasma membrane [Grigoriev et al., 2011]. In
addition to its role in the transport of TGN vesicles, Rab8 was implicated in neuronal growth
through regulating vesicular traffic at the recycling endosomes, a function that is not shared
by Rab6 [Hattula et al., 2006]. For instance induced neurite outgrowth in PC12 cells relies on
the recruitment of Rab8 to recycling endosomes and in fibroblast the overexpression of Rab8
leads to the formation of neurite like protrusions with the accumulation of actin microfilaments
to this protrusion [Kobayashi et al., 2014, Hattula et al., 2006, Peränen et al., 1996]. These
functions of Rab8 rely on its recycling activity and not its excocytic role in TGN. Interestingly,
Rab8 was also involved in the organization of the Golgi apparatus by recruiting the minus actin
motor MyosinIV to the Golgi complex. A disruption of this function leads to a dispersion of
the Golgi complex [Sahlender et al., 2005]. The observed changes in the vesicular transport
of Rab8 without affecting significantly Rab6 marked transport routes therefore indicate that
the knock-down of RIM3γ and RIM4γ preferentially impairs vesicular traffic from the recycling
endosome, leading to reduced neuronal growth and disruption of the Golgi structure.
Correspondingly, the loss of RIM3γ and RIM4γ also affected vesicular transport of Rab11, a
well-known regulator of the recycling endosome. In non-neuronal cells Rab11 regulates vesicular
traffic to the endocytic recycling compartment and from the endocytic recycling compartment
to the plasma membrane [Ullrich et al., 1996, Sönnichsen et al., 2000]. The correct trafficking
of Rab11 vesicles was shown to be crucial for axonal and dendritic growth and arborization
[Takahashi et al., 2012, Takano et al., 2014b, Lazo et al., 2013]. This function of Rab11 seems
to be negatively regulated by the lemur kinase 1 (LMTK1). Phosphorylation of LMTK1 by
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the Cyclin dependent kinase 5 (CDK5) inhibits Rab11 activity and formation of the endocytic
recycling compartment [Takano et al., 2010]. Accordingly, down regulation of LMTK1 leads
to an increase in velocity and trafficking length of Rab11 positive vesicles as well as increased
neuronal growth. Interestingly, CDK5 was identified as possible interaction partner of RIM3γ
and RIM4γ in our screen for novel interaction partners. Thus a hypothetical interference of
RIM3γ and RIM4γ with this cascade via CDK5 could explain the observed reduction in the
path length and velocity of Rab11vesicular traffic as well as a resulting reduction in axonal and
dendritic growth. In addition impaired Rab11 vesicle traffic might change the formation of the
recycling endosome and influence other vesicular trafficking routes associated with the recycling
endosome like Rab8. This however would not explain the observed differential effects of RIM3γ
and RIM4γ on Golgi morphology and vesicular transport routes.
Taken together, the loss of both γ-RIMs leads to a strong reduction in neuronal growth that
affects axon and dendrites. The concomitant isoform specific changes in the Golgi morphology
and vesicular transport suggest that RIM3γ and RIM4γ contribute to protein and membrane
transport during neuronal growth with isoform specific function and are both crucial for neuronal
development.
6.3 Affinity-purification mass spectrometry based proteomics reveals
cytoskeleton and vesicular trafficking associated proteins as
novel γ-RIM binding partners
With two experimental strategies we set out to identify the proteomic interaction partners of
RIM3γ and RIM4γ with a focus on novel binding partners that are associated with neuronal
growth or the regulation of synaptic transmission. Therefore we used two tissue preparations,
whole brain homogenate and the crude synaptosomal fraction and the detergents CL114 and
Triton X-100. Analysis of the identified novel γ-RIMs interaction partners revealed that the
use of synaptosomal fractions and the detergent Cl114 did successfully increase the amount of
synaptic proteins. Cl114 is a detergent of unknown composition, able to solubilize the Triton-X
100 resistant components of the presynaptic active zone. In our last experiment we combined
the screens for novel interaction partners in whole brain homogenates solubilized with Triton
X-110, crude synaptosomes solubilized with Triton X-100 and crude synaptosomes solubilized
with Cl114 in one experiment. In this combinatory approach the use of Cl114 instead of TX-
100 had an impact on the amount of identified synaptic proteins rather than the choice of
the tissue fraction. However, the levels of synaptic proteins were generally much lower in this
combinatory approach when compared to our first independent screen for novel interaction
partners in crude synaptosomal fractions. Thus it might be possible that the preparation of
the crude synaptosomal fraction in the combinatory experiment was not as pure as in the
first experiment. Collectively, by using different tissue fractions and detergents with specific
solubilizing characteristics it seems to be possible to resolve the entity of interaction partners of
a protein belonging to different cellular compartments as well as differing functional complexes.
Except for the independent screen for novel γ-RIM interaction partners in crude synaptosomal
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fractions all experiments revealed a similar distribution of functional categories of novel RIM3γ
and RIM4γ interaction partners (Fig 5.11, 5.12). This overlap in novel RIM3γ and RIM4γ can
be explained by the high sequence homology of both proteins. In addition the similar effects
of RIM3γ and RIM4γ on neuronal growth suggest that both proteins share common interac-
tion partners and participate in the same signaling cascades possibly at different steps. After
the affinity purification the RIM3γ and RIM4γ proteome was analyzed by LC-MS/MS (liquid-
chromatography-mass spectrometry/mass spectrometry) leading to not only the identification
of primary but also secondary and tertiary interactions. Thus if RIM3γ and RIM4γ are involved
in the same signal cascades but at different steps this would lead to identification of a similar
proteome. The detection of nuclear import receptors as specific interaction partners of only
RIM3γ in all approaches however shows that also isoform specific interaction partners could be
detected. Furthermore, together with the strong nuclear localization of RIM3γ that is mediated
by a nuclear localization signal in its N-terminus the discovery of importins in all experiments
shows the potential of affinity-purification mass spectrometry proteomics approaches to identify
protein interaction that might be of physiological relevance.
Analysis of the functional categories of detected proteins revealed that cytoskeletal proteins and
proteins involved in intracellular traffic of proteins and vesicles constitute large groups of novel
interaction partners in all screens. Moreover, most of the proteins that have been identified
in multiple experiments could also be associated with these functional groups, suggesting that
RIM3γ and RIM4γ are involved in processes of cytoskeleton remodeling and vesicular traffic
during neuronal growth. In this context interesting novel γ-RIM interaction partners, that were
identified in two of our experiments are three members of the Exocyst complex sec3, sec8 and
sec6. The Exocyst complex is an important regulator of site directed exocytosis and was shown to
be essential for membrane addition during neurite outgrowth and axon elongation [Vega & Hsu,
2001, Dupraz et al., 2009]. Two of the eight Exocyst subunits, sec3 and Exo70, are associated
with the plasma membrane where they act as spatial landmarks and target arriving transport
vesicles to the correct fusion site. The other Exocyst subunits (sec5, sec6, sec8, sec15 an Exo84)
are directly associated with the transport vesicles. When transport vesicles carrying the six
vesicular Exocyst components arrive at the plasma membrane the octameric complex assembles
and thereby tethers the vesicles to their fusion site, keeping them in close proximity until the
fusion machinery itself arrives [Boyd et al., 2004, Zhang et al., 2005]. Potential interactions of
RIM3γ and RIM4γ with the vesicular Exocyst subunit sec8 and the plasma membrane localized
subunit sec3 suggest that γ-RIMs are either present on transport vesicles guided by the two
exocyst complex components or they influence vesicular traffic through an interaction with the
two exocyst components. A key feature of neuronal growth is the site directed fusion of new
membrane specifically to sites of outgrowth, this requires a high spatial and temporal control
of the fusion event and consequently of the Excocyst complex components [He & Guo, 2009].
Further important regulators of vesicular transport, that were identified in multiple experiments
as novel RIM3γ and RIM4γ interaction partners were several members of the Rab protein family.
Interestingly, Rab11 vesicles were identified as target vesicles for the Exo70 mediated recruitment
to the plasma membrane. Knock-down of Rab11 or Exo70 in cultured HeLa cells inhibits the
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fusion of vesicles derived from the recycling endosome and leads to their accumulation at the
cell periphery [Takahashi et al., 2012]. The interaction of RIM3γ and RIM4γ with the Exocyst
complex and Rab11 could therefore explain the defect in neuronal growth and the disruption
of vesicular transport routes leading to an inappropriate supply of membrane to the Golgi and
hence a disruption of the Golgi morphology. Two members of the IQGAP family, which are
involved in the cross talk of actin and microtubules were identified in two of our experiments.
Interestingly, an interaction of IQGAP1, sec3 and sec8 upon CDC42 activation has been reported
to play a role in the tumor cell invasion [Sakurai-Yageta et al., 2008]. Thus, IQGAPs could act as
a further link between Rho signaling induced local changes in the cytoskeleton and site directed
fusion events combining two fundamental processes of neuronal growth. An interaction of RIM3γ
and RIM4γ with the Exocyst complex, IQGAPs and Rab proteins might therefore bring these
functions together and might explain the observed phenotype after the knock-down of RIM3γ
and RIM4γ.
Collectively, the different proteomics approaches led to the successful identification of interesting
potential interaction partners in order to elucidate the function of RIM3γ and RIM4γ and
a possible role in synaptic transmission. The whole set of proteins was composed of a large
amount of cytoskeleton associated proteins and proteins involved in intracellular traffic. The
comparison of the data sets of the individual experiments revealed a cluster of proteins that
connects signaling pathways involved in cytoskeleton remodeling with site directed vesicular
transport and might explain the phenotype observed in RIM3γ and RIM4γ knock-down neurons.
Future studies on the interaction γ-RIMs, the Exocyst complex components, IQGAPs, CDC42
effector proteins, Rabs and other proteins identified in multiple screens will help to understand
in more detail how the interplay of these protein is involved in signaling cascades and cellular
processes to promote axonal and dendritic growth.
6.4 Novel binding partners suggest an involvement of RIM3γ and
RIM4γ in several cellular processes explaining their role in
neuronal arborization
Interesting candidates identified in the mass spectrometry approaches as potential interaction
partner of RIM3γ an RIM4γ are the cell adhesion molecules plakophilin4 and δ-catenin. The
interactions of plakophilin4 and RIM3γ an RIM4γ were confirmed in vitro (Fig. 5.14). This
in vitro interactions are not caused by a general affinity of plakophilin4 to C2 domains, as
plakophilin4 did not bind to the C2A-C2B-domains of RIM1. Plakophilin4 belongs to a subfamily
of armadillo repeat proteins composed of p120catenin, δ-catenin/NPRAP, ARVCF and the more
distantly related plakophilins1-3, whereby δ-catenin is most closely related to plakophilin4. δ-
catenin is involved in the regulation of dendritic morphology and dendritic spine number by
forming a complex with the actin linker protein cortactin as well as RhoGTPases [Kim et al.,
2007, Martinez et al., 2003]. RhoGTPases are important regulators of the actin cytoskeleton
during various cellular processes including neuronal growth [Bito et al., 2000, Nakayama et al.,
2000]. A specific function of plakophilin4 in neuronal growth was not shown yet, however a screen
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for interaction partners of plakophilin4 revealed, similar to the identified γ-RIM interaction
partners, a high number of cytoskeletal proteins and also a large fraction of proteins involved
in vesicular and intercellular traffic [Keil & Hatzfeld, 2013, Keil et al., 2013]. Thus, a potential
interaction with plakophilin4 or δ-catenin might link RIM3γ an RIM4γ to signaling cascades
involved in the regulation of the cytoskeleton and contribute to their role during neuronal growth.
Another regulator of the cytoskeleton identified as potential interaction partner of RIM3γ
and RIM4γ in the mass spectrometry approaches was IQGAP3. This potential interaction
between IQGAP3 and the γ-RIMs was verified in vitro by GST-pulldown assays and Co-
immunoprecipitation (Fig. 5.16). The closely related protein IQGAP1 in contrast showed no
binding affinity to RIM proteins (Fig. 5.16). IQGAPs have been suggested as critical regulators
of the cross talk between actin an microtubules. Through the direct binding to actin filaments
IQGAPs are able to converge Rac1 and CDC42 signals to the actin cytoskeleton and via micro-
tubule associated proteins also to the microtubule network [Mateer et al., 2002, Fukata et al.,
2002]. Consistently, IQGAPs are involved in various cellular processes by remodeling actin fila-
ments and microtubules [Brandt & Grosse, 2007, White et al., 2012]. A disruption of the correct
interplay of actin and microtubules presumably leads to strong impairments in neuronal growth.
shRNA mediated knock-down of IQGAP1 as well as knock-down of its binding partner CLIP170,
a microtubule plus end tracking protein, reduces the dendritic complexity in primary cultured
neurons. Both knock-down phenotypes can be rescued by addition of the actin polymerizing
drug jasplakinolide, suggesting that both proteins are crucially involved in the crosstalk with
actin filaments during neuronal growth [Swiech et al., 2011]. Knock-down of the other IQGAP
family members, IQGAP2 and IQGAP3 leads to a reduction in NGF (neuronal growth factor)
induced neurite outgrowth in PC12 cells and reduced axonal length of primary hippocampal
neurons [Wang et al., 2007]. This impairment in neurite outgrowth could not be rescued by the
overexpression of CDC42 and Rac1 suggesting that IQGAP2 and IQGAP3 function downstream
of Rac1 and CDC42 in the regulation of the cytoskeleton during neuronal growth. An effect
on axonal growth was in contrast not observed after the knock-down of IQGAP1. Thus, all
members of the IQGAP family seem to be involved conveying growth regulating signals to the
cytoskeleton with differential contribution to axonal and dendritic growth. An interaction of
RIM3γ and RIM4γ with IQGAP3 is therefore a further link to the modulation of the cytoskele-
ton during neuronal growth. IQGAP3 and IQGAP2 seem to be important for initial neurite
outgrowth and axon elongation whereas IQGAP1 is involved in later stages of neuronal growth
during the elaboration of a complex dendritic arbor. The knock-down of RIM3γ and RIM4γ
similar to the knock-down of IQGAP3 impaired neurite growth and axonal elongation. This sub-
stantiates the possibility that RIM3γ and RIM4γ are involved in neuronal growth by interfering
with the transduction of growth regulating signaling on the cytoskeleton via IQGAP3. IQGAP1
showed no binding affinity to RIM proteins further supporting the specificity of the identified
interaction in accordance to the differential function of the IQGAPs during neuronal growth.
However it remains elusive if the positive binding of the C2A-C2B-domains of RIM1 to IQGAP3
in two out of three in vitro protein binding assays is due to a general affinity of IQGAP3 to
C2B domains or a specific interaction of IQGAP3 to RIM1. Nevertheless, the reported role
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in synaptic plasticity of IQGAP1 as modulator of NMDA receptor traffic and activity [Gao &
Frausto, 2011] opens the possibility, that also IQGAP3 might be involved in the organization of
the presynapse. This function of IQGAP3 could involve an interaction with RIM1. Interestingly,
IQGAP1 was also shown to associate with Golgi membranes together with CDC42 suggesting
that IQGAP1 is also involved in the modulation of the Golgi apparatus by local remodeling
of the cytoskeleton [McCallum et al., 1998]. Thus, the interaction of RIM3γ and RIM4γ with
IQGAP3 could explain the role of both γ-RIMs in neuronal growth and the modulation of the
Golgi apparatus assuming a function of IQGAP3 in the modulation of the Golgi apparatus in
accordance to IQGAP1.
The high sequence homology between the 7 RIM family members and their shared synaptic
localization suggests an involvement in common regulatory mechanisms at the presynapse [Wang
et al., 2000, Alvarez-Baron et al., 2013]. In this study the synapse defective protein 1 (Syd-1),
a protein involved in the early steps of active zone assembly [Owald et al., 2012] was identified
as potential interaction partner of RIM3γ and RIM4γ. This potential interaction with RIM3γ
and RIM4γ as well as an interaction with the C2B domain of RIM1 could be verified in in vitro
binding assays (Fig 5.18). The initial steps of the presynaptic assembly include local changes
of the actin cytoskeleton allowing for the subsequent establishment of the tight protein network
of the presynaptic active zone. Syd-1 interacts with this actin network at nascent synapses
and is thought to be involved in the recruitment of active zone proteins via its interaction
with Liprin-α [Wentzel et al., 2013, Li et al., 2014]. Furthermore, Syd-1 was shown to be
involved in coordinating the assembly of pre- and postsynaptic structures in cooperation with the
presynaptic adhesion molecule neurexin, which is known to induce assembly of the postsynaptic
densities via its postsynaptic partner neuroligin [Owald et al., 2012]. Considering the observed
impairments in synapse formation after the knock-down of RIM3γ and RIM4γ as well as their
proposed functions in intracellular traffic it can be envisioned that the γ-RIMs are involved
in the transport of Syd-1 to the assembling presynapse. Thus, a loss of RIM3γ or RIM4γ
would lead to a misslocalization of Syd-1, disrupting the correct assembly of the presynapse and
consequently also the coordinative assembly of the postsynapse. However, the strong deficits
of neuronal growth suggest that the reduced synapse number observed in RIM3γ and RIM4γ
knock-down neurons is rather caused by a disruption of general growth processes. Additionally,
the interaction of Syd-1 not only with RIM3γ and RIM4γ but also the C2B domain of RIM1
suggests, that rather Syd-1 is responsible for the recruitment of RIM proteins to the active zone.
The C2B domain is highly conserved between all RIM family members. Thus if the recruitment
of RIM proteins is mediated through a binding of Syd-1 to the C2B domains, RIM3γ and
RIM4γ could act as dominant negative versions and thereby influence the amount of RIM1 at
the presynapse. This mechanism would allow RIM3γ and RIM4γ to negatively interfere with
the presynaptic release probability and hence synaptic strength. Instead of blocking the binding
of RIM to Syd-1, RIM3γ and RIM4γ could also stabilize this interaction by forming a tripartite
complex with Syd-1 and RIM1 and promote thereby the assembly of the active zone.
Taken together, the in vitro verified interaction of γ-RIMs with IQGAP3 and plakophilin4 pro-
pose several mechanisms explaining how RIM3γ and RIM4γ might interfere with the remodeling
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of the cytoskeleton as well as intracellular traffic of proteins and membrane during growth and
development. However, the questions of how these functions converge and what their individ-
ual contributions to the role of RIM3γ and RIM4γ in neuronal arborization are, remain to be
answered. The interaction with the presynaptic protein Syd-1 suggests that RIM3γ and RIM4γ
exhibit in addition to the growth regulating function a synapse specific role.
6.5 Activity dependent changes in RIM3γ and RIM4γ gene
transcription
During increased neuronal activity neurons undergo changes in molecular composition and struc-
ture in order to adjust their synaptic strength. This neuronal plasticity has been associated with
a variety of physiological processes like learning and memory but also pathological processes like
epileptogenesis [Milner et al., 1998, Bausch et al., 2006]. A possible function of RIM3γ and
RIM4γ in neuronal plasticity was investigated in a model of episodic brain hyperexcitability, by
analyzing the effect of intense neuronal activity on the gene expression of RIM3γ and RIM4γ.
In this model a status epilepticus characterized as an episode of intense synchronized neuronal
activity is induced by the application of the muscarinic agonist pilocarpine. Mice subjected to
pilocarpine induced status epilepticus develop spontaneous seizures after a latency period of two
weeks [Pitsch et al., 2007]. 12 hours after status epilepticus the gene exepression of RIM4γ is
strongly upregulated in the hippocampus. RIM3γ in contrast shows only a weak down regulation
in the dentate gyrus 36 hours after status epilepticus. In accordance RIM4γ was recently shown
to be upregulated in the hippocampus after induction of neuronal activity by the application of
kainic acid [Hermey et al., 2013]. These results suggest a function in the regulation of synaptic
strength for both γ-RIMs with presumably opposing effects of the two isoforms. In the same
animal model of epilepsy the gene expression of RIM1 was unchanged in the acute phase after
status epilepticus though downregulated 28 days after status epilepticus in the chronic phase
when the animals experience spontaneous seizures [Pitsch et al., 2012]. This could be either a
compensatory mechanisms of the neuronal network in order reduce synaptic strength and di-
minish the hyperxcitability of an epileptic brain or the decrease in RIM1 gene expression is part
of the pathomechanisms leading to chronic epileptic seizures. In addition RIM1 was shown to be
differentially regulated after neuronal silencing [Jiang et al., 2010, Lazarevic et al., 2011]. Both
lines of evidence suggest an important role for RIM1 in the adaptation of the synaptic strength
during changes in network activity. RIM1 knock-out mice like RIM3γ knock-out mice show no
obvious motor phenotype. However, detailed electrophysiological and behavioral experiments
revealed that RIM1 knock-out mice do experience impairments in presynaptic release probability
resulting in severe learning and memory deficits and schizophrenia related behaviors whereby
coordination is unchanged [Powell et al., 2004, Blundell et al., 2010b]. Interestingly, changes in
RIM3γ expression levels have been reported in schizophrenia and in lymphoblastoid cells from
autism patients. [Weidenhofer et al., 2006, Weidenhofer et al., 2009, Nishimura et al., 2007].
RIM3γ was further identified as a novel candidate gene for autism in a genetic approach [Kumar
et al., 2010]. These findings suggest that alterations in the loss of RIM3γ gene expression might
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induce the development of neuropsychiatric disorders like schizophrenia and autism in RIM3γ
knock-out mice. In the future electrophysiological analysis together with detailed behavioral
studies on the phenotypes of RIM3γ and RIM4γ knock-out mice will help to unravel the role
of RIM3γ and RIM4γ in synaptic transmission as well as in the development of neurological
disorders.
6.6 Strong motor phenotype in RIM4γ knock-out mice
The shRNA mediated knock-down of proteins allows to analyze the function of the protein
of interest only in a subset of cells at a specific time point during development. In contrast
constitutive knock-out mice allow to study the consequences of the loss of a genes function
throughout development on the whole mouse organism. During this study the introduction of a
splice acceptor site in an intronic region of the RIM3γ and RIM4γ genes lead to the successful
generation of constitutive RIM3γ and RIM4γ knock-out mice. The ablation of the gene of
interest was verified on the level of mRNA expression and on the level of protein expression
(Fig 5.20). Homozygous RIM3γ knock-out (RIM3γ-/-) mice showed a reduction of 90-99% in
mRNA and protein levels depending on the analyzed brain region whereas homozygous RIM4γ
knock-out (RIM4γ-/-) mice revealed a only reduced of 70-98%. The constitutive knock-out of
RIM4γ was induced by the introduction of a splice acceptor cassette in the intron region between
exon one and two. Thus, a successful knock-out should abolish the expression of the full-length
protein. It would however still allow the expression of the first exon. The antibodies used to
detect RIM4γ on western blots as well as the primers used to detect RIM4γ mRNA, both span
boarders of exon one and two. The expression of exon one in the constitutive RIM4γ-/- mice
should therefore not be detectable by western blots and quantitative real time RT-PCR with the
used antibodies and primers. Endogenous RIM4γ expression in the brain is fairly low, leading
to weak signals in western blots and quantitative real time RT-PCR and consequently to small
signal to noise ratio. Thus, the detected signals of RIM4γ expression in RIM4γ -/- mice might be
or partially caused by a relatively a high background signal. Consistently RIM4γ -/- mice exhibit
the highest RIM4γ rest protein expression levels of all tested brain regions in the hippocampus,
the region with the lowest endogenous expression levels. Whereas in the cerebellum the region
with the highest RIM4γ expression levels in the brain the signal was reduced to 2% of wild
type protein expression levels [Alvaréz-Baron, 2010], (Fig 5.20). However, it cannot be excluded
that constitutive RIM4γ -/- mice still express low levels of RIM4γ caused by not 100% effective
splicing of the introduced gene trap cassette. Analysis of conditional RIM3γ and RIM4γ crossed
with a Cre recombinase expressing line leading to the complete excision of the targeted exons
will show if the background in western blots and quantitative real time RT-PCR originates from
ineffective splicing of the gene trap cassette or by unspecific background signals.
In the first weeks after birth RIM4γ -/- and RIM3γ-/- mice cannot be distinguished from wild
type litter mates and show no obvious abnormalities. At three weeks of age, around the time of
weaning, RIM4γ -/- mice develop a severe episodic motor phenotype accompanied by a strong
reduction in weight whereas RIM3γ-/- mice develop normally (Fig 5.22, 5.23). Gait analysis and
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motor tests on a rotating rod revealed that RIM4γ -/- mice also during episodes of no obvious
motor impairments experience coordinative disturbances (Fig 5.24, 5.25). These motor deficits
might be at least partially contributed to a weakened musculature due to the strong episodes
of hind limb impairments and the associated weight loss. The weight reduction in RIM4γ-/-
mice starts to develop at the same time as the episodic motor phenotype and might therefore
be a secondary effect of the motor phenotype. During episodes of motor impairments RIM4γ-/-
mice might be devitalized and less able to reach the food represented in wire-bar cage lids. In
addition, the strong motor abnormalities occurring with a frequency of once every 24 hours
possibly induce physical stress leading to a higher calorie consumption in RIM4γ -/- mice in
comparison to wild type litter mates.
Apart from the frequent episodes of motor disturbances, in rare cases a behavior resembling an
event of epileptic seizures was observed in RIM4γ -/- mice. The difference in the frequency of
theses two events and also in the difference in the behavioral impact suggest that RIM4γ-/- mice
suffer from several neurological impairments leading on the one hand to strong episodic motor
deficits affecting mainly the hind limbs and on the other hand in rare cases to epileptic seizure
like events.
The growth deficits observed in RIM4γ knock-down neurons suggest that the motor phenotype
in RIM4γ-/- mice is caused by impairments in neuronal growth leading to changes in the brain
architecture. Histological stainings of neuronal layers revealed no drastic changes in the overall
architecture of the hippocampus and the cerebellum of RIM4γ -/- and RIM3γ -/- mice (Fig.
5.27). A functional redundancy of RIM3γ and RIM4γ in neuronal growth is already suggested by
the same strong deficits in the neurite growth after the knock-down of either RIM3γ or RIM4γ
and further supported by the finding that the growth impairments can be partially rescued
by the overexpression of the respective other γ-RIM isoform [Alvarez-Baron et al., 2013]. An
upregulation of the respective other γ-RIM isoform in RIM3γ and RIM4γ knock-out mice might
therefore help to overcome or milder the deficits in neuronal growth and aborization in RIM3γ
-/- and RIM4γ -/- mice. Mildered dendritic growth deficits after the complete knock-out of a
protein in comparison to its acute knock-down have been reported for example for δ-cantenin.
Both primary cultured neurons transfected with shRNA agains δ-cantenin and cultured neurons
from δ-cantenin knock-out mice show are reduction in the total dendritic length and the the
number of dendritic endpoints, however this growth impairment was more pronounced in δ-
cantenin knock-down neurons [Arikkath et al., 2008]. This suggests that the full knock-out allows
the induction of compensatory mechanism in order to weaken the consequences of the protein
loss. Interestingly, also the phenotype of reduced glutamatergic synapses after the knock-down
of neuroligin-1 could neither be reproduced in neuroligin-1 nor in neuroligin-1, neuroligin-2 and
neuroligin-3 triple knock-outs [Varoqueaux et al., 2006, Blundell et al., 2010a]. In-vivo studies on
cortical pyramidal neurons in which neuroligin-1 levels had been downregulated from neuronal
birth on revealed that the reduction in glutamatergic synapses was not caused by the loss of
neuroligin-1 but the differing levels of neuroligin-1 in individual neurons [Kwon et al., 2012].
Thus also the varying levels of RIM3γ or RIM4γ after shRNA mediated knock-down in culture
or in vivo could lead to a phenotype that would not be observed in the full knock-out.
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The observed episodes of rapid uncontrolled movements disrupted by phases of rigid immobility
in RIM4γ-/- partially resemble the phenotype of the tottering mouse. Tottering mice carry a
mutation in the calcium channel α1a subunit gene (Cacna1a) that encodes for the pore form-
ing protein of P/Q type calcium channels [Fletcher et al., 1996]. Tottering mice experience
neurological deficits resulting in ataxia, paroxysomal dyskenisia and behavioral absence seizures
resembling petit mal epilepsy. In these mice seizures resembling absence epilepsy have been
associated with spike wave discharge whereas episodes of paroxysomal dyskenisia showed no ob-
vious electroencephalographic correlates [Noebels & Sidman, 1979]. The episodes of dyskenisia
resemble the observed phenotype in RIM4γ-/- mice. The phenotype observed in tottering mice
is accompanied by a local increase in cell death in the cerebellum [Fletcher et al., 1996, Zwing-
man, 2001]. Studies on the expression pattern of the immediate early gene c-fos after induction
of an episode of dyskenisia revealed an increase in neuronal activity in the cerebellum and con-
comitantly in the cerebal cortex [Campbell & Hess, 1998]. An involvement of the cerebellum in
the emergence of the dystonic episodes in tottering mice was further confirmed by the surgical
removal of the cerebellum. Cerebellectomy in tottering mice resulted in some cases in a worsen-
ing of the baseline ataxia however spontaneous dystonic attacks were abolished [Neychev et al.,
2008].
Interestingly, RIM4γ exhibits the highest mRNA expression levels in the cerebellum and was
furthermore suggested to be involved in the modulation of the voltage dependent inactivation
of P/Q type calcium channels in PC12 cells. In in-vitro binding assays RIM4γ was shown
to bind to the β4 and β3 subunits of voltage dependent calcium channels (VDCC) and to
inhibit the voltage dependent inactivation leading to longer calcium channel opening times
[Uriu et al., 2010]. In accordance it was suggested that the phenotype observed in tottering mice
might be caused by reduced current density in Purkinje cells and minor effects on P/Q current
kinetics including changes in the voltage dependence of inactivation [Wakamori, 1998]. Taken
together, the high expression levels of RIM4γ in the cerebellum and the suggested function
in the modulation of calcium channel opening times as well as the resembling motor deficits
of RIM4γ -/- and tottering mice indicate that the phenotype observed in RIM4γ -/- mice is
caused by changes in the electrophysiological properties of the cerebellum. The cerebellum
itself does not initiate movements but it contributes to coordination, precision, accuracy and
timing. Therefore, the observed coordinative disturbances in the RIM4γ -/- mice during the
phenotypic inconspicuous periods further support a dysfunction of the cerebellar circuits in
RIM4γ -/- mice. Furthermore, lately RIM1 and RIM2 were associated with the rare dominantly
inherited episodic movement disorder paroxysmal dyskinesia (PNKD). PNKD is characterized
by childhood onset with involuntary movements in the limbs, trunk, and face manifesting as
dystonia, chorea, and athetosis. The causative gene codes for a novel protein PNKD that has
been show to localize to the presynapse and shows a binding affinity the C2B domain of RIM1
and RIM2 [Shen et al., 2015]. With regard to the reported functional redundancy in neuronal
growth as well as remodeling of calcium channel opening times of both γ-RIMs it is surprising
that RIM3γ -/- mice are behaviorally inconspicuous and do not share the phenotype of RIM4γ
-/- mice [Uriu et al., 2010, Alvarez-Baron et al., 2013]. This contradiction suggests that RIM4γ
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might rather influence the functionality of the cerebellum through a function that is not shared
by RIM3γ. A RIM4γ specific synaptic function is furthermore supported by the strong RIM4γ
transcriptional upregulation after the induction of synaptic activity [Hermey et al., 2013]. The
loss of RIM4γ could therefore impair synaptic transmission especially in the cerebellum leading
to an imbalance and misconnection of neuronal circuits involved in motor coordination.
Taken together, RM4γ -/- mice show a strong episodic motor phenotype and mild coordination
disturbances. The high expression levels of RIM4γ in the cerebellum together with the role of
the cerebellum in motor coordination suggest that the loss of RIM4γ might impair the correct
formation and function of neuronal circuits in the cerebellum leading to the observed phenotype.
RIM3γ -/- mice in contrast showed no drastic motor phenotype or changes in overall brain
architecture. However, possible deficits in learning and memory and behaviors associated with
neuropsychiatric disorders were not investigated in this study and remain to be resolved.
7 Outlook
The findings obtained in this study form the basis for future experiments on the functional role
of RIM3γ and RIM4γ.
Our affinity-purification mass spectrometry approaches revealed a substantial number of inter-
esting novel potential γ-RIM interaction partners. Biochemical studies on the interactions with
these newly identified binding partners will help to unravel the proteomic connectome of RIM3γ
and RIM4γ. In addition, functional assays on the role of these potential interactions in axonal
and dendritic growth, Golgi morphology and vesicular traffic will allow, to elucidate the signaling
cascades that underlie the role of RIM3γ and RIM4γ in neuronal growth.
In shRNA mediated knock-down experiments we could show that the sudden loss of RIM3γ
and RIM4γ leads to strong impairments in neuronal growth in vivo and in vitro. However, in
RIM3γ and RIM4γ knock-out mice the overall brain morphology appears unchanged. Therefore,
detailed studies on the morphology of brain structures and of individual neurons of RIM3γ and
RIM4γ knock-out mice, including the induction of the gene knock-out at different developmental
stages, are required to reveal if possible growth deficits are restricted to specific cell types or
compensated during development through the upregulation of other growth promoting proteins.
The characteristics of the strong motor deficits and the coordinative disturbances as well as
the high expression levels of RIM4γ in the cerebellum raise the question if an impaired cere-
bellar function is responsible for the phenotype of RIM4γ knock-out mice. This question can
be answered by studying the consequence of a conditional RIM4γ knock-out restricted to the
cerebellum or specific neuronal subtypes.
In genexpression assays we could show that RIM3γ and RIM4γ are differentially regulated after
pilocarpine induced status epilepticus. This finding together with a possible role of both pro-
teins in synaptic transmission suggest that γ-RIMs might be crucial for the correct function of a
healthy brain. Electrophysiological measurements in the hippocampus and cerebellum of RIM3γ
and RIM4γ knock-out mice will show if the two γ-RIMs are involved in the establishment of
hippocampal and cerebellar circuits and the regulation of synaptic transmission. Furthermore,
behavioral tests on RIM3γ and RIM4γ knock-out mice considering changes in learning and mem-
ory, schizophrenia related behaviors and the sensitivity to epileptogenic insults will contribute
to our knowledge on the role of RIM3γ and RIM4γ in the pathogenesis of neurological disorders
as well as in normal brain.
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8.1 Tables of by mass spectrometry identified RIM3γ and RIM4γ
binding proteins
8.2 Table 8.1: Proteins identified in the whole mouse brain fraction
gene ID identified protein protein score RIM3γ protein score RIM4γ
intercellular signaling
1175 Adaptor-related protein complex 2, sigma
1 subunit
210 73
116986 ArfGAP with GTPase domain, ankyrin
repeat and PH domain 1
295
9855 FERM, RhoGEF and pleckstrin domain
protein 2
235
9737 G protein-coupled receptor associated
sorting protein 2
449
2778 GNAS complex locus 225 360
84705 GTP binding protein 3 (mitochondrial) 304 112
2770 Guanine nucleotide binding protein (G
protein), alpha inhibiting activity
polypeptide 1
430 384
2782 Guanine nucleotide binding protein (G
protein), beta polypeptide 1
165 213
8471 Insulin receptor substrate 4 1505 1632
5784 protein tyrosine phosphatase,
non-receptor type 14
203 123
5905 Ran GTPase activating protein 1 205
79809 Tetratricopeptide repeat domain 21B 215 328
adhesion molecules
gene ID identified protein protein score RIM3γ protein score RIM4γ
154796 Angiomotin 1547 1610
1495 Catenin (cadherin-associated protein),
alpha 1, 102kDa
659 536
1500 Catenin (cadherin-associated protein),
delta 1
502 285
57530 Cingulin 611 432
1829 Desmoglein 2 479
56704 Junctophilin 1 158 257
3987 LIM and senescent cell antigen like
domains 1
64 207
5318 Plakophilin2 769
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8502 Plakophilin4 129 442
7082 Tight junction protein 1 991 811
intracellular protein and membrane traffic
gene ID identified protein protein score RIM3γ protein score RIM4γ
8546 Adaptor-related protein complex 3, beta 1
subunit
486 532
8943 Adaptor-related protein complex 3, delta
1 subunit
486 532
1176 Adaptor-related protein complex 3, sigma
1 subunit
221 133
55763 Exocyst complex component 1 491 164
60412 Exocyst complex component 4 404 291
9922 IQ motif and Sec7 domain 1 379 789
9928 Kinesin family member 14 321 404
cytoskeletal proteins and cytoskeleton regulating proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
829 Capping protein (actin filament) muscle
Z-line, alpha 1
305 215
11135 CDC42 effector protein (RhO GTPase
binding) 1
484
1674 Desmin 288
128239 IQ motif containing GTPase activating
protein 3 (IQGAP3)
158 603
55700 MAP7 domain containing 1 139 327
79649 MAP7 domain containing 3 874
253260 RPTOR independent companion of
MTOR, complex 2
126 655
89796 Neuron navigator 1 1886 284
6709 Spectrin, alpha, non-erythrocytic 1 3375 2047
6711 Spectrin, beta, non-erythrocytic 1 2333 2143
10381 Tubulin, beta 3 999
synaptic proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
8573 Calcium/calmodulin dependent serine
protein kinase (MAGUK family)
48 83
5573 Protein kinase, cAMP-dependent,
regulatory, type I, alpha
203 123
85360 Synapse defective 1, Rho GTPase,
homolog 1 (syd-1)
246
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116841 Synaptosomal-associated protein, 47kDa 313 89
55014 Syntaxin 17 272
channel proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
7417 Voltage dependent anion channel 2 223 89
729317 Voltage dependent anion channel 2
pseudogene
223 89
nuclear proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
983 Cyclin dependent kinase 1 385 333
79711 Importin 4 150
3843 Importin 5 188
10526 Importin 8 119
calcium binding proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
5954 Reticulocalbin 1, EF-hand calcium
binding domain
658
5955 Reticulocalbin 2, EF-hand calcium
binding domain
396
51150 Stromal cell derived factor 4 453
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8.3 Table 8.2: Proteins identified in crude synaptosomal fractions
gene ID identified protein protein score RIM3γ protein score RIM4γ
synaptic proteins /synaptic vesicle release /synaptogenesis
12217 Bassoon 35 37
234577 Copine-2 33
13838 Ephrin type-A receptor 8 39
20512 Excitatory amino acid transporter 1 69 46
20511 Excitatory amino acid transporter 2 20
73748 Glutamate decarboxylase-like protein 1 28
17475 Multiple PDZ domain protein 16
499191 Neugrin 33
235627 Neurobeachin-like protein 2 40
26875 Piccolo 30
382018 Protein unc-13 homolog A 41 41
116837 Regulating synaptic membrane exocytosis
protein 1
68 121
20615 SNARE-associated protein Snapin 30
27204 Synapsin-3 30
9145 Synaptogyrin-1 60
20614 Synaptosomal-associated protein 25 51
27359 Synaptotagmin-like protein 4 37
20969 Syndecan-1 32
6804 Syntaxin-1A 39
cytoskeletal components and cytoskeleton regulating proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
68743 Actin-binding protein anillin 31
76652 Actin-related protein M1 homolog 35
70 Actin, alpha cardiac muscle 1 100
219144 ADP-ribosylation factor-like protein 11 33
56430 CAP-Gly domain-containing linker
protein 1
43
58804 Cdc42 effector protein 5 30
208846 Disheveled-associated activator of
morphogenesis 1
31 36
17761 Ensconsin (MAP7) 30
56226 Espin 30
56223 Fascin-3 37
232944 MAP/microtubule affinity-regulating
kinase 4
31
CHAPTER 8. APPENDIX 120
270058 Microtubule-associated protein 1S 30 28
78757 Rapamycin-insensitive companion of
mTOR
26
10788 Ras GTPase-activating-like protein
IQGAP2
32
22349 Villin-1 31
intracellular protein and membrane traffic
gene ID identified protein protein score RIM3γ protein score RIM4γ
16476 AP-1 complex subunit beta-1 33
216963 ARF GTPase-activating protein GIT1 26
26357 ATP-binding cassette sub-family G
member 2
43
8455 Attractin 36
13424 Cytoplasmic dynein 1 heavy chain 1 32
235661 Cytoplasmic dynein 1 light intermediate
chain 1
35
13424 Cytoplasmic dynein 2 heavy chain 1 32
110084 Dynein heavy chain 8, axonemal 29
227619 Endoplasmic reticulum
mannosyl-oligosaccharide
1,2-alpha-mannosidase
20
211446 Exocyst complex component 3 (Sec 6) 35
18550 Furin 31
15194 Huntingtin 33
381290 Plasma membrane calcium-transporting
ATPase 4
87
53421 Protein transport protein Sec61 subunit
alpha isoform 1
42
18844 Plexin-A1 32
98732 Rab3 GTPase-activating protein
non-catalytic subunit
27 38
268451 Rab11 family-interacting protein 4 26
34110 Rabenosyn-5 29
19894 Rabphilin-3A 47
104886 Ras-related protein Rab-15 31
19338 Ras-related protein Rab-33B 57
270160 Ras-related protein Rab-39A 19 19
67295 Ras-related protein Rab-3C 57
19341 Ras-related protein Rab-4A 57
19346 Ras-related protein Rab-6A 57
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266781 Sorting nexin-17 34
27096 Trafficking protein particle complex
subunit 3
32
364137 Transmembrane protein 165 42
adhesion molecules
gene ID identified protein protein score RIM3γ protein score RIM4γ
75723 Angiomotin-like protein 1 31
70882 Armadillo repeat-containing protein 3 34
102272429 Claudin-7 30
319565 Nesprin-2 36
17967 Neural cell adhesion molecule 1 44
18081 Ninjurin-1 29
23963 Teneurin-1 37 35
channel proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
243634 Anoctamin-2 16
228432 Anoctamin-3 30
102566 Anoctamin-10 27
1179 Calcium-activated chloride channel
regulator 1
26
12283 Calcium-binding protein 39 36
53321 Contactin-associated protein 1 29
14609 Gap junction alpha-1 protein 32
14616 Gap junction alpha-8 protein 31
16509 Potassium voltage-gated channel
subfamily E member
41
67498 Potassium voltage-gated channel
subfamily V member 1
33 31
110876 Sodium channel protein type 2 subunit
alpha
35
22333 Voltage-dependent anion-selective channel
protein 1
69
22335 Voltage-dependent anion-selective channel
protein 3
69
nuclear proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
30946 Activator of basal transcription 1 32
214444 CDK5 regulatory subunit-associated
protein 2
30
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69131 Cyclin-dependent kinase 12 29
18555 Cyclin-dependent kinase 16 32
76582 Importin-11 33
13555 Transcription factor E2F1 37
15273 Transcription factor HIVEP2 14
17133 Transcription factor MafF 50
270627 Transcription initiation factor TFIID
subunit 1
30
22589 Transcriptional regulator ATRX 29
70207 Translational activator of cytochrome c
oxidase 1
33
calcium binding proteins
gene ID identified protein protein score RIM3γ protein score RIM4γ
69008 Calcium-binding protein 39-like 36
26611 Reticulocalbin-2 88
growth receptors
gene ID identified protein protein score RIM3γ protein score RIM4γ
18212 BDNF/NT-3 growth factors receptor 31
50915 Growth factor receptor-bound protein 14 31
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8.4 Table 8.3: Proteins identified in the combined mass
spectrometry approach
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
cytoskeletal proteins and cytoskeleton regulating proteins
103466 5’-nucleotidase
domain-containing
protein 3
35,30
56444 Actin-related protein 10 85,45
66713 Actin-related protein 2 159,34
35311 Actin-related protein 2/3
complex subunit 2
136,75 65,67 82,39
33864 Actin-related protein 2/3
complex subunit 4
102,72
74117 Actin-related protein 3 164,29
11518 Alpha-adducin 84,14
109676 Ankyrin-2 231,91
11735 Ankyrin-3 90,46
13821 Band 4.1-like protein 1 212,33
13822 Band 4.1-like protein 2 91,18
72832 Cartilage acidic protein 1 215,42
12631 Cofilin-1 174,89 143,70 388,34
53321 Contactin-associated
protein 1
94,70 319,07
12721 Coronin-1A 70,29
76441 Disheveled-associated
activator of
morphogenesis 2
70,72
13429 Dynamin-1 83,49 410,25
13726 Emerin 78,24 31,70
14026 Ena/VASP-like protein 26,47
53972 Ephexin-1 672,64
22350 Ezrin 60,71
14086 Fascin 129,57
74103 LIM zinc-binding
domain-containing
Nebulette
115,91 52,08
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50997 MAGUK p55 subfamily
member 2
224,46 259,52
56524 MAGUK p55 subfamily
member 6
175,77 141,30
228355 MAP kinase-activating
death domain protein
138,58
208158 MAP6 domain-containing
protein 1
78,37 61,41
17760 Microtubule-associated
protein 6
403,93 586,35
13589 Microtubule-associated
protein RP/EB family
member 1
74,59
212307 Microtubule-associated
protein RP/EB family
member 2
79,96
100732 Microtubule-associated
protein RP/EB family
member 3
107,87
17698 Moesin 37,49
50884 Nck-associated protein 1 66,19
18645 Profilin-2 90,65
52822 Protein RUFY3 179,76 203,13
110351 Rap1 GTPase-activating
protein 1
76,22
11852 Rho-related GTP-binding
protein RhoB
39,38
18951 Septin-5 47,90
235072 Septin-7 276,72
20362 Septin-8 90,12
53860 Septin-9 38,92
21894 Talin-1 109,48
22142 Tubulin alpha-1A chain 15161 13562
22143 Tubulin alpha-1B chain 15128 11973 13489 8717
22146 Tubulin alpha-1C chain 7437
22151 Tubulin beta-2A chain 33621 30154 28024 19066
73710 Tubulin beta-2B chain 29618 18378
22152 Tubulin beta-3 chain 20802 19992 17990 12160
22153 Tubulin beta-4A chain 25880 23192 20926 13810
22154 Tubulin beta-5 chain 27471 25095 23377 15947
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67951 Tubulin beta-6 chain 14700 12592 13068 7600
22388 WD repeat-containing
protein 1
113,58
207615 WD repeat-containing
protein 37
40,36
nuclear proteins / transcription machinery
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
67089 26S protease regulatory
subunit 10B
98,77
19182 26S protease regulatory
subunit 6A
76,47
118451 28S ribosomal protein S2,
mitochondrial
83,61
27207 40S ribosomal protein S11 114,90
20085 40S ribosomal protein S19 47,59
27050 40S ribosomal protein S3 272,73 158,37
20102 40S ribosomal protein S4,
X isoform
36,10
20115 40S ribosomal protein S7 69,76
19934 60S ribosomal protein
L22
108,14
65019 60S ribosomal protein
L23
132,55
268449 60S ribosomal protein
L23a
99,74
67671 60S ribosomal protein
L38
177,56 309,11
100503670 60S ribosomal protein L5 129,40 94,71
11737 Acidic leucine-rich
nuclear phosphoprotein
32 family member A
88,87
234734 Alanine-tRNA ligase,
cytoplasmic
88,02
70223 Asparagine–tRNA ligase,
cytoplasmic
29,99 44,73
237397 C2 calcium-dependent
domain-containing
protein 4C
143,34
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12568 Cyclin-dependent kinase
5
120,31 153,07 159,64
13194 DNA damage-binding
protein 1
97,91 260,67 65,21
15502 DnaJ homolog subfamily
A member 1
348,60 133,69 932,72 380,59
56445 DnaJ homolog subfamily
A member 2
209,95 235,65
67838 DnaJ homolog subfamily
B member 11
138,78
23950 DnaJ homolog subfamily
B member 6
111,75 94,87
13002 DnaJ homolog subfamily
C member 5
45,05 20,61
56354 DnaJ homolog subfamily
C member 7
111,59 139,17
13628 Elongation factor 1-alpha
2
480,39 713,68
66656 Elongation factor 1-delta 173,19 107,17
13631 Elongation factor 2 388,90 139,94
74195 Elongator complex
protein 3
58,15
13681 Eukaryotic initiation
factor 4A-I
116,76
13682 Eukaryotic initiation
factor 4A-II
113,28
13664 Eukaryotic translation
initiation factor 1A
57,46
13665 Eukaryotic translation
initiation factor 2 subunit
2
32,30
13669 Eukaryotic translation
initiation factor 3 subunit
A
19,77
8664 Eukaryotic translation
initiation factor 3 subunit
D
60,26
16341 Eukaryotic translation
initiation factor 3 subunit
I
49,05 39,54
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208643 Eukaryotic translation
initiation factor 4 gamma
58,98
26232 F-box only protein 2 163,24
23014 F-box only protein 21 284,66
233038 F-box only protein 50 90,30
214931 F-box/LRR-repeat
protein 16
45,45
15382 Heterogeneous nuclear
ribonucleoprotein A1
115,72 94,32 94,18
56258 Heterogeneous nuclear
ribonucleoprotein H2
174,99 403,88
15387 Heterogeneous nuclear
ribonucleoprotein K
804,49 685,93
76936 Heterogeneous nuclear
ribonucleoprotein M
70,03
15289 High mobility group
protein B1
47,30
16650 Importin subunit alpha-7 151,48 68,06
70572 Importin-5 80,08
17975 Nucleolin 68,63
17955 Nucleosome assembly
protein 1-like 1
201,90
66590 Phenylalanine–tRNA
ligase alpha subunit
124,47
66870 Plasminogen activator
inhibitor 1 RNA-binding
protein
79,81
13207 Probable ATP-dependent
RNA helicase DDX5
144,47
110957 Putative ATP-dependent
RNA helicase Pl10
163,56
192196 Putative RNA-binding
protein Luc7-like 2
107,91 125,65 122,45
170791 RNA-binding protein 39 50,18
20382 Serine/arginine-rich
splicing factor 2
87,87
67332 Small nuclear
ribonucleoprotein Sm D3
86,06
71514 Splicing factor, proline-
and glutamine-rich
62,64 60,06
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19045 Serine/threonine-protein
phosphatase PP1-alpha
catalytic subunit
96,3
229906 Transcription initiation
factor IIB
54,69
66078 tRNA-splicing
endonuclease subunit
Sen34
226,29
phosphatase / kinase
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
238276 A-kinase anchor protein 5 87,37
229949 Adenylate kinase
isoenzyme 5
290,01
18573 Calcium/calmodulin-
dependent 3’,5’-cyclic
nucleotide
phosphodiesterase 1A
36
18574 Calcium/calmodulin-
dependent 3’,5’-cyclic
nucleotide
phosphodiesterase 1B
123,17 148,68
18747 Calcium/calmodulin-
dependent protein kinase
kinase 1
96,79
12322 Calcium/calmodulin-
dependent protein kinase
type II subunit alpha
933,49 1487,90
108058 Calcium/calmodulin-
dependent protein kinase
type II subunit delta
502,37 762,84
12301 Calcyclin-binding protein 91,28
18749 cAMP-dependent protein
kinase catalytic subunit
beta
99,39
19084 cAMP-dependent protein
kinase type I-alpha
regulatory subunit
104,44
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19088 cAMP-dependent protein
kinase type II-beta
regulatory subunit
91,54 270,09
12995 Casein kinase II subunit
alpha
586,92 91,15 308,31 1081,31 113,12 746,57
13001 Casein kinase II subunit
beta
140,63
13480 Dolichol-phosphate
mannosyltransferase
109,84
26398 Dual specificity
mitogen-activated protein
kinase kinase 4
75,00
14555 Glycerol-3-phosphate
dehydrogenase [NAD(+)],
cytoplasmic
130,70 189,23
333433 Glycerol-3-phosphate
dehydrogenase 1-like
protein
136,95 205,04
238024 Ketosamine-3-kinase 59,83
229791 Lipid phosphate
phosphatase-related
protein type 4
150,27
228355 MAP kinase-activating
death domain protein
283,39 209,66
26419 Mitogen-activated protein
kinase 8
42,74
117150 Phosphatidylinositol
5-phosphate 4-kinase
type-2 gamma
62,64 32,85
18655 Phosphoglycerate kinase
1
455,30
23969 Protein kinase C and
casein kinase substrate in
neurons protein 1
153,75 95,32
18751 Protein kinase C beta
type
94,12 634,50
5582 Protein kinase C gamma
type
353,28 660,07
320472 Protein phosphatase 1E 150,97 428,78
14208 Protein phosphatase 1G 47,36
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18746 Pyruvate kinase isozymes
M1/M2
290,57 1004,45
19280 Receptor-type
tyrosine-protein
phosphatase S
95,80
106504 Serine/threonine-protein
kinase 38
987,02 1766,14
381979 Serine/threonine-protein
kinase BRSK1
64,76
13175 Serine/threonine-protein
kinase DCLK1
95,51
70762 Serine/threonine-protein
kinase DCLK2
44,45
51792 Serine/threonine-protein
phosphatase 2A 65 kDa
regulatory subunit A
alpha isoform
575,74 924,47 113,82
19053 Serine/threonine-protein
phosphatase 2A catalytic
subunit beta isoform
153,71 151,00 161,99
19055 Serine/threonine-protein
phosphatase 2B catalytic
subunit alpha isoform
379,51 2224,80 659,75 506,30
72542 Serine/threonine-protein
phosphatase PGAM5,
mitochondrial
106,34 123,22
19046 Serine/threonine-protein
phosphatase PP1-beta
catalytic subunit
121,99
19047 Serine/threonine-protein
phosphatase PP1-gamma
catalytic subunit
88,99
14360 Tyrosine-protein kinase
Fyn
80,29 140,51
intracellular protein and membrane traffic
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
54401 14-3-3 protein beta/alpha 1071,89 649,95
22627 14-3-3 protein epsilon 2280,82 5240,19 1808,00 1611,89 1313,74 780,57
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22629 14-3-3 protein eta 1171,41 669,69
22628 14-3-3 protein gamma 2960,23 1866,78 1780,81 1145,57
22630 14-3-3 protein theta 1168,40 858,59 687,47 258,63
22631 14-3-3 protein zeta/delta 2285,80 1351,08 1384,78 773,58
15108 3-hydroxyacyl-CoA
dehydrogenase type-2
175,68
11842 ADP-ribosylation factor 3 59,30
108124 Alpha-soluble NSF
attachment protein
263,66 149,06
11764 AP-1 complex subunit
beta-1
278,19
232910 AP-2 complex subunit
sigma
44,42
64933 AP-3 complex subunit
mu-2
360,70 85,32
11777 AP-3 complex subunit
sigma-1
96,17
269774 AP2-associated protein
kinase 1
91,64
216963 ARF GTPase-activating
protein GIT1
89,22
17957 Beta-soluble NSF
attachment protein
491,49 153,27
235604 CaM kinase-like
vesicle-associated protein
143,26 360,25 147,37
13016 C-terminal-binding
protein 1
88,40
65945 Calsyntenin-1 69,54
232370 Calsyntenin-3 80,09
12757 Clathrin light chain A 49,94
213827 Coatomer subunit delta 101,22 87,16
235661 Cytoplasmic dynein 1
light intermediate chain 1
185,14
234663 Cytoplasmic dynein 1
light intermediate chain 2
75,90
11258 Dynactin subunit 3 70,42
108123 Gamma-soluble NSF
attachment protein
130,70 90,42 94,91
23897 HCLS1-associated protein
X-1
181,95 215,51
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232227 IQ motif and SEC7
domain-containing
protein 1
130,49
16560 Kinesin-like protein
KIF1A
147,30 196,99
16564 Kinesin-like protein
KIF21A
126,94 155,83 158,97
18039 Neurofilament light
polypeptide
206,39
234267 Neuronal membrane
glycoprotein M6-a
98,22 346,86
2824 Neuronal membrane
glycoprotein M6-b
65,84 209,30
22343 Protein lin-7 homolog C 154,33 114,80
69162 Protein transport protein
Sec31A
42,49
14569 Rab GDP dissociation
inhibitor beta
248,07
52055 Rab11 family-interacting
protein 5
351,37
226407 Rab3 GTPase-activating
protein catalytic subunit
48,37 90,65
19894 Rabphilin-3A 107,11 245,26
19353 Ras-related C3 botulinum
toxin substrate 1
146,43
19325 Ras-related protein
Rab-10
153,05
68365 Ras-related protein
Rab-14
110,46
104886 Ras-related protein
Rab-15
49,64
19339 Ras-related protein
Rab-3A
279,63
67295 Ras-related protein
Rab-3C
225,95
271457 Ras-related protein
Rab-5A
60,03
19346 Ras-related protein
Rab-6A
140,95 105,44
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19418 Ras-specific guanine
nucleotide-releasing
factor 2
73,42
19415 RasGAP-activating-like
protein 1
51,43
11852 Rho-related GTP-binding
protein RhoB
33,42
9522 Secretory
carrier-associated
membrane protein 1
116,51
73094 SH3-containing
GRB2-like protein
3-interacting protein 1
76,74 76,77
20661 Sortilin 87,03
69150 Sorting nexin-4 114,46 110,43
27096 Trafficking protein
particle complex subunit
3
64,01
65114 Vacuolar protein
sorting-associated protein
35
132,72
18195 Vesicle-fusing ATPase 2647,27 4638,43
40919 Vesicular glutamate
transporter 2
1203,59 2237,58
proteasome proteins
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
5700 26S protease regulatory
subunit 4
77,20 152,17
23996 26S protease regulatory
subunit 6B
188,65 273,25
19181 26S protease regulatory
subunit 7
182,60
19184 26S protease regulatory
subunit 8
156,20 414,02
69077 26S proteasome
non-ATPase regulatory
subunit 11
232,54 605,98
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66997 26S proteasome
non-ATPase regulatory
subunit 12
170,63
10213 26S proteasome
non-ATPase regulatory
subunit 14
175,32 87,11 354,03 107,40
57296 26S proteasome
non-ATPase regulatory
subunit 8
70,59
69597 AFG3-like protein 2 66,86
209318 COP9 signalosome
complex subunit 1
141,74 86,01
26891 COP9 signalosome
complex subunit 4
251,40
59026 E3 ubiquitin-protein
ligase HUWE1
112,98
56736 E3 ubiquitin-protein
ligase RNF14
124,41
20821 E3 ubiquitin-protein
ligase TRIM21
34,83 202,33
69807 E3 ubiquitin-protein
ligase TRIM32
124,41
67059 Obg-like ATPase 1 142,17
22284 Probable ubiquitin
carboxyl-terminal
hydrolase FAF-X
66,33 66,33 114,90 114,90
26440 Proteasome subunit alpha
type-1
84,39 171,87
19167 Proteasome subunit alpha
type-3
103,49 114,83
26442 Proteasome subunit alpha
type-5
113,55
26444 Proteasome subunit alpha
type-7
75,81
14467 Protein NipSnap homolog
2
42,30 64,12
22225 Ubiquitin
carboxyl-terminal
hydrolase 5
254,19
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22223 Ubiquitin
carboxyl-terminal
hydrolase isozyme L1
142,26
107260 Ubiquitin thioesterase
OTUB1
100,41 39,39
217342 Ubiquitin-conjugating
enzyme E2 O
135,46 135,46 159,10 159,10
66589 Ubiquitin-conjugating
enzyme E2 variant 1
118,83
synaptic proteins /synaptic vesicle release /synaptogenesis
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
12331 Adenylyl
cyclase-associated protein
1
268,60
12891 Copine-6 120,54
13383 Disks large homolog 1 47,76
20404 Endophilin-A1 160,52
13838 Ephrin type-A receptor 4 140,80
26556 Homer protein homolog 1 105,17
330814 Latrophilin-1 149,34
116838 Regulating synaptic
membrane exocytosis
protein 2
3400,23 2726,31
20965 Synapsin-2 428,38 1070,95
27204 Synapsin-3 99,89
26949 Synaptic vesicle
membrane protein VAT-1
homolog
84,64
20972 Synaptogyrin-1 127,31 115,39
67826 Synaptosomal-associated
protein 47
76,83
20979 Synaptotagmin-1 538,98 1491,77
20980 Synaptotagmin-2 374,07
20910 Syntaxin-binding protein
1
531,70 2063,49
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30960 Vesicle-associated
membrane
protein-associated protein
A
37,57
22318 Vesicle-associated
membrane protein 2
349,20
channel proteins
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
239217 BTB/POZ
domain-containing
protein KCTD12
33,35 85,06
14609 Gap junction alpha-1
protein
123,65 104,77
234267 Neuronal membrane
glycoprotein M6-a
312,28 206,72
12298 Voltage-dependent L-type
calcium channel subunit
beta-4
145,59 85,91
adhesion molecules
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
94332 Cell adhesion molecule 3 43,35
53321 Contactin-associated
protein 1
109,36
13510 Desmoglein-1-alpha 147,97
109620 Desmoplakin 599,42
16480 Junction plakoglobin 740,23 117,15
17967 Neural cell adhesion
molecule 1
665,27 173,09
64652 Nischarin 192,51
18772 Plakophilin-1 634,05
243743 Plexin-A4 49,28
70549 Talin-2 258,14
calcium binding proteins
gene
ID
identified protein RIM3γ
WB
RIM3γ
SS
CL114
RIM3γ
SS
TX100
RIM4γ
WB
RIM4γ
SS
CL114
RIM4γ
SS
TX100
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12317 Calreticulin 169,45 1034,43
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8.5 Table 8.4: Proteins identified in all screens
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
phosphatase / kinase
protein family: Cyclin dependent kinases
983 Cyclin dependent kinase 1 experiment 1: whole brain experiment : whole brain
69131 Cyclin-dependent kinase 12 experiment 2: synaptosome
CL-114
18555 Cyclin-dependent kinase 16 experiment 2: synaptosome
CL-114
214444 CDK5 regulatory
subunit-associated protein 2
experiment 2: synaptosome
CL-114
12568 Cyclin-dependent kinase 5 experiment 3: whole brain,
synaptosome CL-114
experiment1 : whole brain
protein family: calcium calmodulin dependent kinases
8573 Calcium/calmodulin dependent
serine protein kinase (MAGUK
family)
experiment 1: whole brain experiment1 : whole brain
18747 Calcium/calmodulin-dependent
protein kinase kinase 1
experiment 3: whole brain
12322 Calcium/calmodulin-dependent
protein kinase type II subunit
alpha
experiment 3: whole brain
108058 Calcium/calmodulin-dependent
protein kinase type II subunit
delta
experiment 3: whole brain,
synaptosome TX-100
cytoskeletal proteins/ cytoskeleton associated proteins
protein family: IQGAP
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
128239 IQ motif containing GTPase
activating protein 3 (IQGAP3)
experiment 1: whole brain experiment : whole brain
10788 Ras GTPase-activating-like
protein IQGAP2
experiment 2: synaptosome
CL-114
mTOR complex
253260 RPTOR independent
companion of MTOR, complex
2
experiment 1: whole brain experiment1 : whole brain
78757 Rapamycin-insensitive
companion of mTOR
experiment 2: synaptosome
CL-114
CHAPTER 8. APPENDIX 139
CDC42 effector proteins
11135 CDC42 effector protein (RhO
GTPase binding) 1
experiment 1: whole brain
58804 Cdc42 effector protein 5 experiment 2: synaptosome
CL-114
protein family: Fascin
56223 Fascin-3 experiment 2: synaptosome
CL-114
14086 Fascin experiment 3: whole brain
microtubule associated proteins
55700 MAP7 domain containing 1 experiment 1: whole brain experiment1 : whole brain
79649 MAP7 domain containing 3 experiment 1: whole brain experiment1 : whole brain
17761 Ensconsin (MAP7) experiment 2: synaptosome
CL-114
232944 MAP/microtubule
affinity-regulating kinase 4
experiment 2: synaptosome
CL-114
270058 Microtubule-associated protein
1S
experiment 2: synaptosome
CL-114
experiment 2: synaptosome
CL-114
208158 MAP6 domain-containing
protein 1
experiment 3: whole brain experiment 3: whole brain
17760 Microtubule-associated protein
6
experiment 3: whole brain experiment 3: whole brain
13589 Microtubule-associated protein
RP/EB family member 1
experiment 3: whole brain
212307 Microtubule-associated protein
RP/EB family member 2
experiment 3: whole brain
100732 Microtubule-associated protein
RP/EB family member 3
experiment 3: synaptosome
CL-114
intracellular protein and vesicle traffic
Kinesins
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
9928 Kinesin family member 14 experiment 1: whole brain experiment1 : whole brain
16560 Kinesin-like protein KIF1A experiment 3: whole brain experiment3 : whole brain
16564 Kinesin-like protein KIF21A experiment 3: whole brain,
synaptosome TX-100
experiment3 : whole brain
IQ motif and SEC7 domain-containing protein 1
232227 IQ motif and SEC7
domain-containing protein 1
experiment 1: whole brain experiment1 : whole brain
experiment 3: synaptosome
TX-100
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Exocyst complex
55763 Exocyst complex component 1 experiment 1: whole brain experiment1 : whole brain
60412 Exocyst complex component 4 experiment 1: whole brain experiment1 : whole brain
211446 Exocyst complex component 3
(Sec 6)
experiment 2: synaptosome
CL-114
ARF GTPas activating protein GIT1
216963 ARF GTPase-activating
protein GIT1
experiment 2: synaptosome
CL-114
experiment 3: synaptosome
TX-100
Rab protein family and Rab related proteins
98732 Rab3 GTPase-activating
protein non-catalytic subunit
experiment 2: synaptosome
CL-114
experiment 2: synaptosome
CL-114
268451 Rab11 family-interacting
protein 4
experiment 2: synaptosome
CL-114
19894 Rabphilin-3A experiment 2: synaptosome
CL-114
experiment 3: whole brain
experiment 3: whole brain
104886 Ras-related protein Rab-15 experiment 2: synaptosome
CL-114
experiment 2: synaptosome
CL-114
experiment 3: synaptosome
CL-114
19338 Ras-related protein Rab-33B experiment 2: synaptosome
CL-114
270160 Ras-related protein Rab-39A experiment 2: synaptosome
CL-114
experiment 2: synaptosome
CL-114
67295 Ras-related protein Rab-3C experiment 2: synaptosome
CL-114
experiment 3: synaptosome
CL-114
19341 Ras-related protein Rab-4A experiment 2: synaptosome
CL-114
19346 Ras-related protein Rab-6A experiment 3: synaptosome
CL-114
14569 Rab GDP dissociation inhibitor
beta
experiment 3: synaptosome
CL-114
52055 Rab11 family-interacting
protein 5
experiment 3: whole brain
226407 Rab3 GTPase-activating
protein catalytic subunit
experiment 3: whole brain experiment 3: whole brain
19325 Ras-related protein Rab-10 experiment 3: synaptosome
TX-100
experiment 3: whole brain
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68365 Ras-related protein Rab-14 experiment 3: synaptosome
CL-114
19339 Ras-related protein Rab-3A experiment 3: whole brain experiment 3: whole brain
271457 Ras-related protein Rab-5A experiment 3: synaptosome
CL-114
AP-1 adaptor complex / AP-2 adaptor complex / AP-3 adaptor complex
11764 AP-1 complex subunit beta-1 experiment 2: synaptosome
CL-114
experiment 3: synaptosome
TX-100
232910 AP-2 complex subunit sigma experiment 3: synaptosome
TX-100
64933 AP-3 complex subunit mu-2 experiment 3: whole brain
11777 AP-3 complex subunit sigma-1 experiment 3: whole brain
Trafficking particle complex subunit 3
27096 Trafficking protein particle
complex subunit 3
experiment 2: synaptosome
CL-114
experiment 3: whole brain
adhesion molecules
armadillo repeat proteins
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
1495 Catenin (cadherin-associated
protein), alpha 1, 102kDa
experiment 1: whole brain experiment 1: whole brain
1500 Catenin (cadherin-associated
protein), delta 1
experiment 1: whole brain experiment 1: whole brain
1829 Desmoglein 2 experiment 1: whole brain
5318 Plakophilin 2 experiment 1: whole brain
8502 Plakophilin 4 experiment 1: whole brain experiment 1: whole brain
13510 Desmoglein-1-alpha experiment 3: synaptosome
CL-114
18772 Plakophilin-1 experiment 3: synaptosome
CL-114
neural cell adhesion molecule 1
17967 Neural cell adhesion molecule 1 experiment 2: synaptosome
CL-114
experiment 3: synaptosome
TX-100
contactin associated protein 1
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53321 Contactin-associated protein 1 experiment 3: whole brain experiment 2: synaptosome
TX-100
experiment 3: whole brain,
synatosome CL-114
synaptic proteins
synatxins
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
6804 Syntaxin-1A experiment 2: synaptosome
CL-114
55014 Syntaxin 17 experiment 1: whole brain
20910 Syntaxin-binding protein 1 experiment 3: whole brain experiment 3: whole brain
protein family: RIM
116837 Regulating synaptic membrane
exocytosis protein 1
experiment 2: synaptosome
CL-114
experiment 2: synaptosome
TX-100
116838 Regulating synaptic membrane
exocytosis protein 2
experiment 3: whole brain,
synaptosome TX-100
Copines
234577 Copine-2 experiment 2: synaptosome
CL-114
12891 Copine-6 experiment 3: whole brain
Ephrin receptors
13838 Ephrin type-A receptor 8 experiment 2: synaptosome
TX-100
13838 Ephrin type-A receptor 4 experiment 3: synaptosome
TX-100
Synaptosomal associated proteins
20614 Synaptosomal-associated
protein 25
experiment 2: synaptosome
CL-114
116841 Synaptosomal-associated
protein, 47kDa
experiment 3: whole brain
Synaptogyrins1
9145 Synaptogyrin-1 experiment 2: synaptosome
CL-114
experiment 3: whole brain
experiment 3: whole brain
Synaptotagmins
27359 Synaptotagmin-like protein 4 experiment 2: synaptosome
CL-114
20979 Synaptotagmin-1 experiment 3:whole brain experiment 3:whole brain
Synapsins
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20965 Synapsin-2 experiment 3: whole brain experiment 3: whole brain
27204 Synapsin-3 experiment 3: synaptosome
TX-100
experiment 2: synaptosome
CL-114
channel proteins
voltage dependent anion channels
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
7417 Voltage dependent anion
channel 2
experiment 1: whole brain experiment 1: whole brain
729317 Voltage dependent anion
channel 2 pseudogene
experiment 1: whole brain experiment 1: whole brain
22333 Voltage-dependent
anion-selective channel protein
1
experiment 2: synaptosome
CL-114
22335 Voltage-dependent
anion-selective channel protein
3
experiment 2: synaptosome
CL-114
nuclear proteins
Importins
gene
ID
identified protein screen ident. prot X as
RIM3γ binding protein
screen ident. prot X as
RIM4γ binding protein
79711 Importin 4 experiment 1: whole brain
3843 Importin 5 experiment 1: whole brain
experiment 3: whole brain
10526 Importin 8 experiment 1: whole brain
76582 Importin-11 experiment 2: synaptosome
CL-114
16650 Importin subunit alpha-7 experiment 3: whole brain,
synaptosome CL-114
Ca2+ binding proteins
Reticulocalbins
5954 Reticulocalbin 1, EF-hand
calcium binding domain
experiment 1: whole brain
5955 Reticulocalbin 2, EF-hand
calcium binding domain
experiment 2: synaptosome
CL-114
experiment 1: whole brain
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8.6 Supplementary figures
Figure 8.1: Peptide block reveals specificity of polyclonal RIM3γ and RIM4γ antibodies. A, Western
blots of HEK293T cell lysates overexpressing RIM3γ, whole brain lysates and lysates of only the cerebellum,
olfactory bulb and cortex were stained with polyclonal RIM3γ antibodies, revealing a RIM3γ specific band at
35 kDa. When western blots of the same lysates were incubated with polyclonal RIM3γ antibodies that were
preincubated with RIM3γ-GST coupled to agarose beads the RIM3γ specific band was strongly reduced. B,
Western blots of HEK293T cell lysates overexpressing RIM4γ and tissues lysates as described in A, were incubated
with polyclonal RIM4γ antibodies revealing a RIM4γ specific band at 30 kDa. However a preincubation of RIM4γ
antibodies with RIM4γ-GST coupled to agarose abolished the RIM4γ specific band.
9 Abbreviations
AAV Adeno-associated virus
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ANOVA Analysis of variance
ARVCF Armadillo repeat gene deleted in Velo-Cardio-Facial syndrome
AZ Active zone
BICDR Bicaudal-D related protein
BL6 J mice Black six J mice
BME Basal Medium Eagle
bp Base pair
BSA Bovine serum albumin
C. elegans Caenorhabditis elegans
CA Cornu amonis
Cacna1a Calcium channel a1a subunit gene
CAMK Ca2+/calmodulin-dependent protein kinase
CDC42 Cell division control protein 42 homolog
CdH1-APC Cdh1-anaphase promoting complex
CDK5 Cyclin dependent kinase 5
cDNA Complementary DNA
CLASP Cytoplasmic linker associated protein
CLIP Cytoplasmic linker protein
CMV Cytomegalie virus
Co-IP Co-immunoprecipitation
ConstKO Constitutive knock-out
cortico-LA Lateral nucleus of the amygdala
CRM1 Chromosome region maintenance 1
ct Cycle threshold
Cy Cyanine dye
DEPC Diethylpyrocarbonate
DG Dentate Gyrus
DIV Day in vitro
DMEM Dulbecco’s Modified Eagle’s Medium
DNA Desoxyribonucleic acid
E Embryonic day
EDTA Ethylenediaminetetraacetic acid
EphB2 receptor Ephrin type-B receptor 2
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ER Endoplasmic reticulum
FBS Fetal bovine serum
FCS Fetal calf serum
FITC Fluorescein isothiocyanate
FOX Forkhead-Box-Proteine
Fw Forward
GAPs GTPase activating proteins
GDP Guanosindiphosphat
GEF Guanine exchange factors
GFP Green fluorescent protein
GM130 Golgi matrix protein 130
GRD Calcium/calmodulin and a Ras-GAP related domain
GRIP Glutamate receptor-interacting protein
GST Glutathione-S-transferase
GTP Guanosintriphosphat
h Hour
HA Human influenza hemagglutinin
HAT Sodium hypoxanthine, aminopterin, thymidine
HBSS Hank’s Buffered Salt Solution
HCL Hydrochloride
HEK cells Human embryonic kidney cells
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
het Heterozygous
HIV Human immunodeficiency virus
HLP Hind limb impairments
ID2 DNA-binding protein inhibitor 2
Ig Immune globulin
IMDM Iscove’s Modified Dulbecco’s Medium
IPTG Isopropyl b-D-1-thiogalactopyranoside
IQGAP IQ-motif GTPase-activating protein 1
kb Kilobase pair
kg Kilogram
KO knock-out
KOMP Knock-out Mouse Project
LAR Leukocyte commonantigen-related
LAR-RPTPs LAR-receptor protein tyrosine phosphatases
LB Luria Broth
LC-MS/MS Liquid chromatography–mass spectrometry/mass spectrometry
LMTK1 Lemur kinase 1
LTP Long-term plasticity
M Molar
MAGUK Membrane-associated guanylate kinase
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MAP Microtubule associated protein
mDia Mammalian diaphanous
MEM Minimum essential medium
mg Milligramm
min Minutes
ml Milliliter
mM Millimolar
mm Millimeter
mRNA Messenger RNA
Munc-13 Mammalian Unc-13 homolog
NA Numerical aperture
NBQX 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo-[f]-quinoxalin-7-sulfonamide
NES Nuclear export signal
NeuroD Neurogenic differentiation 1
NG108-15 Neuroblastoma glioma cell line 108-15
NLS Nuclear localization signal
nM Nanomolar
nm Nanometer
NPRAP Neural plakophilin-related armadillo protein
OD Optical density
OE Overexpression
P Postnatal day
PAK p21-activated kinase
PBS Phosphate buffered saline
PCR Polymerase chain reaction
PDZ-domain Post synaptic density protein-Drosophila disc large tumor
suppressor-zonula occludens-1-domain
PEI Polyethylenimine
pen/strep Penicillin/streptomycin
PFA Paraformaldehyde
Pfu Pyrococcus furiosus
PI Propidium iodide
PKA Protein kinase A
PSD Postsynaptic density
PSM Peptide spectrum matches
qPCR Quantitative PCR
Rab Ras-related in brain
Rac1 Ras-related C3 botulinum toxin substrate 1
Rev Reverse
RFP Red fluorescent protein
Rho Ras homolog
RhoA Ras homolog gene family, member A
CHAPTER 9. ABBREVIATIONS 148
RIMs Rab3-interacting molecules
RNA Ribonucleic acid
ROCK Rho-associated protein kinase
RPM Rounds per minute
SDS Sodium dodecyl sulfate
SDS PAGE SDS polyacryalmid gel electrophoresis
SE Status epilepticus
sec Second
SEM Standard error of mean
SF-TAP Streptavidin/FLAG-tandem affinity purification
SH3-domain Src-homology 3-domain
shRNA Small hairpin RNA
SNAP25 Synaptosomal-associated protein 25
SNARE Soluble N-ethylmaleimide-sensitive-factor attachment receptor
SYD Synapse defective
SYN Synapsin
TAP Tandem affinity purification
TBS Tris-buffered saline
TBST Tris-buffered saline and Tween 20
TEMED Tetramethylethylenediamine
TGN Trans-Golgi-network
TIPs Microtubule plus end tracking proteins
TX-100 Triton X-100
VSV-G Vesicular stomatitis virus
WAVE Wiskott–Aldrich syndrome protein
WB Western blot
μl Microliter
μm Micrometer
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